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Abstract
The reported depletion of the stratospheric ozone layer, which serves as a protective
shield against ultraviolet B (UVB) light reaching the Earth's surface, has focussed
much attention on the harmful effects of UV radiation. Exposure to UVB radiation
induces both local and systemic immunosuppression. Whether this modulation in
immunity may lead to a decreased resistance to systemic, as well as to cutaneous
infections, and ultimately to an increased incidence and/or severity of infectious
diseases remains unknown.
The contact hypersensitivity (CH) response is a commonly used model of cutaneous
immunity, in particular to explore the integrity of the cutaneous immune response
following UVB exposure. Irradiation of mice prior to sensitisation is known to result
in suppression of the induction phase of CH. Studying the effects of UVR on the
elicitation phase of CH would appear to better represent the natural sequence of
events in human contact sensitisation than traditional experiments. A mouse model
of CH, using oxazolone as the contact sensitiser, was tested and the results provided
limited evidence to support the previously reported enhancement of CH by exposure
of mice to UVB prior to challenge.
Murine herpesvirus-68 (MHV-68) is a natural pathogen of mice which causes an
acute lung infection and subsequently establishes latency in B lymphocytes of the
spleen. A protocol was established for the induction and elicitation of a DTH
response to MHV-68 in C3H/HeN mice. Exposure of mice to a single suberythemal
dose of UVB (96mJ/cm2) mree days prior to sensitisation resulted in a suppression
of the DTH response (by approximately 40%) upon ear challenge. This suppression
was specific for MHV-68 and was long-lasting (tested up to one month). UVB
exposure also suppressed the elicitation phase of DTH in mice infected several days
before UVB exposure and in latently infected mice. Preliminary data suggest that
x
exposure of mice to suberythemal UVB has no effect on the replication of MHV-68
in the lungs following primary infection and did not reactivate latent virus.
While the systemic immune responses generated in herpes simplex virus type 1
(HSV-1) infections have been well documented, little is known about the cytokines
induced locally in the epidermis in response to the virus. These may be critical in
determining the outcome of the infection and the subsequent interaction of the virus
with the host during latency and recrudescence. Cytokine mRNA profiles in both an
in vitro and an in vivo model of HSV infection were studied. A mouse keratinocyte
cell line (PAM-212) and mouse back skin were infected with HSV-1 and RNA was
extracted at various times thereafter from lysed cells or skin homogenates.
Interleukin-1 (IL-1), IL-10 and tumour necrosis factor-a (TNF-a) mRNAs were
assayed by semi-quantitative RT-PCR, with normalisation relative to (3-actin mRNA
signals. Most notably, the expression of IL-10 mRNA in vitro peaked at 12 hours
post-infection, and an increase in mRNA expression in the skin was seen from 96
hours post-infection. This would suggest that HSV-1 is inducing keratinocytes in the
epidermis to produce IL-10 and this may represent a possible immune evasion
strategy of HSV-1 by diverting the immune response away from a Thl type
response, known to be effective for viral clearance. UVB exposure of PAM-212
cells induced IL-10 mRNA by 24 hours. The effect of UVB exposure on the
synthesis of IL-10 mRNA by HSV-infected PAM-212 cells was also examined.
To study the effects of UVB exposure on the functional activity of human epidermal
cells (EC) to act as antigen presenting cells, the mixed skin lymphocyte reaction
(MSLR) was used. EC were obtained from suction blister roofs of volunteers. In
vitro irradiation of EC appeared to suppress the MSLR to near background levels. In
vivo irradiation of subjects with 0.5 minimal erythemal dose (MED) for seven days
on the subsequent skin blister site, also caused some suppression of the MSLR.
Urocanic acid (UCA) has been proposed as a photoreceptor for UV radiation and cis-
xi
UCA mimics some of the effects of UVB on the immune system. Treatment of EC
with cA-UCA in vitro caused suppression of the MSLR by an average of 71%.
Normal subjects, known to be seropositive for HSV, underwent a standard course of
broadband UVB phototherapy, as used in the treatment of psoriasis. They received
whole body irradiation three times a week, with incremental doses depending on skin
type. Blood samples were taken before the start of treatment, after one week and
after four weeks. The ability of these individuals to mount an HSV-specific
cytotoxic T cell response was examined, using autologous B cell lines (prepared by
infection with Epstein-Barr virus), infected with HSV-1 as targets. The cytotoxic
response was not altered in all four subjects examined to date. However, the natural
killer cell activity was suppressed within the first week of phototherapy, further
suppressed at four weeks, but returned to the pre-irradiation value within a week
after the final UVB exposure .
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1.1 Skin Immune system
1.1.1 The concept of skin-associated lymphoid tissue
The skin is the largest organ of the body. It is in continual contact with the external
environment and therefore, in addition to its roles in controlling water loss, and in
temperature regulation, it encounters a wide range of potentially damaging factors such as
ultraviolet radiation (UVR), chemicals and microorganisms. An extensive immune system
is known to exist within the skin and this responds to a variety of stimuli including the
presence of malignancies or microorganisms in the cutaneous microenvironment and
exposure to certain chemicals. A comprehensive model for this skin immune system,
known as skin-associated lymphoid tissue (SALT), has been proposed involving a
network of antigen-presenting cells and cytokine-producing keratinocytes, poised to
encounter foreign substances within the cutaneous compartment and then engage more
central components of the immune system to provide specific immunity (Bos and
Kapsenberg, 1986; Bos and Kapsenberg, 1993; Streilein, 1978; Streilein, 1991). SALT
therefore provides the skin with the ability to detect and eliminate both neoplastic cells and
exogenous pathogens. A schematic representation of the skin immune system , during the
course of a cutaneous immune response is shown in Figure 1.1.
1.1.2 Langerhans' cells
Langerhans' cells (LC) were first observed in 1868 and are now known to be the major
antigen-presenting cell of the skin (Langerhans, 1868). They are of bone-marrow origin
and are defined by their dendritic morphology and possession of a unique intracytoplasmic
organelle called a Birbeck granule, the function of which remains unclear
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Figure 1.1 Schematic diagram of the skin immune system during















Langerhans cells (LC^) reside in the epidermis where they take up and process
foreign antigen (• )(1). Antigen-loaded LC then migrate via the lymphatic vessels
(2) to the draining lymph node, where antigen presentation to CD4+ T cells (©)
takes place in the paracortical (shaded) atea (3). Antigen-specific T cells then
leave the lymph node through the efferent lymphatic vessel, enter the bloodstream
through the thoracic duct and migrate via the blood (4) to the site of antigen
invasion. The T cells extravasate through high endothelial venules (5) and
participate in the immune response to eliminate the antigen (6). Keratinocytes (CD),
once activated, are able to secrete immunomodulatory cytokines and affect the
immune response. Adapted from Henry & Tschachler (1996).
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(Birbeck et al., 1961). They are also distinguished by phenotype, being major
histocompatability complex (MHC) class II+, CD45+, Thy-1", CD3~, CD1 lb+ and they
possess Fc receptors for IgG and IgE. Langerhans cells were first thought to be involved
in cutaneous immunity when studies of contact hypersensitivity responses, in which
haptens were applied through sites naturally deficient in LC, such as mouse tail skin and
hamster cheek pouch epithelium, revealed that specific unresponsiveness to the applied
hapten occurred upon challenge (Bergstresser et al., 1980; Streilein and Bergstresser,
1981; Toews et al., 1980). The phenotype, function and role of LC in cutaneous
immunity are discussed further in section 1.2 and in detail elsewhere (Lappin et al.,
1996b; Teunissen et al., 1997a).
1.1.3 Dendritic cells other than Langerhans cells
Dermal dendritic cells (DC) comprise a mixed group of cells. Several populations of
MHC class II+ cells have been described in both murine and human skin, defined
according to their phenotypes and it remains to be shown whether these cells represent
separate antigen-presenting cell populations or migratory populations of DC trafficking to
or from the epidermis (reviewed in Lappin et al., 1996b). In human skin, dermal
dendrocytes are factor XIII+. This factor is involved in scab formation by the cross-
linking of fibrin with structural proteins and therefore dermal dendrocytes may be
important in wound healing. It has also been suggested that these cells are immature
precursors of LC. The DC of the skin, as well as CDlb+ macrophages, have been
extensively reviewed elsewhere (Rowden, 1997).
1.1.4 Lymphocytes
Dendritic epidermal T cells (DETC) comprise between 0.8% to 2% of murine epidermal
cells (Bergstresser et al., 1993; Tigelaar et al., 1990). They reside in the basal layer of the
epidermis and express Thy-1 cell surface glycoprotein, CD3 and CD45, but lack class II
MHC antigen (Bergstresser et al., 1983; Tschachler et al., 1983). The T cell lineage of
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these cells is confirmed by evidence that the numbers of DETC are significantly reduced in
athymic nude mice (Bergstresser et al., 1983; Tschachler et al., 1983). DETC do not
express CD4 or CD8 and the CD3 antigen is predominantly associated with T cell receptor
(TCR) y/5 heterodimers. These cells do not participate in the recirculation pathways
described for a/(3 T lymphocytes (see below). Their specific function remains unclear but
it has been suggested that they are involved in the induction of tolerance (Welsh and
Kripke, 1990). It has recently been suggested that cytokines such as interleukin-2 (IL-2),
IL-7 and IL-15, secreted by neighbouring cells, promote the residence of DETC and
regulate their immune function (Takashima and Bergstresser, 1996). Conversely, DETC
are thought to regulate the function of neighbouring keratinocytes and LC by elaborating
other growth factors and cytokines. The molecular and cell biology of DETC has been
recently reviewed (Boismenu et al., 1996).
To date no human T cell population comparable to the DETC has been identified. Most T
cells of human skin reside in the dermis rather than the epidermis and predominantly
express TCR oc/(3 rather than y/8 (Bos et al., 1987; Foster et al., 1990). Intradermal T
cells consist of both CD4+ and CD8+ populations and are found clustered around
postcapillary venules and skin appendages (Bos et al., 1987). The vast majority of T cells
in human skin are CD45RO+, suggesting that they are memory cells (Foster et al., 1990).
1.1.4.1 T helper cell subsets
The division of T helper (Th) cells into Th type 1 (Thl) and Th type 2 (Th2) on the basis
of cytokine production profiles was originally described among mouse CD4+ T cell clones
(Mosmann et al., 1986) and has since been described in human T cells (Del Prete et al.,
1988), although the synthesis of certain cytokines is not as tightly restricted to a particular
subset in humans. Mouse Thl cells produce IL-2, interferon-y (IFN-y) and tumour
necrosis factor-(3 (TNF-(3), whereas Th2 cells produce IL-4, IL-5, IL-6 and IL-10. IL-3,
granulocyte-macrophage colony-stimulating factor (GM-CSF) and TNF-a are secreted by
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both Thl and Th2 clones. The existence of Thl and Th2 cytokine producing CD8+ T
cells is now recognised both in mice (Salgame et al., 1991) and in humans (Croft et al.,
1994). At present no definitive cell surface marker exists to allow separation of Thl and
Th2 cells, although they do exhibit preferential expression of some activation markers.
For example, CD30 is mainly expressed in Th2 and cytotoxic T cell clones, whereas
lymphocyte activation gene 3 (LAG-3) preferentially associates with Thl-like cells
(Romagnani, 1997). The cytokine profiles of these Th cell subsets correlate well with their
function. Thl cells are involved in cell-mediated responses such as delayed-type
hypersensitivity (DTH) and cytotoxic responses, while Th2 cytokines induce antibody
production, in particular IgE responses (Mosmann and Coffman, 1989).
Although many T cell clones and in vivo immune responses demonstrate a dramatic
dichotomy in cytokine secretion patterns, it is now clear that the situation is of greater
complexity than was first suggested. Other patterns of cytokine secretion are known to
exist, for example cells designated ThO, which secrete both Thl and Th2 cytokines, and
Th3 cells which produce large amounts of transforming growth factor-|3 (TGF-(3)
(Mosmann and Coffman, 1989; Romagnani, 1991; Romagnani, 1996). This subset
complexity may be due to quantitative differences in cytokine production at different
developmental stages, or due to the existence of a continuum of possible cytokine
secretion patterns with the Thl and Th2 profiles as the extreme situations.
It is currently thought that both Thl and Th2 cells derive from a common IL-2-producing
precursor cell and that differentiation may proceed through an intermediate state in which
multiple cytokines are expressed. Costimulatory molecules have also been suggested to
selectively influence differentiation and antibodies against B7-1 and B7-2 have been
shown to selectively inhibit the development of Thl and Th2 cells respectively
(Thompson, 1995), although the situation now appears to be more complex than this
simple relationship suggests. The process of differentiation is also believed to be
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controlled by cytokine secretion, probably by other cell types, such as macrophages and
natural killer (NK) cells, especially in a primary immune response during which antigen-
specific T cells will be present at low frequencies. For example, IL-4 is known to
stimulate Th2 cell differentiation while, IFN-y, IL-12 and TGF-(3 all enhance Thl cell
development (Muller et al., 1995; Seder and Paul, 1994).
Cross-regulation is known to occur between the two subsets, with cytokines from each
subset being inhibitory for the differentiation and effector function of the reciprocal
subset. For example, IFN-y selectively inhibits proliferation of Th2 cells and IL-10
inhibits Thl cell cytokine synthesis (Mosmann and Coffman, 1989). Therefore once
induced, the cytokines produced by each subset act to increase the number of effector cells
committed to that particular subset, while acting in an antagonistic manner towards the
induction of effector cells of the other Th subset.
1.1.4.2 Lymphocyte trafficking
Circulating skin-homing lymphocytes are crucial to the initiation and execution of
cutaneous immune responses. Intercellular adhesion molecules expressed on dermal
endothelial cells may mediate leucocyte adhesion, migration through vessel walls and
trafficking into the dermis. T lymphocytes can adhere to endothelial cells and to
keratinocytes specifically through lymphocyte function-associated antigen (LFA-1;
CD 11 a/CD 18) and intercellular adhesion molecule-1 (ICAM-1; CD54) binding.
Endothelial cells constitutively express low levels of ICAM-1 but can be induced to
express increased levels by IL-1, TNF-a and IFN-y (Detmar et al., 1992), as can
keratinocytes by TNF-a and IFN-y (Barker et al., 1990). Cutaneous lymphocyte-
associated antigen (CLA) is a carbohydrate epitope present on memory/effector T cells that
infiltrate inflammed skin. E-selectin (CD62E), formerly termed ELAM-1 (endothelial cell-
leucocyte adhesion molecule) is the ligand for CLA and is induced by inflammation on
endothelial cells. Memory, but not resting T cells adhere to E-selectin (Shimizu et al.,
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1991). This interaction may therefore also direct the movement of specific T lymphocytes
into the skin (Fresno et al., 1997; Picker et al., 1991). It has been suggested that CLA
has a homing function in directing the T cell to subsequently interact with LFA-l/ICAM-1
and/or very late antigen-4 (VLA-4)/vascular cell adhesion molecule-1 (VCAM-1), which
results in enhanced adhesion and migration across cytokine-activated endothelial cells
(Santamaria Babi et al., 1995). Recently it has been demonstrated that Thl but not Th2
cells are able to bind to E-selectin resulting in the selective recruitment of Thl cells into
inflammed skin, providing the first evidence of differential trafficking of these T helper
cell subsets (Austrup et al., 1997).
1.1.5 Keratinocytes
Keratinocytes comprise over 80% of epidermal cells, forming a stratified multilayered
epithelium. Keratinocytes adjacent to the basement membrane are predominantly rapidly
proliferating stem cells and, as they become committed to differentiation migrate through
the suprabasal layer towards the stratum corneum, losing their capacity to proliferate as
they do so. Terminally differentiated keratinocytes are shed from the stratum corneum as
dead cornified squames. It is now known that in addition to their structural role,
keratinocytes are immunologically active cells, being an important source of
immunomodulatory cytokines.
Before the ability of LC to process native antigen was recognised, it had been suggested
that keratinocytes were the source of processed antigen in the epidermis (Luger et al.,
1983; Streilein, 1991). It now seems unlikely that epidermal LC require such peptides,
but the knowledge that keratinocytes can be induced to express class II MHC molecules
by IFN-y (Basham et al., 1985; Nickoloff and Turka, 1994) and that they are able to
provide accessory cell function to T cells previously stimulated with superantigens or anti-
CD3 monoclonal antibody (Nickoloff and Turka, 1994), means that these cells are likely
to play an important role as antigen presenting cells in secondary, but not primary immune
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responses. The importance of keratinocytes as antigen-presenting cells stems from their
sheer number in the epidermis. They are likely to play a role in situations such as that
following UV exposure when LC are lost from the epithelium. The resulting environment
is one in which epithelial cells may predominate in the initial immune response.
Keratinocytes, when used as accessory cells, have been shown to induce T cells defective
in IFN-y production (Goodman et al., 1994). This lack of IFN-y production in
keratinocyte-supported cultures is thought to be due to the failure of keratinocytes to
produce IL-12 (Goodman et al., 1994; Nickoloff and Turka, 1994). In the skin, failure of
keratinocyte-supported responses to induce IFN-y in T cells, resulting in the generation of
Th2 cytokines, may play a role in the termination of cell-mediated immune responses such
as the challenge phase of contact hypersensitivity (Nickoloff and Turka, 1994).
Keratinocytes constitutively secrete, or can be induced to secrete, a large number of
cytokines that can affect the immune response, including both stimulatory and inhibitory
molecules. One of the first pro-inflammatory factors shown to be produced by
keratinocytes was originally described as epidermal thymocyte activating factor (ETAF)
(Luger et al., 1981), and is now known to be composed of a mixture of low molecular
weight cytokines, namely IL-1, IL-8 and TNF-a. Keratinocytes produce mRNA for IL-
la and IL-1 [3 but only IL-1a activity has been identified in culture. This is explained by
the fact that keratinocytes lack a specific protease necessary to cleave the biologically
inactive IL-1 (3 into the active form (Mizutani et al., 1991). In addition to pro-inflammatory
cytokines such as IL-1 and TNF-a, keratinocytes are also able to produce growth factors
for immunocompetent cells, chemoattractants, and also suppressive cytokines such as IL-
10, the production of which remains controversial in human keratinocytes but which has
been implicated in UV-induced immunosuppression (see section 1.5.3.2). The currently
available data about keratinocyte-derived cytokines are summarised in Table 1.1.
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1.1.6 Melanocytes
Melanocytes are neural crest-derived cells which are present in the basal layer of the
epidermis and their primary function appears to be protection of the host from the
detrimental effects of UV irradiation. This is mediated by the production and transfer of
melanin to keratinocytes. Melanocytes can respond to a number of cytokine-mediated
signals and once stimulated thay are able to secrete cytokines such as IL-la, IL-1(3,
TGF-(3 and IL-8 (reviewed in Armstrong and Ansel, 1994).
1.1.7 Mast cells
These bone-marrow-derived cells are located in the skin in the vicinity of blood vessels
but are rarely found in the epidermis. Mast cells store pre-formed enzymes,
glycosaminoglycans and mediators of inflammation such as TNF-a and histamine. They
secrete cytokines in a pattern similar to that of Th2 cells (see section 1.1.4.1), which
favour the induction of IgE-dependent immune processes, and express the high affinity
IgE receptor on their surface.
1.1.8 Humoral constituents of the skin immune system
In addition to the keratinocyte-derived cytokines previously discussed, other humoral
factors, particularly eicosanoids, are thought to play a role in cutaneous immune
responses. Eicosanoids are generated from arachidonic acid which is released from
membrane phospholipids, either directly by phospholipase A activity or indirectly by
phospholipase C. Arachidonic acid can then be metabolised either by the cyclooxygenase
pathway to give prostaglandins (PG) and thromboxanes, or by the lipoxygenase pathway
to give leukotrienes. Since the skin lacks the capacity to synthesise arachidonic acid, it
must obtain it from endogenous sources (Iversen and Kragballe, 1997). The leukotriene
LTB4, prostaglandin PGE2 and 12-HETE (12-hydroxyeicosatetraenoic acid) have all
been demonstrated to have proinflammatory activity (Iversen and Kragballe, 1997) and in
general all appear to modulate inflammatory response by potentiating the effects of other
mediators.
12
Histamine is another important inflammatory mediator. It is involved physiologically in
such processes as allergic responses, vasoconstriction and vasodilation but is also
important in immunoregulation. Histamine influences the cytokine network, both by
acting as a modulator of certain cytokine-receptor interactions and by being released as a
target of cytokine action (Falus and Meretey, 1992). Large amounts of histamine are
stored in mast cells located in the superficial dermis of the skin and are released upon
appropriate stimulation (Benyon, 1989). However, human epidermal cell cultures have
also been shown to produce significant amounts of histamine (Malaviya et al., 1996). It
was found that approximately 40% of subjects demonstrated high basal histamine levels
and that histamine was induced in the skin of some individuals after exposure to UVB.
These observations suggest that histamine release by epidermal keratinocyte may
contribute significantly to skin inflammatory responses.
1.2 Cutaneous Immune Responses
1.2.1 Contact hypersensitivity
Induction of a contact hypersensitivity (CH) reaction follows application of a sensitising
chemical to the skin (Streilein, 1991). These contact allergens are generally small,
structurally simple and consequently not generally recognised by the immune system in
their native form. However, the haptens are reactive with protein in the skin which they
bind to, producing hapten-derivatised self-proteins. These act as epitopes and a
hapten/protein-specific immune response is generated against them (reviewed inBour et
al., 1997). In order for such an immune response to be generated, the antigen must be
taken up and processed by antigen-presenting cells, primarily LC, which migrate to the
lymph node(s) draining the site of antigen encounter.
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They present the antigen to antigen-specific CD4+ T cells, which are induced to proliferate
and differentiate into an effector population, which travels via the peripheral blood system
to the initial site of infection (see Figure 1.1). These T cells then extravasate into the skin
site where they serve to orchestrate the effector response and eliminate the antigen. It is
believed that previously encountered antigens may evoke a response involving peripheral
antigen presentation to recirculating memory T cells.
The CH response can be divided into the sensitisation (afferent) phase and the elicitation
(efferent) phase. The former occurs at the first contact of the skin with a particular hapten
and leads to the generation of hapten-specific T cells in the lymph node and their migration
back into the skin. This sensitisation phase lasts 10-15 days in man and 5-7 days in the
mouse. The elicitation phase occurs as a result of challenge with the same hapten and
comprises of an early (1-2 hours) and a late (24-48 hours) phase of tissue swelling in mice
(MacKenzie and Hillier, 1981; van Loveren et ai, 1983). The early phase is thought to
involve the degranulation of mast cells and the release of vasoactive amines such as
histamine and serotonin, which induce vasodilation and other physiological changes.
These changes facilitate the entry of effector T lymphocytes which mediate the classical
delayed type hypersensitivity reaction. This late efferent phase of CH peaks at 72 hours in
man.
The antigen-processing pathway for CH responses is thought to model the mechanisms of
antigen-processing for other antigens and CH responses are therefore commonly utilised
as models in which to investigate the integrity of cutaneous immune responses. In most
experimental protocols, challenge of the animal involves the application of a sub-
inflammatory concentration of the same chemical used for sensitisation, to either the
dorsum of the ears or to the footpad. These sites allow for easy quantification of the
inflammatory response by measurement of the increase in thickness of the site. In humans
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the CH response is generally measured by scoring features of inflammation such as
erythema, oedema and epidermal necrosis (Tie et al., 1995).
1.2.2 Delayed-type hypersensitivity
Delayed-type hypersensitivity (DTH) responses are similar to CH responses, except that
the antigen is usually a protein rather than a hapten and is administered intradermally.
DTH inflammatory reactions are characterised by the infiltration ofmononuclear cells into
the dermis, with less cellular infiltration into the epidermis compared with CH responses.
1.2.3 Antigen processing
Langerhans cells are the main antigen-presenting cell (APC) of the cutaneous immune
system. In order to be an effective APC, LC must have the ability to internalise and
process antigen in the epidermis. This process takes place intracellularly in acidified
endosomes / lysosomes. Freshly isolated murine LC are known to have phagocytic
activity and have been shown to process and present the protein ovalbumin and L.major
amastigotes, but this ability is lost during culture (Moll, 1993; Streilein and Grammer,
1989).
1.2.4 Langerhans' cell migration and differentiation
For effective induction of a primary immune response, antigen processed in the epidermis
must be transported to the local draining lymph node (DLN) and be presented to antigen-
specific T cell clones in order to stimulate proliferation and differentiation of these cells.
LC are known to be able to migrate out of the skin in response to a number of stimuli such
as UVB and skin-painting with contact sensitisers (Bergstresser et al., 1980). Depletion
of murine LC by such treatments results in a subsequent accumulation of DC in the lymph
node draining the treated site (Kinnaird et al., 1989; Moodycliffe et al., 1992), attributed
to an influx of LC and/or DC from the skin. The most compelling evidence for epidermal
LC migration to the DLN after antigen challenge, comes from a model in which nude mice
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were sensitised with the contact sensitiser fluorescein isothiocyanate (FITC) on an
allogeneic skin graft. Birbeck granule-containing DC bearing the hapten could be
recovered from the DLN of the nude mice and these cells were able to induce sensitisation
to FITC upon injection into naive mice of the same haplotype as the graft donor (Kripke et
al., 1990). This confirmed that at least some of the antigen-presenting cells in the DLN
are derived from the skin and are LC in origin.
A signal is required to initiate the migration of hapten-loaded LC to the DLN. Contact
sensitisers, as well as UVB, cause the upregulation of cytokines including IL-la, IL-3,
IL-6, IL-8, GM-CSF. TNF-a and TGF-p by keratinocytes (Bos and Kapsenberg, 1993;
Enk and Katz, 1992b; Koch et al., 1990). Topical application of contact sensitisers to
mice was shown to result in increased epidermal expression of IL-la, IL-ip, GM-CSF,
TNF-a, macrophage inflammatory protein-2 (MIP-2) and interferon-inducible protein-10
(IP-10) mRNA (Enk and Katz, 1992a; Enk and Katz, 1992b).
Message for TNF-a is also upregulated after exposure to contact sensitisers and UVB.
Additionally, intradermal injection of TNF-a causes an accumulation of DC in the DLNs
of mice (Cumberbatch and Kimber, 1995) and a decrease in epidermal LC numbers
(Cumberbatch et al., 1994), implicating TNF-a as an important signal for LC migration
after sensitisation. Also pre-treatment of mice with neutralising antibodies to TNF-a
before UV exposure, prevented the normal UV-induced accumulation of DC in the DLN
(Moodycliffe et al., 1994).
IL-ip has recently been implicated in the migration of LC from the epidermis and their
accumulation in draining lymph nodes as DC (Cumberbatch et al., 1997). Depletion of
epidermal subsets revealed that IL-ip is mainly LC-derived and this cytokine was
demonstrated to be an important initiator signal for the induction of contact sensitisation
(Enk et al., 1993a). IL-1 P injected intradermally resulted in a similar cytokine profile to
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that which occurred following sensitisation and a neutralising antibody to IL-1 (3 was able
to block sensitisation (Koch et al., 1990).
The most notable difference between the effects of treatment of mouse ears with
recombinant TNF-a and IL-113, is the kinetics of the induced changes in LC frequency
and DLN DC numbers. The delayed responses seen after IL-ip treatment have led to the
hypothesis that IL-1P stimulates migration of LC secondary to a paracrine induction of
increased TNF-a production and that it is this latter cytokine that acts directly upon local
LC to stimulate their movement from the skin (Cumberbatch et al., 1997). This hypothesis
is supported by the fact that intradermal injection ofmice with IL-1P results in a rapid and
marked transcriptional activation of cutaneous TNF-a (Enk et al., 1993a).
LC undergo morphological, phenotypical and functional changes as they migrate to the
DLN, with molecules essential for antigen-presentation being upregulated as they mature.
This process is believed to be mimicked by in vitro culture of LC and MHC class I and II
are upregulated on cultured LC (Schuler and Steinman, 1985; Shimada et al., 1987).
MHC expression is increased on lymph node-isolated DC in comparison to epidermal LC
(Cumberbatch et al., 1991). ICAM-1 is also upregulated on cultured LC (Aiba et al.,
1993) and is thought to be important in providing the initial antigen-independent
interaction between DC and T cells.
LC migration is thought to come about as a result of phenotypic alteration. For example,
epithelial (E)-cadherin is expressed at high levels by LC (Blauvelt et al., 1995; Tang et al.,
1993) and is believed to be the molecule through which LC bind to keratinocytes (Tang et
al., 1993). E-cadherin expression is down-regulated on LC during culture (Tang et al.,
1993) and on the sub-population of LC, determined morphologically and phenotypically
to be activated, following epicutaneous application of contact allergen to murine skin
(Schwarzenberger and Udey, 1996). Hence a signal such as TNF-a may cause down-
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regulation of E-cadherin, reducing the adhesion between LC and keratinocyte, allowing
the LC to move out of the epidermis. ICAM-1 and LFA-1 may also be involved in this
process since intravenous injection of monoclonal antibodies against these molecules
caused a reduction in the number of hapten-bearing DC found in the DLN after skin
painting of the hapten, and an inhibition of the induction of CH resulted (Ma et al., 1994).
The expression of molecules such as CD44, VLA-4 and ICAM-1 on differentiated LC
may also play a role in LC migration by their interaction with ligands expressed for
example on high endothelial venules (Aiba et al., 1993; Omary et al., 1988; Springer,
1990).
1.2.5 Antigen presentation and induction of a cutaneous immune response
Once LC have migrated into the afferent lymphatics they are known as veiled cells (Knight
et al., 1982). They drain into the lymph node and localise in the paracortical region where
they are called interdigitating cells because of the extensive contact of their dendritic
projections with surrounding cells (reviewed inLappin et al., 1996b). They present
antigen in an MHC-restricted manner to T cells and upon receiving signals, both soluble
and via the costimulatory molecules of the APC, antigen-specific T cells are induced to
proliferate and differentiate (Budjoso et al., 1989; McKeever et al., 1992).
Antigen-independent adhesion takes place between T cells and APC prior to antigen-
dependent clustering of these cells and this process may allow 'sampling' of different T
cells (Inaba and Steinman, 1986). The interaction is thought to involve LFA-1 and
ICAM-1 binding, since in a mouse model in which mutant APC expressed reduced levels
of ICAM-1, these cells had a greatly impaired ability to present antigen to T cells (Dang et
al., 1990). This was restored upon reconstitution of ICAM-1 by transfection of the gene
into the APC.
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Functional effector cells are only generated from naive T cells if the cell receives signals,
not only through the antigen-restricted TCR/MHC pathway, but also through non-antigen
specific costimulatory pathways. Such pathways proposed to date include the interactions
between CD28/CTLA-4 and molecules of the B7 family; CD2 and LFA-1 and heat stable
antigen and its ligand. Soluble signals mediated by cytokines such as IL-1 and IL-2 are
also important in T cell activation.
CD28 is expressed widely on both human and mouse resting T cells, while CTLA-4
expression is limited to activated T cells (June et al., 1994). B7-1 (CD80) is not expressed
constitutively on epidermal LC but is induced during culture (Inaba et al., 1994; Larsen et
al., 1992; Symington et al., 1993). B7-2 (CD86) is found constitutively at low levels on
murine epidermal LC and is greatly up-regulated after 24 hours in culture (Inaba et al.,
1994). Expression of B7-2 is also found on peripheral blood DC (Young et al., 1992),
amongst other cells. Freshly isolated LC are less able to stimulate allo-responses than are
cultured LC (Freeman et al., 1991; Larsen et al., 1992; Symington et al., 1993). The
ability of cultured LC to induce these responses is blocked using CTLA-4-Ig (Symington
et al., 1993). This is a fusion protein with the extracellular portion of CTLA-4 spliced to
the constant region of human IgGl and acts as a soluble ligand for B7-1 and B7-2 (Lane
et al., 1993). There is some evidence that B7-1 signalling induces Thl type response,
while B7-2 mediates Th2 response, although this hypothesis is still controversial (Corry et
al., 1994; Sayegh et al., 1995).
After being stimulated to proliferate and differentiate, antigen-specific T cells leave the
lymph node in the efferent lymph, enter the bloodstream via the thoracic duct and migrate
preferentially to the skin where they orchestrate adaptive immune responses such as CH
and DTH. A schematic representation of such a primary cutaneous immune response is
shown in Figure 1.1.
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Once the immune system has been exposed to a particular hapten, a pool of activated or
semi-activated T cells specific for the antigen will exist. Therefore in a secondary
response, for example upon subsequent hapten challenge, T cells could encounter the
antigen in the periphery, presented by LC or by other APC populations such as B cells,
macrophages or keratinocytes. Memory T cells (CD45RO-expressing) can be activated by
a wide range of APC in contrast to naive T cells which require DC (Bradley et al., 1993).
It is thought that antigen-specific skin-homing T cells, once activated in the periphery,
could initiate a cascade response, perhaps through cytokine production, resulting in the
migration of further effector cells into the site of antigen challenge
1.2.6 Effector cells of CH/DTH
The effector phase of hypersensitivity is associated with the infiltration of T cells, as well
as cells of the macrophage/monocyte lineage, into the dermis and epidermis (reviewed
inBour et al., 1997; Streilein, 1991). T cell-derived IFN-y induces the activation of
macrophages, causing them to produce pro-inflammatory cytokines and increase their
phagocytic activity. Therefore the infiltration of T cells and macrophages into the skin is
the main effector response and is responsible either directly or indirectly for the clincial
features associated with these types of immune response.
The classical effector cell of CH, induced 24-48 hours after challenge is a CD3+, CD4+,
IL-2R+, TCRtx/p+ T cell (Ptak et al., 1996). Experiments using CD4 knockout mice, in
which reduced CH responses to DNFB were observed, confirmed the role of CD4+ T
cells in the CH response (Cavanagh et al., 1996).
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1.3 Ultraviolet (UV) radiation
1.3.1 UV wavelengths and sources
UV radiation (UVR) is commonly divided, depending on wavelength, into three parts,
UVC (200-290 nm), UVB (290-315 nm) and UVA (315-400 nm). The division is
somewhat arbitrary, although roughly corresponds to the behaviour of the UVR in the
atmosphere. Approximately 9% of the solar radiation is in the UV waveband, although
this is not what reaches the Earth, as UVR of wavelengths shorter than 280 nm are
effectively filtered out by the atmospheric ozone. As the wavelengths increase more
photons pass unhindered and UVR of wavelengths greater than 320 nm are hardly
affected at all by ozone and follow the same path as visible light. The UV spectrum of the
sun at ground level is dependent on geographical location, the time of day, month of year
and also on weather, air pollution and reflection from the Earth's surface. Exposure to
UVR for the majority of individuals is primarily from the sun, although the use of
sunbeds and the phototherapy treatment of some skin conditions mean that artificial
sources are also relevant. Throughout this study Philips TL-20 W/12 lamps are used as a
source of broadband UV-B, the output spectrum of which is shown in Figure 2.1.
1.3.2 Environmental considerations
Since 1985 seasonal fluctuations in the ozone layer have been observed regularly in
Antarctica and in some parts of the northern hemisphere where there is minimal air
pollution (Farman et al., 1985). These measurements, together with the environmental
politics surrounding the discovery that chlorofluorocarbons (CFCs) were causing
depletion of the ozone layer, focussed attention on the harmful effects of UV light. It is
believed that any reduction in the atmospheric ozone layer will lead to increased
environmental exposure, in particular to UVB which reaches the Earth's surface in
amounts inversely proportional to the concentration of atmospheric ozone (Kerr and
McElroy, 1993). The Convention for the Protection of the Ozone Layer, adopted in
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Vienna in 1985, as well as the Montreal Protocol and the subsequent Copenhagen
amendments of it, resulted in an international commitment to reduce the production and
emission of ozone-damaging chemicals. As a result the increase in CFCs in the
atmosphere appears to be levelling off, which may eventually lead to a recovery of the
ozone layer.
1.3.3 Biological effects
Wavelengths in the UVB range are present in sunlight at a lower intensity than UVA (100-
1000 times less), but have the largest biological effect per unit of irradiation. Concern is
growing about the impact of increased UVR exposure on animal and plant ecosystems, as
well as on humans. Investigations are currently being carried out on populations as
diverse as Antarctic phytoplankton, thought to have decreased photosynthetic capability;
Patagonian sheep suffering from UV-related eye diseases; and frog populations in
Oregon, believed to be declining due to a combination of increased UV exposure and low
photolyase activity (Baustein et al., 1994; Nilsson, 1996). A direct link between
increased UV exposure as a result of ozone depletion and any of these observations has
not been made, but such studies continue in an attempt to identify any causal links and
assess any potential risks.
In humans the effects of UVR exposure are known to be both positive and negative.
UVR is critical for the photochemical formation of vitamin D3 in the skin, which is
necessary for bone formation. In addition, as mentioned above, UVR has beneficial
effects in the treatment of certain skin diseases such as psoriasis. In addition, tanning for
cosmetic reasons is promoted in our society as a symbol of health and sun exposure is
linked to a general feeling of well being. In contrast the sun can cause the development of
erythema or 'sunburn', with redness resulting from vasodilation of the blood vessels in
the skin. More seriously UV exposure has been linked to the development of both
melanoma and non-melanoma skin cancers (discussed in section 1.4.1.1), cataract
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formation and is known to contribute to a range of photoaging effects (Reviewed in
Browder and Beers, 1993; Goettsch, 1995).
1.4 UVB and Immunosuppression
1.4.1 Role of UVB in photocarcinogenesis
1.4.1.1 Epidemiology of skin cancer
The incidence of both melanoma and non-melanoma skin cancers has been rising for the
past 20 years with epidemiological evidence suggesting an association between exposure
to sunlight and the development of cutaneous malignancies of all types (Last, 1993;
McKenzie and Sauder, 1994). Attempts have been made to estimate future risks of skin
cancer development, as a result of current ozone depletion, and to compare the effects of
the restrictions specified under the Montreal Protocol and the Copenhagen Amendments
(section 1.3.2) on this risk (Slaper et al., 1996). Without the legislation of the
Copenhagen Amendments, the risk model predicts a runaway increase in skin cancer,
providing some evidence for the importance of such international measures.
Non-melanoma skin cancers (NMSC; basal cell carcinomas and squamous cell
carcinomas) are the most common skin tumours in white populations. Sun exposure is
one of the most important risk factors for NMSC, especially squamous cell carcinomas, as
they occur predominantly on chronically exposed body regions. Fair skin is also a
significant risk factor, probably due to a lack of protective pigment (Green and Battistuta,
1990; Vitaliano and Urbach, 1980).
Although cutaneous malignant melanoma (CMM) is a relatively rare tumour in comparison
to NMSC, the incidence of CMM has increased rapidly in all white populations and in
some countries, including Scotland, the incidence has doubled or tripled during the past
thirty years (MacKie et al., 1992; MacKie and Hole, 1996; Nilsson, 1996). However, a
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less well established relationship exists between sun exposure and the development of
CMM (Elwood, 1992). Immunocompetent hairless mice, if chronically exposed to UVB,
never develop melanoma and outdoor workers are less at risk from melanoma than indoor
'white-collar' workers (de Gruijl, 1993). However, epidemiological evidence supports an
association between episodes of childhood sunburn as well as occasional high exposures,
for example from summer holidays abroad, with the development of melanoma later in life
(Goettsch, 1995).
1.4.1.2 The role of UVB in tumourigenesis
The phenomenon of UV-induced modulation of tumour immunity was first identified by
Kripke and co-workers who demonstrated that UV-induced skin tumours, transplanted to
normal syngeneic mice, were rejected by these immunocompetent hosts. However the
tumours grew progressively if the recipient had been UV-irradiated, with subcarcinogenic
doses of UV radiation, prior to transplantation (Fisher and Kripke, 1977; Kripke, 1974;
Kripke, 1976).
The majority of experimental models of UV-induced carcinogenesis have been carried out
using the hairless mouse, in which irradiation induces mainly squamous cell carcinomas
(de Gruijl and Forbes, 1995). Studies of melanocytic tumour development have been
extremely limited since these tumours have only been induced by UV in fish (hybrids of
the genus Xiphophorus) (Setlow et al., 1989) and opossums (.Monodelphis domestica)
(Ley et al., 1989). Kripke and coworkers have however recently developed a murine
melanoma model which has allowed the role of the local microenvironment in the
immunological control of tumour development to be examined (Donawho et al., 1996).
The action spectrum for carcinogenicity in mice, depicting the wavelength dependence of
squamous cell carcinoma induction in the hairless mouse (de Gruijl et al., 1993), as well
as that for non-melanoma skin cancer development in human skin, closely resemble the
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human erythemal action spectrum (Parrish et al., 1982). These action spectra show that
UVB radiation is the most effective wavelength (the peak carcinogenicity per unit of
ultraviolet exposure (J/m2) occurs at 293nm). UVA has also been demonstrated to play a
role in carcinogenesis and in fact there is a second peak in the action spectra for SCC
induction in the UVA range (de Gruijl et al., 1993). It is therefore an important factor to
consider because of the high intensity of UVA in sunlight and the inability of certain
sunscreens to block UVA wavelengths effectively.
1.4.1.3 UVB induction of tumours by DNA damage
DNA is known to absorb UV radiation in the range 230-300 nm (Kochevar, 1995).
Damage can be caused as a result, including single strand breaks and most commonly, the
formation of cyclobutyl pyrimidine dimers between adjacent pyrimidines on the same
DNA strand (Beukers and Berends, 1960). These distort the secondary helical structure
of the DNA molecule, blocking the processes of replication and transcription (reviewed
inJung and Bohnert, 1995). Mutations result from transcriptional errors introduced
during the course of repairing these alterations in DNA. The most superficial cells of the
epidermis, which receive the greatest UV exposure, are committed to terminal
differentiation as they move into the stratum comeum and therefore injury of these cells is
not highly significant. However, mutation of the basal-layer stem cells may result in the
development of malignancy. The process of excision repair is essential for the repair of
UV-induced dimer photoproducts within cellular DNA.
Patients with the hereditary condition xeroderma pigmentosum can develop skin tumours
at an early age by exposure to sunlight (Daya-Grojean et al., 1995; Lambert et al., 1995).
Research has revealed that cells derived from these individuals have defective repair of
UV-induced damage in cellular DNA (Cleaver, 1968). This indicates that DNA damage
produced by sunlight is directly involved in the process of carcinogenesis. DNA absorbs
UV light and the role of DNA damage in UVB-inauced immunosuppression will be
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discussed in section 1.5.1.1. However, the importance of UVB as an initiator of the
process of tumourigenesis is thought to result from its ability to cause mutations in genes
crucial for cell cycle regulation such as proto-oncogenes like ras and tumour suppressor
genes such as p53. Cells in the epidermis will accumulate DNA errors replicated over
years of sun exposure and these dysfunctional genes can eventually cause a malignant
transformation. For example, without functional p53, cells are unable to arrest in the G1
phase of the cell cycle. G1 phase arrest is critical for DNA repair and cells unable to carry
out these repair processes will accumulate DNA damage and subsequently have an
increased risk of transformation. A high percentage of sunlight-induced human skin
cancers and UV-induced murine skin cancers contain unique p53 mutations (Dumaz et al.,
1993; Kress, 1992; Sato et al., 1993). Such mutations are thought to be an early event in
UV-induced carcinogenesis, being detected in mouse skin months before the appearance
of skin tumours (Ananthaswamy et al., 1997). Examination of p53 gene sequences in
individual basal and squamous cell carcinomas reveals that dimers of the same base
composition at different sites can have quite different mutagenic potentials. Different
regions of the p53 gene were found to be repaired at different rates in cultured human
cells, with the sites of mutations observed in human cutaneous cancers being poorly
repaired (Tornaletti and Pfeifer, 1994).
1.4.1.4 UVB promotion of tumours by suppression of immunosurveillance
It is thought that the skin immune system is important in the control of certain tumours by
performing an immunosurveillance role, monitoring for changes associated with cellular
transformation. In order for this surveillance mechanism to be broken, a transformed cell
would need either to outgrow the immune response or the immune response itself would
need to be weakened in some way. Some evidence that UV-induced immunosuppression
plays a role in carcinogenesis comes from data collected from renal allograft recipients
receiving immunosuppressive drugs. These individuals have a highly increased risk of
developing squamous cell carcinomas, which are generally found on sun-exposed skin
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sites (Hartevelt et al., 1990). In addition over 92% of individuals with a previous history
of basal/squamous cell carcinomas show susceptibility to UVB, as defined by a
suppressed CH response following UVB exposure (Streilein et al., 1994), compared to a
40% susceptibility frequency in the normal adult Caucasian population (Yoshikawa et al.,
1990). Therefore UVB appears to have the potential to act both as a tumour initiator, by
causing DNA damage, and as a tumour promotor by inhibiting tumour surveillance and
hence has been described as a 'complete carcinogen'.
1.4.2 Suppression of CH and DTH
1.4.2.1 Contact hypersensitivity
Probably the most extensively studied immune reaction in the skin is that of contact
hypersensitivity, described in section 1.2.1. In animal models, chemical allergens such as
dinitrochlorobenzene (DNCB) and oxazolone (OXA) are used to induce contact sensitivity
and these systems have been used to try to elucidate the mechanisms involved in UV-
mediated immunosuppression.
UVR is known to cause suppression of CH responses both in mice (Moodycliffe et al.,
1994; Shimizu and Streilein, 1994a; Toews et al., 1980) and in humans (Tie et al., 1995).
From early murine studies it was shown that exposure to sub-erythemal doses of UVB on
four consecutive days resulted in a significant decrease in the number of Langerhans' cells
in the exposed skin (Toews et al., 1980). Exposed sites and also sites naturally deficient
of LC such as tail skin, were unable to support the induction of CH. A direct correlation
between LC numbers in the epidermis and the ability to induce CH was found. The
immunosuppression induced in this system was confined to the irradiated site, a
phenomenon known as local immunosuppression. In addition, the immunosuppression
generated was demonstrated to be highly specific for DNCB, the sensitiser used. Since
mice failed to respond to DNCB following resensitisation through unirradiated skin 14
days later, but retained the capacity to become sensitised to unrelated molecules, specific
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tolerance was said to have been induced, rather than a general unresponsiveness. A similar
situation has been demonstrated in humans, with UVB able to suppress CH to DNCB in
certain individuals for up to 4 months. Tolerance was induced in approximately 30% of
subjects who were exposed to DNCB through irradiated skin (Cooper et al., 1992).
UVB-induced immunosuppression of the CH response is known to result in the
generation of hapten-specific T suppressor cells in the spleens of various strains of mice,
irrespective of whether they demonstrate suppressed CH responses following UV
exposure or not (Glass et al., 1990). This cell population, when adoptively transferred
into naive syngeneic mice, induces suppression of the elicitation phase of CH responses
(Elmets et al., 1983; Glass et al., 1990).
1.4.2.2 Local and systemic immunosuppression
Irradiation of mice with UVB suppresses CH either 'locally', when the contact sensitiser
is applied to the UV-irradiated site (Streilein and Bergstresser, 1988; Toews et al., 1980),
or 'systemically', when the sensitiser is applied to a site distant from the site of UVB
exposure (Noonan et al., 1981). The timing of exposure to UVB in relation to
sensitisation is now known to be a critical factor in determining whether local or systemic
immunosuppression occurs. It was originally thought that this distinction was dependent
on the UVB dosage, with high doses resulting in systemic suppression, but it has since
been demonstrated that for a given strain of mouse, the UV dose-response for local and
systemic immunosuppression is identical (Noonan and De Fabo, 1990). It was found that
local suppression was initiated if the sensitiser was applied immediately, or up to two days
after UV exposure, whilst systemic suppression was initiated only if sensitisation was
delayed until three days after the last irradiation (Kripke and Morison, 1986; Noonan and
De Fabo, 1990; Shimizu and Streilein, 1994b). It is thought that the mediators of
systemic and local immunosuppression may be different. For example, treatment of mice
with antiserum to TNF-a was protective against local CH impairment (Moodycliffe et al.,
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1994) but not against systemic suppression of CH (Shimizu and Streilein, 1994a). Other
mediators which have been implicated in the systemic suppression induced by UVB
include cA-urocanic acid (UCA) and IL-10 which will be discussed in sections 1.5.1.2
and 1.5.3.2 respectively.
1.4.2.3 Resistant and susceptible phenotypes
Strain differences in the susceptibility to UVB induced immunosuppression of CH
responses have been reported in mice (Noonan and Hoffman, 1994; Streilein and
Bergstresser, 1988). There appear to be similar differences in susceptibility in humans
(Cooper et al., 1992; Tie et al., 1995). In mice two main models have been used and
various anomalies exist which result from the different protocols employed.
A model of local immunosuppression in which the mice are sensitised immediately
following irradiation on the exposed site (Streilein and Bergstresser, 1988) identified two
groups; UVB susceptible strains (UVB-S; C57BL/6 and C3H/HeN) that showed over
80% suppression of CH responses following UVB, and resistant mice (UVB-R; BALB/c)
which showed less than 10% suppression. Matings of BALB/c with C3H/HeN mice
produced F1 hybrids which proved to be UVB-S and so this trait appeared to be
dominant. It was then demonstrated that C3H/HeJ mice were UVB-R. C3H/HeN and
C3H/HeJ mice differ only at the Lps locus which regulates the production of
proinflammatory cytokines (IL-1, IL-6 and TNF-a). It was therefore hypothesised that
polymorphisms at genes regulating cytokines might be the basis of UVB-S.
Analysis of the effects of UVB radiation on CH induction in H-2 congenic mice suggest
that the H-2 complex contains one or more loci governing UVB-S (Kurimoto and
Streilein, 1994; Streilein and Bergstresser, 1988; Vincek et al., 1993). Molecular genetic
studies identified a series of alleles at the Tnfa locus and there is correlation between the
Tnfa allele and the UVB-R trait. These polymorphisms reside at regulatory regions of the
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Tnfa gene and it has therefore been hypothesised that UVB, either directly or indirectly,
promotes activation of the Tnfa gene in UVB-exposed cutaneous cells. Therefore, UVB
impairs CH induction in mice with a genetic predisposition. Susceptibility to this
deleterious effect of UVB radiation appears to be dictated by alleles at polymorphic loci
that regulate the production of proinflammatory cytokines, especially TNF-a. However,
despite wide acceptance of this proposal that differences in the Tnfa locus confer
resistance and susceptibility to UVB-induced immunosuppression, the evidence is not
definitive and the mechanism remains speculative.
A model of systemic immunosuppression in which trinitrochlorobenzene (TNCB) was
used as a sensitiser reported three subsets of mice; a high susceptible group, a group
showing intermediate susceptibility and a low susceptible group (Noonan and Hoffman,
1994). This model employed much higher doses of UV and comparison of the results
from the local and systemic studies showed a number of differences in the allocation of
mouse strains between the groups.
Outbred human populations also seem to show differing susceptibilities to UVB-induced
immunosuppression. Normal individuals were subjected to low-dose UVB and were then
immediately sensitised with DNCB on the UVB-exposed site. Approximately 40% of the
total population show a suppression of the CH to DNCB upon challenge (Tie et al.,
1995). Interestingly, a similar outcome was observed when subjects with deeply
pigmented skin were subjected to an identical experimental protocol (Vermeer et al.,
1991). Similar findings have been reported by others (Cooper et al., 1992), although the
sensitising dose of DNCB utilised varied beween these studies, as did the UV irradiation
regimen employed. Susceptibility to UVB-induced immunosuppression is in fact a risk
factor in the development of cutaneous cancers (section 1.4.1.4). Among basal and
squamous cell cancer patients, more than 90% displayed the UVB-S phenotype and all the
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patients studied with malignant melanoma were judged to be UVB-S (Yoshikawa et al.,
1990).
1.4.3 Photoprotection from immunosuppression
Extensive research has led to the development of highly effective sunscreens, which are
assessed by their ability to inhibit human erythema, expressed as the sun protection factor
(SPF). Action spectra for human erythema indicate that UVB is 3-4 times more effective
than UVA, and so despite the high UVA content of solar UVR, solar UVB is primarily the
cause of sun-induced erythema. The majority of sunscreens therefore contain UVB
blocking agents, although some do include UVA-absorbing molecules as well. Effective
use of high SPF sunscreens can result in substantial changes in sun-exposure behaviour,
particularly of those individuals with sun-sensitive skin types (I and II) who are enabled to
receive prolonged solar exposure without burning. In addition, the use of sunscreens will
alter the spectral distribution of UVR to which the skin is exposed. For example, use of
UVB protection alone will allow individuals to become exposed to higher doses of UVA
than they would normally, the consequences of which are unknown.
There are currently no reliable data on the long-term effects of the use of sunscreens on
human health, and the scientific justification for their use comes from mouse models.
Such studies have demonstrated that sunscreen application prior to UVR exposure can
reduce photocarcinogenesis and photoaging (Harrison et al., 1991; Wulf et al., 1982).
However, these experiments do not take into account any alterations in sun-exposure
behaviour which may result from the use of sunscreens.
In order to protect against skin cancer, sunscreens should offer effective protection against
DNA damage. This has a critical role in the development of skin cancer, as demonstrated
by the propensity of subjects with xeroderma pigmentosum, who have a deficiency in
excision repair, to develop squamous cell carcinoma (Kraemer, 1980; Lambert et al.,
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1995). In addition, the incidence of skin cancer in mice is reduced by the topical
application of a dimer-specific repair enzyme, T4 endonuclease V (T4N5), contained in
liposomes, post-irradiation (Yarosh et al., 1992). Current data, although limited, show
that sunscreen application inhibits UVR-induced DNA damage (Ananthaswamy et al.,
1997; Freeman et al., 1988; Wolf et al., 1993c). However, there are conflicting results
regarding the capacity of sunscreens to protect against the immunosuppressive effects of
UVR. While some authors have reported that various sunscreens offer minimal protection
against local and systemic suppression of CH in mice after chronic UV irradiation (Bestak
et al., 1995; Wolf et al., 1993b), others have claimed that the immunoprotective capacity
of some sunscreens exceeded their SPF with respect to local (Roberts and Beasley, 1995;
Roberts and Beasley, 1997) and systemic (Roberts and Beasley, 1997) suppression of
CH in mice or epidermal alloantigen-presenting capacity in a human skin explant system
(Davenport et al., 1997). The current literature is reviewed extensively elsewhere (Young
and Walker, 1995). It appears that the ability of sunscreens to provide immunoprotection
depends critically on the dose and wavelength(s) of UVR used, as well as the model
system. Ultimately, the ability of sunscreens to protect against environmental UVR must
be assessed in humans exposed to solar UV, using biologically relevant endpoints (Wolf
and Kripke, 1996). In the meantime fundamental questions remain to be answered. In
particular, how different wavelengths of UVR alter immune function and how best to
assess immunoprotection. It is clear that sunscreens effective in preventing erythema are
either ineffective or less effective at preventing UVR-induced immunosuppression, in
spite of apparent protection against LC damage.
1.5 Mechanisms of UVB-induced Immunosuppression
1.5.1 Photoreceptors for UVB
1.5.1.1 DNA
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In addition to its role as a tumour-inducer, in particular of non-melanoma skin cancer
(section 1.4.1.3), there is evidence that DNA damage causes suppression of the immune
response necessary for tumour surveillance, as discussed in section 1.4.1.4. When used
to treat UV-irradiated mouse skin, T4N5 increased the rate of dimer removal. This
treatment was able to prevent the UVB-induced suppression of CH and DTH following a
single exposure to 10kJ/m2 of UVB (Kripke et al., 1992). Spleen cells taken from these
T4N5-treated, UVB irradiated mice failed to transfer immunosuppression of CH
responses. It is currently not fully understood how DNA damage modulates immune
responses at a distant site. However it has been proposed that DNA damage induces the
release of immunoregulatory cytokines (Kripke et al., 1992). Application of T4N5 in
liposomes onto UV-irradiated skin of C3H mice also prevented the loss of LC from the
skin and reduced the local immunosuppression caused by UVB (Wolf et al., 1995). The
T4N5 was detected in LC and DC in the DLN as well as in keratinocytes (Wolf et al.,
1995). Using a monoclonal antibody against cyclobutyl thymine dimers, it was
demonstrated that cells containing these dimers were present in the DLN following a
single dose of UVB irradiation, and were believed to have originated from the skin
(Sontag et al., 1995). These findings led to the hypothesis that immune cells contain
DNA damage and serve as cellular targets of UV-induced local immunosuppression
(reviewed in Vink et al., 1996). It is hypothesised that UVR damages DNA in APC
resulting in altered antigen presentation, while DNA damage in keratinocytes causes the
release of immunomodulatory cytokines (O'Connor et al., 1996), resulting in local and
systemic immunosuppression respectively.
1.5.1.2 UCA
Urocanic acid (UCA) is synthesised as the trans-isomer from histidine, by the enzyme
histidase, and is predominantly located in the stratum corneum of the skin where it
accumulates. Trans-UCA represents 0.7% of the dry weight of the epidermis (Norval,
1996) and following irradiation it converts to the cA-isomer in a dose-dependent manner
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until the photostationary state is reached with about equal quantities of the two isomers
(Norval et al., 1989). Once formed, cis-UCA persists in the epidermis for several weeks.
It is found in sweat and suction blister fluid in humans following UV phototherapy
treatment. After a single UVB exposure it is present transiently in the serum of mice
(Moodycliffe et al., 1993) and in the urine of human subjects for at least a week
(Kammeyer et al., 1997).
Urocanic acid was originally proposed as a photoreceptor for UV irradiation and as a
mediator of the immunosuppressive effects of UV exposure when the absorption spectrum
of trans-UCA was found to match the action spectrum for the inhibition of CH in mice,
with a peak at 270 nm (De Fabo and Noonan, 1983). However, it has since been
demonstrated that the trans- to cis- isomerisation actually occurs in the UVA range and at
these wavelengths CH is not suppressed (Reeve et al., 1994). More recently the action
spectrum for the isomerisation of UCA in mouse skin in vivo has been produced which
peaks at 300-310 nm (Gibbs et al., 1993). Further evidence for the involvement of cis-
UCA in UV-induced immunosuppression came from mice which congenitally lack the
histidase gene and hence have only 10% of the normal UCA levels (De Fabo and Noonan,
1983). The parent strain mice develop UV-induced immunosuppression, whereas the
histidase-deficient mice were found to be resistant to such suppression. Indeed, increased
dietary levels of histidine, resulted in an increase in mouse skin UCA levels and enhanced
UVB-induced immunosuppression of CH (Reilly and DeFabo, 1991).
A body of evidence exists which demonstrates that cA-UCA mimics some of the effects of
UVB. These effects include depletion of LC from the epidermis (Kurimoto and Streilein,
1992; Moodycliffe et al., 1993; Norval et al., 1990) and suppression of the HSV-specific
DTH response (Ross et al., 1986; Ross et al., 1988) as well as suppression of CH
responses (Kondo et al., 1995; Kurimoto and Streilein, 1992).
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The production of a monoclonal antibody against cA-UCA has been useful in providing
clearer evidence for the role of cA-UCA in immunosuppression (Moodycliffe et al.,
1993). For example, the reduction in LC number achieved by UVB exposure or topical
application of cA-UCA was shown to be abrogated by pretreatment of mice with this
monoclonal antibody (El-Ghorr and Norval, 1995). In addition the cis-UCA monoclonal
antibody blocked the suppression of the HSV-specific DTH response induced by UVB
(El-Ghorr and Norval, 1995) and the CE1 response to DNFB (Kondo et al., 1995).
In contrast to UVB exposure, painting of cA-UCA onto mouse ears does not induce
accumulation of DC in the DLN (Moodycliffe et al., 1992) nor does intra-peritoneal
injection of cA-UCA block UVB-induced DC accumulation (El-Ghorr and Norval, 1995).
Therefore it would seem that although cA-UCA mimics many of the in vivo effects of
UVB, the relationship between the photoisomerism of UCA and UVB-induced
immunosuppression does not appear to be a direct or simple one.
To date there is no evidence to suggest the possibility of an inter-relationship between
DNA and cis-UCA as • chromophores, although there may be a common
immunosuppresive mediator downstream in the immunosuppressive pathway that links
the chromophores and the molecular events triggered by UVB exposure (Simon et al.,
1994b; Vinketa/., 1996).
1.5.2 Effect of UVB on cutaneous immune cells
1.5.2.1 Langerhans'cells
Both sub-erythemal and erythemal doses of UVB cause a decrease in the number of LC
within human skin (approximately 20% and 70% respectively) (Cooper et al., 1992). In
addition, morphological changes of LC take place, such as loss of dendricity, as well as
alterations in cell surface marker expression. UVB exposure of 5-10 mJ/cm2 in vitro was
demonstrated to inhibit the upregulation of ICAM-1 expression on LC which normally
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takes place on culture (Tang and Udey, 1991). UVB has also been reported to inhibit the
functional expression of B7-1 and B7-2 in a dose-dependent manner (Weiss et al., 1995).
These molecules are known to deliver important co-stimulatory signals through their
interaction with CD28 and CTLA-4 on T cells. In contrast, other authors have
demonstrated that the cell surface expression of membrane determinants necessary for
effective antigen presentation, including ICAM-1 and B7-2 on DC in DLN, remains
unaffected by in vivo immunosuppressive doses of UVB given prior to hapten
sensitisation (Lappin et al., 1996a).
UVB exposure also has effects on the functional abilities of epidermal LC. In vitro
irradiation (10-20 mJ/cm2) of both human epidermal cell suspensions and purified LC
populations resulted in a significant inhibition of the ability of these cells to stimulate
primary alloresponses and proliferation in response to mitogens and recall antigens (Rattis
et al., 1995). The exposure of murine epidermal cells to 2.5 mJ/cm2 UVB in vitro
reduced anti-CD3 induced T cell proliferation (Tang and Udey, 1991). However,
contradictory evidence also exists with regards UVB effects on LC function. For
example, the ability of DC, taken from the DLN of contact sensitised mice, to induce
hapten-specific secondary T lymphocyte proliferative responses or mixed lymphocyte
reactions in vitro were unaffected by the treatment of mice, prior to sensitisation, with
immunosuppressive doses of UVB (Lappin et al., 1996a).
The division of Th lymphocytes into Thl and Th2 subsets was discussed in section
1.1.4.1. Briefly, Thl cells are capable of stimulating cell-mediated inflammatory
responses through the production of cytokines such as IL-2 and IFN-y, while the
activation of Th2 cells favours the induction of humoral responses, by way of Th2
cytokines such as IL-4, IL-5, IL-6 and IL-10. There is now evidence to suggest that
UVB irradiation of LC results in an inability of these cells to stimulate Thl cells. A
schematic diagram of the effect of UVB on the antigen-presenting ability of LC is shown
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in Figure 1.2. Purified LC were exposed to 20 mJ/cm2 UVB and their ability to present
keyhole limpet haemocyanin (KLH) to Th cell clones was studied. Irradiated LC induced
tolerance (for up to 16 days) in antigen-specific Thl cell clones but activated Th2 cells,
specific for KLH (Simon etal., 1992; Simon etal., 1991).
A study of cytokine production by lymph node cells following UVB irradiation has
provided some in vivo evidence for UVB-mediated alterations of APC function. Mice
were exposed to 20 mJ/cm2 UVB on four consecutive days and were then sensitised with
DNFB on the final day and 24 hours later. UVB-treated mice demonstrated suppressed
CH responses, as well as reduced proliferative responses of lymph node cells to DNFB in
vitro in comparison to unirradiated control mice (Simon et al., 1994a). Most significantly,
lymph node cells from UVB exposed mice produced lower levels of the Thl cytokines IL-
2 and IFN-y when stimulated with DNFB in vitro.
1.5.2.2 Lymphocytes
Local UV irradiation of human skin has been shown to cause a decrease of intraepidermal
CD3+ T lymphocytes and an increase in dermal CD3+ T cells by 24 hours post-
irradiation. This infiltration reached a maximum at 48 hours and the CD3+ cells were
demonstrated to coexpress CD4 (Di Nuzzo et al., 1996),
UV irradiation of mice for six consecutive days induces an alteration in the distribution of
lymphocytes, with an increased migration of lymphocytes to the peripheral lymph nodes
in UV-irradiated mice compared with unirradiated control mice (Spangrude et al., 1983).
Lymphocytes are retained for a prolonged period in the lymph nodes possibly as a result
of PG released following UV irradiation, since PGs are known to induce efferent
lymphatic blockage (Chung et al., 1986). UV exposure may also affect the homing
patterns of lymphocytes by altering the expression of adhesion molecules such as ICAM-1
which will affect the normal balance of cell recirculation (Norris et al., 1990).
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Figure 1.2 The effect of UV exposure on the generation
of an immune response
Epidermis
Dermis
UV is absorbed by cutaneous chromophores such as trans-UCA and DNA. It can
alter an immune response either by direct action on LC or by activating
keratinocytes causing the release of immunomodulatory cytokines or through other
molecules like prostaglandins (PGE2) and histamine. UV-exposed LC are able to
activate Th2 cells but induce tolerance or clonal anergy in Thl cells. Keratinocyte-
derived cytokines, in particular IL-10, can affect the function of LC locally but can
also act systemically to inhibit the antigen presentation ability of other professional
antigen presenting cells (APCs). Suppression of Thl cell function and the
activation and expansion of Th2 cells result. The production of IL-4 and IL-10 by
Th2 cells serves to further suppress Thl cell function and hence suppress the
induction of inflammatory immune responses. (Abbreviations and symbols as in
Figure 1.1).
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Finally, the effect of UVR on the function of circulating lymphocytes remains a
controversial issue. A transient decrease in function has been reported following UVR
irradiation or PUVA (8-methoxypsoralen (8-MOP) plus UVA light) photochemotherapy
(Morison et al., 1979; Rivers et al., 1989). A significant suppression in
lymphoproliferative responses has also been shown in patients after four weeks of TL-01
(narrow-band UVB) phototherapy (Jones et al., 1996). Others have observed no
significant alteration in the numbers and function, including lymphoproliferative response,
of circulating lymphocyte subsets in patients with psoriasis undergoing broad-band UVB
phototherapy (Gilmour et al., 1993b; Jones et al., 1996). In contrast, depressed NK cell
activity was exhibited in psoriatic patients during treatment with broad-band UVB.
narrow-band UVB and PUVA (Gilmour et al., 1993a). The narrow-band UVB caused a
significant reduction in NK cell activity after one week of treatment (Guckian et al.,
1995). The apparently conflicting data may result from variations in UV source, dose and
timing of both the UV exposure and sample collection.
1.5.2.3 Keratinocytes
At the level of the single cell, UVB can induce the formation of apoptotic keratinocytes or
'sunburn cells', which appear in the epidermis. However, it would appear that
keratinocytes are capable of playing a major role in UVB-induced immunosuppression, by
means of the production of immunosuppressive soluble factors (see Table 1.1 and Figure
1.2). For example, sera taken from UVB-irradiated mice and also culture supernatants
from UVB-irradiated epidermal cells have been shown to suppress CH when infused into
normal recipients (Schwarz et al., 1986; Swartz, 1984).
One of the first factors released by keratinocytes into the epidermis upon UV exposure is
IL-1 which is stored in vast amounts in keratinocytes but is only released in response to a
stimuli such as tissue injury or exposure to UVB (Ansel et al., 1988; Kupper et al., 1987;
Murphy et al., 1989). The fever response following sunburn has been attributed to UV-
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induced increases in keratinocyte IL-1 production (Granstein and Sauder, 1987; Kupper et
al., 1987) and IL-1 has also been implicated as a suppressive factor for the induction of
CH responses in mice (Schwarz et al., 1986). In addition, murine keratinocytes have
been shown to produce an inhibitor of IL-1, known as contra-IL-1. (Schwarz et al., 1987)
This inhibitor has been found in serum following UV exposure of mice (Schwarz et al.,
1988) and is thought to be important in limiting inflammatory responses. Although contra-
IL-1 has not been sequenced to date, it is believed to be a soluble type II IL-1 a receptor,
based on its molecular weight. Type II receptors can bind IL-1 a, 11-1(3 and IL-1 receptor
antagonist (IL-1 Ra), which is structurally related to IL-1 (3.
IL-6 serum levels are elevated in individuals with sunburnt skin and this IL-6 is Helieved
to be keratinocyte-derived (Urbanski et al., 1990). Human keratinocyte IL-6 mRNA
stability is increased by UVB irradiation suggesting possible post-transcriptional
regulation of IL-6 gene expression after UV exposure (de Vos et al., 1994).
Keratinocyte-derived IL-6 is believed to partially mediate the 'sunburn' reaction including
the acute phase response and is induced in response to pro-inflammatory cytokines such
as TNF-a.
IL-8 production by human keratinocytes has been shown to be up-regulated immediately
after UV-exposure in vitro (Kondo et al., 1993), with significant levels found in cell
supernatants 24 hours after irradiation. Evidence has since been provided that IL-8 is
rapidly upregulated in human skin after UVB irradiation (Strickland et al., 1997). Both
mRNA and protein increased at 4 hour post-irradiation and reached a maximum between 8
and 24 hours. IU-8 is a pro-inflammatory cytokine and additionally is a chemoattractant
for neutrophils. Neutrophil infiltration into UVB-irradiated human skin was first observed
at 8 hours and then progressively increased (Strickland et al., 1997). This provides some
evidence that IU-8 may be acting as a chemoattractant for neutrophils following UVB
irradiation
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UVB radiation has also been shown to induce secretion of TNF-a and IL-10 by
keratinocytes (Enk et al., 1995; Grewe et al., 1995; Kock et al., 1990). Both of which
are also induced in response to contact allergens (Enk and Katz, 1992b; Enk and Katz,
1992c). They have therefore been implicated as important mediators of UVB-induced
immunosuppression and are discussed in sections 1.5.3.1 and 1.5.3.2 respectively.
Finally, keratinocytes demonstrate enhanced PG secretion following UVB exposure, in
particular of PGE2 which is also believed to contribute to some extent to UVB-induced
immunosuppression. For example, treatment of mice with the prostaglandin inhibitor,
indomethacin, has been shown to abrogate the capacity of UVB radiation to induce
suppression of contact allergy in mice (Robertson et al., 1987).
1.5.2.4 Macrophages
CD1 lb+ macrophages are stimulated to appear in the epidermis of human skin between 2
and 3 days following in vivo exposure to 2-4 minimal erythemal doses (MED) UVB
(Cooper et al., 1985; Cooper et al., 1986; Cooper et al., 1992). They are ultrastructurally
and phenotypically distinct from LC and have been shown to be potent producers of IL-10
in the epidermis (Kang et al., 1994). The ability of murine splenic and peritoneal
macrophages to phagocytose and inactivate bacteria following high-dose in vivo UVB
exposure was found to be significantly suppressed when tested (Jeevan et al., 1995).
Recently the action spectra for UV-induced inhibition of the mixed lymphocyte reaction
(MLR) and mixed epidermal cell lymphocyte reaction (MECLR) were determined (Hurks
et al., 1995). Human peripheral blood mononuclear cells (PBMC) or epidermal cells were
irradiated with monochromatic light of various wavelengths and then used as stimulator
cells in the MLR or MECLR. The maximum of both spectra was found to lie at 254 nm.
but both the MLR and MECLR were also sensitive to irradiation in the UVB range.
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1.5.2.5 Endothelial cells
There is evidence to suggest that E-selectin expression is upregulated on blood vessels of
the superior plexus venosus in humans by 6 hours following UV exposure of skin (Norris
et al., 1991). This upregulation peaks at 24 hours after irradiation and correlates with the
accumulation of inflammatory neutrophils and macrophages.
1.5.2.6 Mast cells
Mast cells play an important role in the generation of the 'sunburn' response through the
UV-mediated release of vasoactive substances. Mast cell degranulation is known to be
induced by UVA and high dose UVB (Danno et al., 1980) and histamine levels are
elevated in venous blood taken from UV-exposed skin (Beissert and Granstein, 1997).
Mast cells are located in the dermis of the skin and since UVB is thought to penetrate the
skin poorly, it is likely that the effects of UVB on mast cells are mediated through the
release of soluble mediators in the epidermis, such as IL-1 and PGs.
1.5.3 Soluble suppressor factors
1.5.3.1 TNF-a
Exposure to UVB radiation results in depletion of epidermal Langerhans' cells and an
impairment of CH (Aberer et al., 1982; Toews et al., 1980). As described in section
1.4.2.3, TNF-a has been implicated as the key to the phenomenon of UVB susceptibility
and resistance with respect to CH responses and hence the primary mediator of these
deleterious effects (Piguet et al., 1991). Intradermal injection of recombinant murine
TNF-a has been shown to reproduce the effects of UVB described above and these effects
can be abrogated by systemic treatment with anti-TNF-a antibody (Yoshikawa and
Streilein, 1990). It is thought that TNF-a impairs CH induction by interfering with the
ability of hapten-bearing Langerhans' cells to move to the DLN and hence stimulate
activation of hapten-specific T cells. Streilein has hypothesised that epidermal
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Langerhans' cells are immobilised in the epidermal compartment, based on evidence that
TNF-a profoundly alters the functional properties of these cells, and hence they fail to
arrive in the DLN in sufficient numbers during the 24 hours after irradiation (Streilein,
1991). The cellular source of this mediator of UVB immunosuppression is thought to be
epidermal keratinocytes, which in culture produce large amounts of TNF-a following in
vitro UVB exposure (Kock et al., 1990). Increased TNF-a levels have been detected in
the serum of humans 12 and 24 hours after a single total body UVB exposure, providing
evidence for the in vivo release of TNF-a after UV exposure (Kock et al., 1990).
1.5.3.2 IL-10
1.5.3.2 (i) Sources and function of IL-10
IL-10 was originally identified as 'cytokine synthesis inhibitory factor' because of its
ability to inhibit the production of IFN-y produced by Thl cell clones (Fiorentino et al.,
1989). IL-10 is produced by B cells (Go et al., 1990), mast cells (Thompson-Snipes et
al., 1991) and monocytes (de Waal Malefyt et al., 1991), as well as by Th2 cell clones
(Fiorentino et al., 1989). It enhances B cell class II MHC expression and viability (Go et
al., 1990) and prevents antigen-specific T cell proliferation by inhibiting monocyte
antigen-presenting capacity through down regulation of MHC class II expression (de Waal
Malefyt et al., 1991). In synergy with IL-2 and IL-4 it acts as a growth cofactor for
mature and immature T cells (MacNeil et al.. 1990) and with IL-3 and IL-4, IL-10 induces
rapid proliferation of mast cells (Thompson-Snipes et al., 1991).
Both murine and human keratinocytes have been demonstrated to produce IL-10 (Enk and
Katz, 1992c; Enk et al., 1995; Rivas and Ullrich, 1992), although its production by
human keratinocytes remains controversial (Jackson et al., 1996b; Teunissen et al.,
1997b). The mRNA for IL-10 is detectable in human skin in Th2-like skin conditions
such as poison ivy dermatitis, and also following tape-stripping (Nickoloff et al., 1994).
Throughout the epidermis, IL-10 mRNA was identified, predominantly localised within
43
the cytoplasm of keratinocytes. In contrast, no IL-10 mRNA was detected in normal or
psoriatic plaque keratinocytes (Nickoloff et al., 1994). Another study could not detect IL-
10 gene expression in human keratinocytes either constitutively or following stimulation
with IL-1(3, IL-6, IL-8, TNF-a IFN-y, retinoic acid, osmotic stress or UV irradiation
(Ried et al., 1994). Extensive investigation by Teunissen (Teunissen et al., 1994;
Teunissen et al., 1997b) also failed to detect either IL-10 mRNA or protein in human
keratinocytes or in the keratinocyte cell lines HaCaT and A431. It has been argued that
contaminating melanocytes in human epidermal cell cultures are responsible for the
production of IL-10 mRNA (Teunissen et al., 1997b).
The ability of murine keratinocytes to synthesise IL-10 is generally accepted. Cell
depletion studies have been used to implicate keratinocytes as the main source of IL-10
mRNA in the murine epidermis following application of contact allergens (Enk and Katz,
1992c) and IL-10 mRNA expression has been shown to occur late in the induction phase
of CH in mice (Enk and Katz, 1995) . IL-10 protein was detectable in keratinocyte
cultures derived from skin of mice of different strains, and also from the mouse
keratinocyte cell line PAM-212 following hapten stimulation (Enk and Katz, 1992c).
1.5.3.2 (ii) Induction of IL-10 by UV irradiation
Both murine and human keratinocytes have been shown to produce IL-10 in response to
UVB irradiation (Enk et al., 1995; Rivas and Ullrich, 1992). Supernatants from UV-
irradiated keratinocytes were shown to contain IL-10 bioactivity as determined by their
ability to suppress IFN-y production by antigen-stimulated Thl cells and anti-IL-10
monoclonal antibodies were able to block these suppressive effects.
Following UVB irradiation, CDllb4" macrophages infiltrating the epidermis, have also
been demonstrated to produce both IL-10 mRNA and protein and were shown to secrete
200-400 fold higher levels of protein than the (CD1 lb") keratinocytes (Kang et al., 1994).
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Since the cellular infiltration of macrophages into the epidermis is one of the major events
in CH and DTH responses, the production of IL-10 by these cells, in addition to the
keratinocyte, may play an important role in the down-regulation of the inflammatory
response.
1.5.3.2 (iii) The role of IL-10 in suppression of CH and DTH responses
IL-10 has been implicated as a mediator of UVB-induced suppression of CH and DTH
responses. IL-10 gene-targetted (IL-10T) mice, lacking expression of IL-10, exhibit a
normal DTH response following UVB treatment in contrast to the suppressed response
seen in normal mice (Beissert et al., 1996). However, UVB exposure could suppress the
induction of CH to a hapten applied at a distant non-irradiated site in these IL-10 T mice,
supporting the concept that the regulatory pathways of CH and DTH responses which UV
affects differ in some way.
Recombinant IL-10 (rIL-10), when injected intra-peritoneally into mice, suppressed their
ability to be sensitised to trinitrophenyl-coupled spleen cells for a DTH response (Schwarz
et al., 1994). Furthermore, administration of neutralising antibodies to IL-10 largely, but
not completely, inhibited the ability of UVB irradiation to suppress sensitisation to
alloantigens (Rivas and LTlrich, 1994). Treatment of mice with rIL-10 resulted in the
blocking of the elicitation phase of DTH as well as the sensitisation phase (Schwarz et al.,
1994).
In contrast to the DTH response, injection of rIL-10 into mice blocks the effector phase
but not the induction phase of the CH response (Schwarz et al., 1994). This effect is only
seen if IL-10 is administered at least 12 hours before hapten challenge, which suggests
that IL-10 works indirectly through the action of other mediators. An exaggerated CH
response was mounted by IL-10T mice, in terms of both magnitude and duration of the
response (Berg et al., 1995). Conversely, exogenous IL-10, when injected into mouse
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ears was found to be effective in reducing ear swelling, leukocyte infiltration and IFN-y
mRNA expression in DNFB-sensitised and challenged mice (Kondo et al., 1994).
A recent study has implicated IL-10 as an important mediator in hapten-specific tolerance
induced by acute low-dose UVB exposure (Niizeki and Streilein, 1997). While no role
was found for IL-10 as a mediator of the deleterious effects of UVB on CH, using this
model system, UVB-dependent IL-10 production in the skin was found to be effective in
promoting tolerance to a contact sensitiser. Neutralising antibodies to IL-10 significantly
reversed the tolerance induced by UV irradiation.
Production of IL-10 by keratinocytes is markedly increased by application of contact
sensitisers, but irritants and tolerogens do not have the same effect (Enk and Katz,
1992c). The signal strength of IL-10 mRNA in response to antigen was found to increase
at 4-6 hours, reaching maximal strength 12 hours after allergen application (Enk and Katz,
1992c). This increase in IL-10 mRNA signal strength was accompanied by abrogation of
T cell-derived IFN-y and IP-10 mRNA signals suggesting a possible counter-regulatory
role for IL-10 in skin DTH reactions.
In a separate study IL-10 protein production was found to peak at 10-14 hours after
antigenic challenge (Ferguson et al., 1994). This would seem to indicate that in such
secondary responses, IL-10 production corresponds with the late induction of, or peak in
the inflammatory response, providing an anti-inflammatory effect to limit the response. A
neutralising IL-10 antibody prolonged the CH response to 72 hours which upholds a role
for IL-10 in the down-regulation of CH responses. This anti-inflammatory activity of IL-
10 may occur through the down-regulation of macrophage-derived pro-inflammatory and
chemotactic cytokines and probably serves to minimise inflammatory tissue damage. IL-4
has also been implicated as an important down-modulator of inflammation. Sensitised
mice have been shown to have significantly elevated IL-4 mRNA levels compared to naive
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mice, after challenge with a contact sensitising agent (Asada et al., 1997). Treatment of
mice with anti-IL-4 antibody before challenge resulted in increased ear swelling 24 hours
after challenge compared to mice pretreated with isotype control antibody.
UVB exposure has been shown to induce IL-10 mRNA transcription in keratinocytes 8
hours after irradiation (Enk et al., 1995). If sensitisation takes place through an irradiated
site, the presence of UVB-induced IL-10 means that LC take up and process antigen in an
IL-10 rich environment which can affect the antigen-presenting cell function of the LC
(see below). The role of UVB-induced IL-10 in a secondary response seems clearer. Here
IL-10 is present 4-24 hrs after challenge and therefore this anti-inflammatory signal will
prevent the inflammatory response from starting, hence causing the characteristic
immunosuppression.
1.5.3.2 (iv) The effect of IL-10 on antigen presentation
Pretreatment of LC with UV-irradiated PAM-212 supernatants, but not with mock-
irradiated cell supernatants inhibited the ability of LC-enriched epidermal cells to elicit a
DTH response to tumour-associated antigens (Beissert et al., 1995). The role of IL-10 in
this keratinocyte-mediated suppression was tested using neutralising IL-10 antibodies
which confirmed that IL-10 in the UV-irradiated supernatants was responsible for the
inhibition of antigen presentation both for the induction and elicitation of immunity. Other
experiments involving the pre-treatment of APC with IL-10 showed that IL-10 acts
principally on the APC to inhibit IFN-y production by Thl clones (Fiorentino et al.,
1991). A more recent study has been carried out in which it was found that both IL-10-
pretreated LC and untreated LC were able to induce Th2 cell proliferation equally well,
while IL-10-treated LC were essentially unable to induce Thl cell proliferation in response
to native protein or peptide antigen and instead induced anergy in these Thl clones (Enk et
al., 1993b). From studies of LC it now seems likely that IL-10 prevents upregulation of
costimulatory molecules necessary for T cell activation and so tolerance results (Thl-
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specific), although there is no evidence of this to date. Since IL-10 is induced late in the
cytokine cascade initiated during the generation of a primary immune response in the skin,
it is likely that IL-10 exerts inhibitory effects late in the inflammatory response. It may
convert LC migrating to the DLN late in the inflammatory response to tolerising cells and
so potentially limit the number of antigen-specific T cells activated (Enk et al., 1993b).
The IL-10-mediated effects of UVR on the generation of a cutaneous immune response are
shown schematically in Figure 1.2.
1.6 Herpes Simplex Virus
1.6.1 Herpes simplex virus and its pathogenesis
Herpes simplex virus (HSV) has all the unifying features of the herpes virus family,
including an enveloped icosahedral capsid of approximately 100 nm in diameter,
containing a linear double-stranded DNA genome of approximately 152 kilobase pairs.
This genome encodes approximately 80 proteins, including mRNA/DNA synthesis
regulatory proteins and enzymes that promote viral DNA replication. HSV is a prototype
member of the a-herpesvirinae subgroup which are able to replicate in a wide variety of
cultured cells and to form infective virions rapidly.
Herpes simplex virus type 1 (HSV-1) and herpes simplex virus type 2 (HSV-2) are
closely related viruses which are morphologically identical and have approximately 46%
DNA homology (Kieff et al., 1972). Both initially infect and replicate in mucoepithelial
cells and then establish latent infection of the innervating neurons. HSV-1 is usually
associated with orolabial infections, while HSV-2 is, in general, associated with genital
infections. The natural history of a particular HSV infection depends on a complex
interaction between virus and host.
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The primary exposure to HSV-1 generally occurs at an early age, with the virus acquired
from infectious saliva. Commonly an asymptomatic infection results from the interaction
between host and virus, as the high prevalence of HSV antibodies in individuals with no
history of clinical symptoms illustrates. This suggests that host responses are generally
effective in controlling the primary disease (Gibson et al., 1990; Johnson et al., 1989).
Only a minority of individuals present with clinical symptoms during primary infection
and, of these, most develop relatively mild and localised vesicular lesions on the mucous
membrane ('cold sores') which ulcerate liberating progeny virus and then heal after
several days. It is a localised process but the virus very rapidly finds sensory nerve
terminals which have vims receptors and penetrates into the nerve axon. In this site the
vims was previously thought to be inaccessible to the immune system. However, despite
obvious constraints on the immune system within such tissue, there is increasing evidence
that an active immune response exists in latently infected ganglia (Shimeld et al., 1995)
Recovery from the primary infection is associated with the establishment of viral latency in
the dorsal route ganglia of the nerves which serve the site of the original lesion (Stevens
and Cook, 1971).
At intervals there may be reactivation of the vims in the nervous tissue. The virus then
moves to the peripheral site, either initiating a lesion in the neurodermatome relating to the
particular ganglion (recrudescence) or not causing an observable clinical lesion
(recurrence). Certain common triggering factors for recrudescence are recognised in
human subjects including exposure to UV light (see section 1.8.1.1), fever, skin trauma
and immunosuppression. A typical human recmdescent orofacial HSV-1 lesion is shown
in Figure 1.3. Recrudescent herpetic infections are generally mild and limited to the same
anatomical location as the primary infection. Exceptions are the comparatively rare severe
and/or disseminated HSV disease, mainly restricted to individuals who are in some way
immunocompromised. For example, neonates, patients with Hodgkin's lymphoma,
individuals suffering from severe burns (Kohl and Erisson, 1982) and those undergoing
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Figure 1.3 A typical human recrudescent orofacial HSV lesion
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the immunosuppressive regimen associated with organ transplantation (Ho, 1977; Pass et
al., 1979; Rand et al., 1976). Such observations naturally lead to the conclusion that the
control of HSV disease, including periodic recrudescence, is a function of the immune
system.
1.6.2 Immune Response to HSV
Observations from patients with a range of clinical conditions have given insight into the
immune mechanisms involved in HSV infections. For example, patients with depressed T
cell function may develop severe HSV disease, whereas individuals with an
immunoglobulin defect appear competent to control HSV infections (Corey and Spear,
1986). Also human immunodeficiency virus-1 (HIV-1) infected individuals, in which
CD4+ T cells are depleted as a result of this infection, frequently develop severe HSV
lesions (Siegal et al., 1981). There is a high dependency on animal models to provide
further information about immune mechanisms that act against HSV infection, based on
these clinical observations (Wildy and Gell, 1985). They have confirmed that cell-
mediated immune responses are crucial in the clearance and recovery from HSV infection,
while antibody responses seem to be less important.
1.6.2.1 Local immune responses
HSV infections are, in general, confined to the epidermis of the skin and therefore the
local elements of the skin immune system are critical in control of the infection and
elimination of the vims. It is likely that LC are involved in initiating the immune response
to the virus. In fact, the pathogenicity of HSV-1 in mice has been shown to be dependent
on epidermal LC density (Sprecher and Becker, 1987; Sprecher and Becker, 1989). It
has been shown that the epidermis is unable to initiate a rapid specific T cell response to
HSV in situ (Williams et al., 1991). However, LC are able to efficiently present antigen
to HSV-specific primed T cells upon secondary challenge, for example during a recurrent
infection. Therefore in a primary response, LC are thought to take up the viral antigens
and travel to the DLN where presentation to T cells takes place. However, there is
evidence that LC can become infected with HSV which has implications for the systemic
spread of the virus.
The following events are then believed to occur following sensitisation, starting with the
recirculation of activated T cells to the skin (reviewed inNash and Cambouropoulos,
1993). The infiltrating T cells secrete IFN-y which results in the expression ofMHC class
II antigens and ICAM-1 on keratinocytes, and the release of IL-1 from LC and
keratinocytes. Expression of adhesion molecules on keratinocytes may enhance T
cell/keratinocyte interactions and the migration of CD8+ lymphocytes into the epidermis
found late in HSV lesions. Within the epidermis there is a release of inflammatory
mediators and cytokines, such as IL-1, which attract effector cells and amplify the immune
response. It is known that both cytotoxic and DTH responses are required for the efficient
clearance of HSV from the skin (Martin and Rouse, 1987; Wildv and Gell, 1985). Helper
T cells may act by producing lymphokines which attract and activate cytotoxic T
lymphocytes (CTL), NK cells and macrophages. Infected cells can be lysed by CTL
which may produce TNF-[3. Macrophages are found in advanced necrotic lesions and are
important in the control of infection (Morahan et al., 1985). They exhibit intrinsic
resistance to HSV replication and function to ingest and inactivate HSV, destroy infected
cells and inhibit viral spread between cells. In addition they produce mediators which
serve to enhance inflammatory responses to HSV, as well as TNF-a, thought to cause
lysis of virally-infected cells and inhibit viral growth. NK cells and neutrophils are also
found in the epidermal infiltrate, while few B cells have been observed (Heng et al.,
1989).
1.6.2.2 Systemic immune responses
Most human subjects develop high antibody titres to the vims during a primary infection,
which remain elevated throughout the life of the subject, and vary little even with
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recrudescences (Vestey et al., 1989). Although high antibody titres do not appear to
prevent recrudescence (Douglas and Couch, 1970; Zweerink and Stanton, 1981), there is
evidence that antibody-dependent cell-mediated cytotoxicity (ADCC) may play a role early
in HSV infections (Kohl, 1991). In addition, studies in mice have suggested that spread
of virus from epidermal sites to neuronal tissue, and the reverse spread upon reactivation
of latent virus, may be contained to some extent by the presence of antibodies (Simmons
and Nash, 1985).
With regard to cell-mediated responses to HSV, both Th responses, as determined by in
vitro lymphoproliferative responses to HSV antigens, during primary infections and CTL
responses occur. The degree of lymphoproiiferative response varies between individuals
but is not related to the severity or likelihood of subsequent recrudesences. Both DTH
responses to intra-epidermal HSV challenge and HSV-specific CTL responses are
detectable. These responses both persist, indicating the establishment of immunological
memory. Studies involving the analysis of HSV-expanded lymphocyte clones from
patients have revealed the main CTL subset to be CD4+ MHC class Il-restricted, although
CD8+ MHC class I-restricted CTL have also been reported (Schmid, 1988).
Analysis of NK cell activity, HSV-specific lymphoproliferation and IFN production
suggests that a temporary depression in immune responses may occur just before or
during a recrudesence (Vestey et al., 1989). It is possible that triggering factors for
recrudescent HSV, such as UVR, may play a role in the suppression or delay in the
normal cell-mediated immune response resulting in recrudescence. This may allow an
asymptomatic recurrent infection to progress to replication in the epidermis and result in
the development of a lesion.
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1.7 Murine Herpes Virus-68
1.7.1 Murine gammaherpesvirus : the virus
Murine gammaherpesvirus-68 (MHV-68) was originally isolated from Clethrionomys
glareolus (bank vole) in Slovakia (Blaskovic et al., 1980). Initially thought to be an
alphaherpesvirus, MHV-68 was reclassified because its genome structure and organisation
were found to share homology with those of other gammaherpesviruses such as Epstein-
Barr virus (EBV; recently renamed human herpes virus-4 (HHV-4)) and herpesvirus
saimiri (HVS) (Efstathiou et al., 1990a; Efstathiou et al., 1990b). In fact MHV-68 is the
first natural pathogen of murine rodents to be classified as a gammaherpesvirus.
Gammaherpesviruses are a subset of the Herpes Virus Family, classified by their ability to
grow in lymphoblastoid cells. As with all herpesviruses, gammaherpesviruses are double-
stranded DNA viruses which have the capacity to establish life-long latent infections from
which virus may be reactivated. These viruses share the capacity to establish latent
infections in lymphocytes, with EBV adapted to infect and persist in B lymphocytes and
HVS able to persist in T lymphocytes. They also have the ability to induce
lymphoproliferative disease in the infected host. There is growing interest in
gammaherpesviruses, EBV in particular, because of their association with cell
proliferation and with neoplasia.
MHV-68 replicates in epithelial cells in vitro and has also been demonstrated to infect cell
lines of B cell origin but not of T cell origin in vitro (Sunil-Chandra et al., 1993).
Infection of myeloma cells induces persistence without any apparent cytopathic effect but
with the production of infectious virus. Following treatment of these cells with the anti-
heipetic agent acyclovir, the productive infection is abolished while a large number of cells
harbour virus in a latent form, providing some evidence that MHV-68 can latently infect
B lymphocytes (Sunil-Chandra et al.. 1993). In fact B lymphocytes have been
demonstrated to be necessary for establishment of splenic latency in vivo (Usherwood et
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al., 1996b). Some contradictory evidence exists (Week et al., 1996) which may reflect
the different routes of viral inoculation used in these studies.
1.7.2 Pathogenesis of MHV-68 infection
The pathogenesis of MHV-68 is represented diagrammatically in Figure 1.4. Briefly,
upon intranasal administration of MHV-68 to mice, the virus establishes a productive
infection in the lung, localised to alveolar epithelial and mononuclear cells (Rajcani et al.,
1985; Sunil-Chandra et al., 1992a). Infectious virus can be detected in the lungs between
days 1 and 7 post-infection and then declines to undetectable levels by days 10 to 15.
Following the acute respiratory infection, the virus spreads to the spleen where a
productive infection also results. The pathogenesis of the primary infection closely
resembles that of EBV in infectious mononucleosis. Subsequently, the virus is found in a
latent state in B lymphocytes in the spleen (Sunil-Chandra et al., 1992b; Sunil-Chandra et
al., 1993). Latent virus is not present in any organs other than the spleen and lungs,
suggesting these to be the only sites of virus persistence (Rajcani et al., 1985; Sunil-
Chandra et al., 1992a). Viral DNA has been observed in the lung long after primary
infection, but it remains unclear whether this represents a latent infection or a low level
chronic productive infection with virus shedding. This occurs even without B cells and so
represents a difference between the model of persistence of MHV-68 and that proposed
for EBV. Splenomegaly has been observed to occur from 14 days post-infection and then
gradually decline (Sunil-Chandra et al., 1992a; Usherwood et al., 1996a). During the
splenomegaly there is a large increase in the number of latently infected spleen cells
(Sunil-Chandra et al., 1992b). In addition, inbred mice chronically infected with MHV-
68 develop lymphoproliferative disease at a frequency of 9% of all infected animals
(Sunil-Chandra et al., 1994). The lymphoproliferative disease is similar to that seen in
patients infected with EBV and 50% of affected mice display high grade lymphomas.
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Figure 1.4 Schematic of the pathogenesis ofMHV-68
and the immune response following a primary
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1.7.3 Immune response to MHV-68
1.7.3.1 Cellular immune response
During the first three days of an MHV-68 infection in the lung, the host response is
characterised by an infiltration of monocytes/macrophages. This initial response declines
as the number of T lymphocytes in the lung, which are almost exclusively CD8+.
increases. Lymphocyte depletion studies revealed that removal of CD4+ T lymphocytes
had relatively little impact on clearance of the virus from the lung (Ehtisham et al., 1993).
In contrast, the absence of CD8+ T cells allowed the continued replication of the virus
instead of the usual elimination of infectious virus by 10-12 days. It was also observed
that, although CD8+ T cells do not prevent the establishment of latency (Ehtisham et al.,
1993; Week et al., 1996), they do play a role in the control of latently infected B
lymphocytes in the spleen (Nash et al., 1996). This CD8+ T cell-mediated control of
persistent MHV-68 infection was shown to be lost in the absence of the CD4+ T cell
subset, using CD4~ T cell (MHC class II -/-) deficient mice (Cardin et al., 1996). This is
in contrast to the situation with HSV in which CD8-deficient mice cleared an infection
normally while CD4-deficient mice showed a markedly delayed clearance and a worse
infection of the nervous system (Nash et al., 1987). With regard to the development of
lymphoproliferative disease in chronically infected mice, it appears that there is a role for T
cells in controlling the emergence of tumours since cyclosporin A treatment of mice,
which interferes with T cell function, resulted in an increase in the number of animals with
lymphomas (Sunil-Chandra et al., 1994).
During splenomegaly the numbers of B lymphocytes and both CD4+ and CD8+ T
lymphocytes increase (Usherwood et al., 1996a). Depletion of CD4+ T cells prevents the
splenomegaly, but has no effect on the long-term level of latently-infected cells in this
model. It is thought that as well as the presence of CD4+ T cells, infected B cells are also
required for splenomegaly to occur (Usherwood et al., 1996a; Usherwood et al., 1996b).
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Cells from the spleen and lung-draining lymph nodes produce high levels of IL-6 and
IFN-y and lower levels of IL-2 and IL-10 following MHV-68 infection (Sarawar et al.,
1996). A similar pattern of cytokine production is also seen in the bronchoalveolar lavage
fluid from infected mice. While IFN-yis known to play a role in clearance of other severe
herpes infections (Lucin et al., 1992; Smith et al., 1994), IL-6 and IL-10 have been
implicated in the establishment and maintenance of latent EBV infections (Miyazaki et al.,
1993; Tanner and G, 1991) and it will therefore be interesting to further study the role of
cytokines in this gammaherpesvirus model.
1.7.3.2 Humoral immune response
The antibody response to a primary MHV-68 infection is delayed, with antibody
production occurring between days 15 and 20 (Nash and Sunil-Chandra, 1994). Recently
the ability of MHV-68 to establish latency in mice deficient in B lymphocytes has been
studied using transgenic mice in which there is a disruption in the (I immunoglobulin chain
gene, resulting in an inability of pre-B cells in the bone marrow to develop successfully
(Usherwood et al., 1996b). In these mice little change was seen in the acute lung
infection or virus clearance, indicating that antibody does not contribute significantly to
recovery from the infection. Since a slight delay in viral clearance has been observed in
both CD4 T cell and B cell-deficient mice, it is possible that the removal of CD4+ T cells
deprives B cells of immunological help, resulting in a weaker antibody response to the
virus. No splenomegaly was observed in these mice and neither free nor latent virus
could be detected in their spleens. However, MHV-68 genome was detected in the lungs
of both control and the transgenic mice by PCR analysis. These data would seem to
suggest that although cells in the lung may act as a reservoir of latent virus which is
independent of the B cell infection, the splenic B lymphocytes are the major reservoir for
latent MHV-68.
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1.7.4 MHV-68 as a model for Epstein-Barr virus
EBV is the best known human virus in the gammaherpesvirus sub-family and humans are
the exclusive natural host. EBV is generally transmitted by saliva and approximately 90%
of the human population are latently infected (Wolf et al., 1993a). The virus is most
commonly involved in asymptomatic infections early in childhood or in the classical
infectious mononucleosis (glandular fever) of adolescents in the developed world.
However, the virus was first described by Epstein, Barr and Achong in cells from a
common lymphoma in African children studied by Burkitt (Burkitt, 1962). A viral
aetiology for the tumour is now well-established (Epstein et al., 1965; Magrath et al.,
1992) and an association between EBV and a number of lymphoproliferative diseases
exists (Rickinson and Kieff, 1996; Young et al., 1989). EBV has a very limited tissue
tropism, defined by the expression of CD21, the receptor for the virus which is expressed
on mature resting B lymphocytes and on cells of the basal layer of stratified squamous
epithelium (Nemerow et al., 1985). Virus production is restricted to the differentiated
cells of the granular layer and above (Sixbey et al., 1983). Since it is technically very
difficult to grow differentiating epithelia in culture, studies of the replication of EBV have
been limited. It is known that cell-mediated immunity is essential for controlling EBV-
associated disease since individuals with either acquired or congenital immunodeficiency
have difficulties in resolving EBV infections (reviewed in White and Fenner, 1994). The
lack of an effective model for EBV infections means that relatively little is known about
the interactions of EBV with the host immune system. The known association of EBV
with tumours such as nasopharyngeal carcinoma and Burkitt's lymphoma (Magrath, 1990;
reviewed in Rickinson and Kieff, 1996; zur Hausen et al., 1970), together with the facts
that the only natural host for EBV is man and that there is no completely productive or
permissive system for culture of the virus, emphasise the need for an animal model to
study the natural history of this virus. MHV-68 infects a wide variety of cell types from a
number of different species. It has similar coding sequence organisation and related
proteins to both EBV and HVS. MHV-68 latently infects B lymphocytes and several
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features of the primary and persistent infection resemble EBV infection in man. In vitro
studies with MHV-68 and the mouse model of infection with this virus therefore provide
invaluable tools with which to study detailed events in the life cycle of
gammaheipesviruses.
1.8 Suppression of immune responses to infectious diseases
by UV exposure
The evidence presented in section 1.4 demonstrates the role of UVB in the suppression of
cutaneous immune responses. There is growing concern about the implications of UV-
induced immunosuppression for the pathogenesis of infectious disease. The currently
available data, although limited, would seem to suggest that UVB exposure can indeed
affect the immune response to pathogenic organisms and is discussed below.
1.8.1 Human infections modulated by UV radiation
Three viral infections of human subjects provide evidence for the influence of UVR, in the
form of natural exposure to sunlight, on viral pathogenesis; namely infections caused by
HSV, human papillomavirus (HPV) and HIV.
1.8.1.1 Herpes simplex virus
HSV and its pathogenesis have been discussed more fully in section 1.6.1. Briefly, the
virus replicates in epidermal cells and then is capable of establishing latency in the
trigeminal ganglia and upon appropriate stimulation is able to travel back to the periphery,
where it can replicate and cause a clinically apparent lesion. One of the commonest and
most recognisable triggers for this phenomenon of recrudescence is exposure to UV and,
in a study group in Edinburgh, 30% of the subjects who suffered from frequent orolabial
lesions identified sunlight as a stimulus for the virus to recur (Vestey et al., 1989).
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It is not known how UV acts as a stimulating factor although a temporary suppression in
various immune responses at the time of a recrudescence has been described, such as NK
activity, HSV-specific lymphoproliferation and IFN production (Norval, 1992). It is
possible, therefore, that an asymptomatic recurrent infection, where the virus reaches the
epithelial cells from the neurons, could progress to a clinically apparent lesion if there is a
delay in, or down-regulation of, the normal cell mediated immunity (Yasumoto et al.,
1987). Certainly UV has been shown to reduce the capacity of epidermal cells to present
HSV antigens at the site of exposure (Howie et al., 1986). In addition, some
inflammatory mediators released in skin following UV radiation, such as prostaglandins,
may enhance HSV replication and increase the number of virus particles released per
infected cell. However, whether UV-induced immunosuppression in the local cutaneous
site is critical to the development of the recrudescence or whether this modulation is
connected to some, as yet, undefined neurotransmitter is not known.
1.8.1.2 Human papillomaviruses
Cutaneous and mucocutaneous infections with various types of HPV are associated with
the development of several tumours. With regard to UV, the most relevant of these are the
squamous cell carcinomas (SCC) found in immunosuppressed individuals and in those
subjects with the rare genetic disease, epidermodysplasia verruciformis (EV). In the
former group, there is a high incidence of warts compared with the general population and
the number rises in proportion to the duration of graft survival. Similarly the incidence of
SCC is high and rises with graft survival so that, for example, in South-East Scotland
20% of renal allograft recipients had HPV infection and 2% skin cancers up to 5 years
post-transplantation; from 5-22 years post-transplantation these figures increased to 77%
and 13% respectively (Barr et al., 1989). The development of SCC is almost totally on
areas of the body exposed naturally to sunlight, such as the backs of the hand and the
face, and in addition, the prevalence of these tumours is highest in sunny climates. Recent
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studies have shown that at least 65% of such SCC contain HPV DNA covering a variety
of types, including the EV types (Proby et cil., 1996). In EV itself, there is the
development of multiple flat warts and macular lesions induced by at least 20 HPV types,
and an underlying defect in cell-mediated immunity which has not been defined. During
the third decade of life in one-third of the patients, some of the warts progress to SCC,
most frequently on sun-exposed areas of the body (Majewski and Jablonska, 1995).
The precise roles of UV and HPV in the oncogenic process have not been defined and a
complex relationship is envisaged. It is believed that HPV alters the local cutaneous
immune environment to enable it to persist. For example, decreased LC numbers and
altered cytokine patterns have been observed in association with HPV infections (Jackson
et ai, 1994; Jackson et al., 1996a). Exposure to the sun may induce changes in epidermal
DNA which could be perpetuated and amplified by the cellular proliferation stimulated by
HPV infection. In addition the irradiation could alter local immune responses leading to
lowered surveillance. This could be significant even if the individual is already
immunosuppressed as a result of taking drugs, as in the renal allograft recipients, or due
to a genetic defect, as in EV.
1.8.1.3 Human immunodeficiency virus
There is a major cutaneous involvement in HIV infections with more than 90% of subjects
developing disorders of the skin or mucous membrane. This can occur at any stage of the
disease, not only during the terminal immunodeficiency. Indeed in many cases the skin is
the first organ affected and the ability to generate DTH responses has been suggested as a
more accurate indicator of disease progression than CD4 counts in the blood (Henry and
Tschachler, 1996).
Several in vivo and in vitro investigations have shown that exposure to UV can lead to
activation of HIV and its promoter. For example, latent HIV in chronically infected
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cultured monocytes was activated by UVB (Stanley et al., 1989), and HIV gene
expression was induced by sunlight in transgenic mice carrying the long terminal repeat
(LTR) and tat gene elements (Vogel et al., 1992). The mechanisms whereby UV radiation
promotes LTR activation have been studied and there is evidence for the involvement of
DNA damage and of cellular transcription factors.
Data on the situation during natural HIV infection are lacking, especially at the early stages
of the disease. Patients infected with the virus have a variable, but frequently prolonged,
latent period before symptoms of AIDS develop. Activation of transcription of viral
structural genes is thought to represent a critical step in this process. As many HIV-
infected individuals use sunlamps cosmetically or have holidays in the sun, and, as
treatment of their skin conditions may involve phototherapy (Adams et al., 1996), it is
important to establish whether UV exposure could lead to disease progression or to a drop
in CD4 T cell numbers. There is the additional worry that, as HIV infection is thought to
cause a shift from a type 1 to a type 2 profile of cytokine production (Clerici and Shearer,
1993), this may be accentuated by UV irradiation.
1.8.2 Animal models of infectious disease
A variety of mouse and rat models have been developed in which the effect of UV on the
course of infection and on resistance can be assessed. An outline of the results obtained
from these models is shown in Table 1.2. As indicated, the protocols involve different
organisms administered by different routes and, in addition, the doses and wavelength of
UV, the lamps, the timing of the irradiation with respect to infection and whether the
infection occurs at an exposed or unexposed site vary between one model and another. An
additional complication arises from the different parameters employed to determine any
effect of UV on the outcome of infection, ranging from clinical symptoms and counting
the number of organisms to measurement of antigen-specific immune responses, such as
DTH and lymphoproliferation. However, in many instances, suppression of immunity can
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be demonstrated and, in addition, a decreased ability to clear the pathogen. It is interesting
to note that UV exposure can influence both skin-associated infections, such as HSV, and
others which are systemic with no cutaneous involvement. One example of the latter
category is Trichinella spiralis infection in rats where the worms are administered by
mouth, with subsequent spread of the larvae from the gut to muscle tissue (Goettsch et ai,
1994). In this case the antigen presenting cells will be totally different from the
Langerhans' cells in the epidermis, but UV radiation is still capable of suppressing
immunity to the parasite and increasing the number of larvae in the muscle compared with
unirradiated control rats.
Recently an attempt was made to develop a quantitative risk assessment for lowered
resistance to infections in human subjects due to solar exposure (Garssen et al., 1996).
Using data generated for Listeria infection in the rat model and other results which
compared the effects of UV on immunological parameters in human and rat skin, it was
calculated that exposure to about 100 minutes of sunlight at noon in Italy or Spain would
suppress the lymphoproliferative response to Listeria by 50%.
1.8.3 Differential effects of UV radiation on T cell subsets in
infectious disease
Recent evidence has been obtained from murine studies in vitro and in vivo that UV
radiation may lead to the promotion of Th2 type responses with anergy of Thl responses.
These events are summarised in Figure 1.2.
Most work so far on the UV effects on Th subset induction has not involved
microorganisms except for two cases. In the first, mice were immunised with inactivated
Borrelia burgdorferi, a protocol which preferentially elicits a Thl response. The effect of
UV-B irradiation before immunisation on DTH, as a measure of T cell activity, and on
antibody subclasses as a means of distinguishing Thl and Th2 activity was assessed
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(Brown et al., 1995). In addition to stimulating cell-mediated inflammatory responses,
such as DTH and CH, Thl cells stimulate the production of IgG2a, IgG2b and IgG3
(opsonising and complement-fixing antibodies). In contrast, activation of Th2 cells
favours the induction of humoral responses, in particular the production of IgGl and IgE.
Irradiated animals demonstrated suppressed DTH to Borrelia on challenge. In addition the
IgG2a and IgG2b primary responses were reduced while the IgGl secondary response
was slightly elevated in the exposed mice. Thus these results indicate a depressed Thl
response but without a dramatic shift to a Th2 response. In the second study, it was found
that UV irradiation prior to intradermal infection ofmice with HSV-1 resulted in a marked
suppression of IFN-y production and enhancement of IL-4 synthesis by lymph node and
spleen cells compared with unirradiated controls (Yasumoto et al., 1994). In addition the
lesions were more severe in the irradiated animals. Thus a link between the UV-induced
alteration in cytokine profile and clinical symptoms is substantiated.
It is becoming clear that some microorganisms induce a predominant Thl or Th2 response
in mice and human subjects, and alteration of these profiles by cytokines or cytokine
antibodies can change host resistance or susceptibility. If the cytokine profile is
characterised, it may be possible to predict which particular microbial infections might be
affected adversely by UV exposure. Thus UV radiation could alter the outcome where a
Thl reponse is preferentially induced and is protective, but may not have measurable
effects in the case of a Th2 response unless this is associated with disease progression.
Studies regarding the effects of UV radiation on microbial infections are only just
beginning but it is important to recognise that, in addition to acting as a mutagenic agent,
exposure also modulates immunity. In three natural infections of human subjects and in
several animal models of infection, resistance is impaired together with suppressed
antigen-specific immune responses, and, in some cases, decreased ability to clear the
microorganisms. It is important to note that in many of the studies small doses of UV
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were employed, frequently suberythemal, and ones which would be encountered in
natural sunlight. In addition, while the incidence of skin cancer is known to be higher in
fair-skinned individuals than in those with highly pigmented skin (Cooper, 1996), there is
evidence that susceptibility with respect to infectious disease may affect people with darker
skins too (Oberhalman et al., 1994; Scheibner et al., 1987; Vermeer et al., 1991). This
would suggest that pigmentation provides no protection and hence the susceptibility group
for UV suppression in relation to infectious disease can be extended to the general
population (Cooper, 1996).
1.9 Aims
1) To study the effects of UVB on the elicitation phase of CH and to try to repeat the
findings of others, which indicate that exposure of mice to UVB prior to elicitation results
in an enhancement of the CH response. Such experiments better represent the natural
sequence of events in human contact sensitisation than traditional CH experiments.
2) To establish an effective protocol for the induction and elicitation of an MHV-68-
specific DTH response in C3H/HeN mice. It was anticipated that the effect of a single
sub-erythemal dose of UVB, or a series of such exposures on both the induction and
elicitation phases of this immune response would be examined.
3) To develop and characterise in vitro and in vivo murine models of HSV infection
and to study cytokine profiles, (IL-la, TNF-a and IL-10) at the mRNA level, in these
models following HSV infection, using semi-quantitative RT-PCR. The effect of UVB
irradiation on expression of these cytokines was also to be examined in a mouse
keratinocyte cell line.
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4) To carry out a preliminary investigation into the effects of UVB exposure on the
functional activity of human EC from skin blister roofs. The effect of in vitro and in vivo
UVB exposure on the alloantigen presentation by epidermal LC, as measured in a MSLR
were to be examined, as well as the effects of pre-treating EC with cis- and trans-UCA to
identify any role for UCA as a mediator of the observed UVB effects .
5) To examine the effects of a standard course of UVB phototherapy on two
parameters of systemic immunity, namely HSV-specific T cell cytotoxicity and NK cell
activity, in normal individuals. To date no studies have identified effects of broadband
UVB phototherapy on CTL activity directed at viral antigens. In addition, the phenotypes






2.1.1 Media and supplements
RPMI-1640 (Flow Laboratories, Irvine, Ayrshire, UK) was supplemented with 100
Iu/ml penicillin, 200(ig/ml streptomycin, 2mM L-glutamine, lOOpg/ml gentamicin,
lOjig/ml fungizone and 10% heat inactivated foetal calf serum (FCS; Gibco BRL.
Paisley, UK), designated RPMI-FCS throughout. Dulbecco's Modified Eagles
Medium (DMEM; Gibco) was supplemented as for RPMI, but without the addition of
L-glutamine since it contained glutaMAX™ (580p.g/ml).
2.1.2 Cells
Baby hamster kidney (BHK-21) cells were obtained from Prof.A.A.Nash (Department
of Veterinary Pathology, University of Edinburgh). They were cultured in DMEM
supplemented with 7% FCS and were used for growing MF1V-68 viral stocks and
initially for plaque assays. Vero cells were cultured in RPMI-FCS and were used for
HSV plaque assays and for some MHV-68 plaque assays as described. PAM-212
cells (Yuspa et al., 1980) were obtained from Dr.R.McKenzie (Department of
Dermatology, University of Edinburgh) and were cultured in DMEM-FCS,
supplemented with 25mM HEPES buffer (Gibco). L929 cells were cultured in RPMI-
FCS and were used as target cells in the murine cytotoxic T cell assay. K562 cells
were grown in RPMI-FCS and were used as target cells in the NK cell assays. Cells




2.1.3.1 Herpes simplex virus
The virus used throughout these experiments was a plaque-purified isolate of herpes
simplex virus type 1 (HSV-1) from a clinical case (Howie et al., 1986a). It was
passaged in vitro in Vero cells at a low multiplicity of infection (moi; 0.2 pfu/cell). The
titre of stock virus was determined by plaque assay (section 2.1.3.3) and the virus was
stored at -70°C in small aliquots for up to one year, after which the infectivity of the
virus diminished. Three different viral stocks were used throughout the study which
varied in titre from 2xl06 to lxlO7 plaque forming units (pfu)/ml.
2.1.3.2 Murine Herpes Virus-68
The Gil sub-stock of MHV-68 was obtained from Prof.A.A.Nash (Department of
Veterinary Pathology, University of Edinburgh). Viral working stocks were prepared
from this by infection of BHK-21 cells at a low moi of 0.1 pfu/cell. Virus
suspensions in DMEM were clarified by centrifugation, and the supernantant, as well
as the pellet were sonicated and the titre of each stock determined by plaque assay
(section 2.1.3.3). Viral stock titres varied from 2xl07 to 4xl08 pfu/mi.
2.1.3.3 Determination of viral titre
Plaque assays for infectious virus were performed using monolayers of BHK or Vero
cells in 96-well flat-bottomed plates (Nunclon, Roskilde, Denmark) with 0.25%
Seaplaque agarose (FMC Bioproducts, Rockland, ME. USA) in the overlay medium.
After 2-3 days incubation for HSV, and 4 days incubation for MHV (Sunil-Chandra et
al., 1992) at 37°C, the cells were fixed in formal saline, stained with 10% Giemsa,
and the plaques counted under the low power of a light microscope.
2.1.3.4 Preparation of viral antigen
UV-inactivated viral stocks were prepared by exposing thin films of sonicated virus to
approximately 300 mJ/cm2 UVB. UV-inactivated MHV-68 antigen was used in DTH
experiments and proliferation assays (sections 2.3.2 and 2.3.4). Sonicated BHK cells
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were used as control antigen in these experiments. UV-inactivated HSV was used in
the HSV-specific cytotoxicity assays (section 2.6.2).
2.1.4 Mice
C3H/HeN (H-2k) female mice were obtained from the specific-pathogen-free animal
breeding facility at the Department of Medical Microbiology Transgenic Unit,
University of Edinburgh. Mice were aged 6-10 weeks at the start of each experiment,
except in the case of some experiments involving infection with MHV-68 (see section
2.3.1), and mice did not differ in age by more than 2 weeks within any experiment.
The mice were housed in a room where ambient light was regulated on a 12 hour
light/dark cycle, and had free access to food and water.
2.1.5 UVB Irradiation
2.1.5.1 UVB source
Two Philips TL-20W/12 bulbs with an output range of 270-350nm (peak 305nm),
emitting 80 mW/cm2 were used throughout these studies (see Figure 2.1). The output
of this source was determined by Dr. Neil Gibbs (Photobiology Unit, University of
Dundee) using a filtered photodiode meter, calibrated against measurements made with
a UV-visible spectroradiometer (model 742, Optronic Laboratories) across the spectral
range 250-400nm. The tube to target distance was 16cm.
2.1.5.2 UVB irradiation of cells
PAM-212 cells, used for cytokine mRNA analysis (section 2.4.1), were irradiated as
monolayers in culture plates, prior to HSV infection. Medium was removed
immediately prior to U v exposure and the cells were bathed in phenol red-free
phosphate-buffered saline (PBS). The PAM-212 cells received 10-20 mJ/cm2 UVB.
Epidermal cells, undergoing in vitro UVB irradiation prior to use in mixed skin
lymphocyte reactions (section 2.5.1), were resuspended in 500 pi of PBS and
transferred to a sterile petri dish prior to UVB exposure. These cells received between
5-60 mJ/cm2 UVB as stated.
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Figure 2.1: Relative spectral energy distribution of a
Philips TL-20W/12 UVB lamp
2.1.5.3 UVB irradiation of mice
Mice were irradiated on the ears or shaved dorsum and were contained in a perspex
box, with a maximum of four mice per box to prevent shielding by littermates.
Control mice were dorsally shaved where apropriate. One MED for C3H/HeN mice
under these conditions was 150 mJ/cm2. Where avoidance of irradiation of the ears
was necessary, mice were anaesthetised by intra-peritoneal injection of 0.1ml sterile
distilled water containing 0.83mg/ml Hypnovel (Roche, Welwyn Garden City, UK)
and 1.67mg/ml Hypnorm (Janssen Pharmaceutical, Oxford, UK) and their heads were
covered with aluminium foil to protect them from UVB exposure.
2.2 Contact Hypersensitivity Experiments
2.2.1 Contact Sensitiser
4-ethoxymethylene-2-phenyloxazol-5-one (oxazolone; OXA) was obtained from
Sigma-Aldrich (Poole, UK). Oxazolone was dissolved in a 4:1 acetone : olive oil
(AOO) vehicle at 0.25% (w/v) for challenge and at 1% (w/v) for sensitisation.
2.2.2 UVB Irradiation
Mice were exposed on shaved dorsal skin to UVB irradiation doses equivalent to 70
mJ/cm2, which corresponds to 0.44 MED for this mouse strain. They were irradiated
daily for four days either on days -3 to 0 or days 4 to 7 of each experiment, as
described.
2.2.3 Measurement of contact hypersensitivity
2.2.3.1 Effect of UVB prior to sensitisation on the CH response
The CH reaction to OXA was measured 24 hours after challenge and the protocol was
based on that of Polla Polla, 1986 #264 . Briefly, 7 mice per group received a
sensitising dose of 50pl 1% OXA in AOO topically, on their abdomen, on day 0,
having been UVB irradiated on days -3 to 0 as described. Abdominal fur was
removed prior to sensitisation using electric clippers and the abdomen was then shaved
lightly with a razor blade to remove all traces of hair. CH was elicited on day 7 by
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challenging the dorsum of both ears of each mouse with 25pl of either 0.25% OXA or
AOO vehicle (VEH). Control groups of mice were either sensitised but not irradiated
or neither sensitised nor irradiated. Ear thickness was measured using a spring-loaded
micrometer (Draper Precision Instruments, Japan), as shown in Figure 2.2.
Measurements were made 24 hours after application of the challenge dose and
compared with ear thickness prior to challenge. The increment in ear swelling was
used as a measure of the development of CH. Mean values for incremental ear
swelling and standard errors of the mean (SEM) were calculated for each group. The
student's t test was used to compare the differences between mean values. Results are
expressed as the mean challenge-induced increase in ear thickness in mm'2 ± SEM.
2.2.3.2 Effect of UVB after sensitisation on the CH response
The experimental protocol was as described in section 2.2.3.1 except that mice were
UVB irradiated on days 4 to 7 after sensitisation and CH was elicited four hours after
the final irradiation on day 7. Additional control groups were included in which mice
were sensitised with VEH, UVB irradiated as described on days 4 to 7 and then
challenged with OXA. The mean response for this group, in which ear swelling is
assumed to be due to the UVB treatment alone, was used to control for this swelling in
the experimental group, in order to determine whether any enhancement in the specific
CH response was elicited. In later experiments, mice were UVB irradiated on days 3
to 6 so that challenge took place 24 hours after the final UV exposure, by which time
UV-induced swelling of the ears was negligible. In experiments designed to study the
systemic effects of UVB on this system, mice were anaesthetised and their ears
covered during UV exposure as described in section 2.1.5.3.
The percentage suppression was calculated as described (Noonan et al., 1984),
according to the formula :-
% suppression = 100 - { 100 x net increase in UV-irradiated mice!
{ net increase in control mice }
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Figure 2.2 Measurements of mouse ear thickness made using
a spring-loaded micrometer
2.3 MHV-68 Experiments
2.3.1 MHV-68 infection of mice
Mice were inoculated intranasally with 4xl05 pfu MHV-68. The volume of the
inoculum varied from 20-40|il per mouse, depending on the viral stock used. Mice
were lightly anaesthetised with halothane before administration of the virus, as this
aided inhalation of the inoculum. Control mice were infected with an equivalent
number of sonicated BHK-21 cells (lxlO4 per mouse), suspended in the same volume
of PBS and sonicated prior to use. In certain experiments latently infected mice were
required and these were infected intranasally when 3-4 weeks old as described, at least
three weeks before the start of the experiment to allow latency to be established.
2.3.2 Delayed-type hypersensitivity (DTH) assay
Mice were infected intranasally at 6 weeks of age, as described above and eight days
after this primary infection, they were individually tail-marked within each group, and
their ear thicknesses were measured using a micrometer gauge, as shown in Figure
2.2. The mice were then challenged by injection of lOpl containing 4xl06 pfu UV-
inactivated MHV-68, using a 31 gauge needle, in both ear pinnae. Twenty-four hours
after challenge the ear thicknesses were again measured and the increase in each ear
thickness was calculated. A mean and SEM for each experimental group were
calculated and the student's t test was used to compare the differences between mean
values.
2.3.2.1 The effects of UVB on the DTH response to MHV-68
2.3.2.1 (i) The effect of UVB on the sensitisation phase of DTH
To identify any effects of UVB irradiation on the generation of DTH to MHV-68, mice
were irradiated with 96 mJ/cm2 UVB (corresponding to 0.6 MED in these mice) as
described in section 2.1.5.3, three days prior to initial infection with MHV-68. The
DTH response was elicited as described eight days later and the mean increase in ear
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thickness per group was calculated as well as the SEM. Percentage suppression was
calculated according to the formula shown in section 2.2.3.2.
Any subsequent challenges of the mice, used to investigate the establishment of
tolerance, were made at 2 week intervals and no additional UV exposures of the mice
were carried out.
2.3.2.1 (ii) Attempt to transfer MHV-68-specific tolerance into syngeneic mice
The protocol employed was based on that of Howie (Howie et al., 1986b). Briefly,
mice were sensitised as described for a DTH experiment, with either BHK-21 cell
sonicate (lxlO4 cells/mouse) or MHV-68 (4xl05 pfu/mouse) intranasally. Eight days
later single cell suspensions of spleen cells were prepared from untreated control mice,
and from mice exposed to 96 mJ/cm2 UVB prior to sensitisation with MHV-68 and
demonstrated to exhibit a depleted DTH response. Red blood cells were lysed by brief
exposure to sterile distilled water. The remaining splenocytes were counted and
resuspended at 2xl08 cells/ml in PBS. The cell suspension was allowed to warm to
room temperature and 2xl07 control or UV-spleen cells were transferred intravenously
(i.v), by tail vein injection, into MHV-68-sensitised mice (eight per cell type).
Twenty-four hours later the recipient mice, along with mice sensitised with BHK-21
cell sonicate and MHV-68 to act as negative and positive controls for the DTH
response respectively, were challenged in the dorsum of each ear. The mean increase
in ear thickness was calculated for each group, as well as the SEM.
2.3.2.1 (iii) The effect of UVB on the elicitation phase of DTH
Groups of mice were either infected with MHV-68 on day 0 or were latently infected
(see section 2.3.1) with MHV-68 at the time of UVB exposure. They were exposed to
one of two UVB regimes; either 96 mJ/cm2 per day on days 6, 7 and 8, or 144
mJ/cm2 once, on day 8. Groups of positive control, unirradiated animals were
included which were either infected on day 0 or were latently infected at this time. All
mice were challenged on day 11.
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2.3.3 The effects of UVB on viral titre
Mice were either exposed to 144mJ/cm2 UVB on their shaved dorsum or were shaved
but unexposed to UVB. Twenty-four hours later all mice were infected with MHV-
68. On days 1. 3, 5 and 10 after infection, mice were killed and their lungs and
spleens removed aseptically and stored in PBS at -70°C. Organs from 3 mice per
group were pooled for each time-point. Organs were homogenised in 500pl PBS in a
lml glass homogeniser (Jencons, Leighton Buzzard, UK). Tissue suspensions were
sonicated before being centrifuged at 10,000g for 10 mins and the supernatants
collected. The supernatants were assayed for infectious virus particles as described in
section 2.1.3.3.
To determine whether a sub-erythemal dose of UVB irradiation was able to cause
reactivation of latent virus in mice, latently infected mice (section 2.3.1) were exposed
to 144 mJ/cm2 UVB on shaved dorsal skin. Spleens from these mice were collected
on days 2, 4 and 6 after UV-exposure and homogenised as described above. The
supernatants were assayed for infectious viral titre by plaque assay and compared with
homogenate supernatants of organs taken from latently infected but unexposed mice.
2.3.4 Lymphoproliferative response to MHV-68
At various time intervals after either primary or secondary MHV-68 infection, mice
were killed by cervical dislocation and lymph node or spleens were removed
aseptically and collected in PBS containing 10% FCS. Single-cell suspensions were
prepared by mechanical disaggregation of tissue through 200-mesh stainless steel
gauze (J.Stanier and Co, Manchester, UK). Red blood cells in the spleen cell
suspensions were lysed by brief exposure of the cell suspension to sterile distilled
water. The cells were washed twice in RPMI-FCS and viable cells counted by
exclusion of 0.5% trypan blue. Cells were plated out into 96 well round-bottomed
plates at a concentration of 2xl05 cells/well. They were stimulated in triplicate wells
with either concanavalin A (con A; 2.5pg/ml), UV-inactivated MHV (equivalent to moi
of 1, 0.5 and 0.25) or BHK cell sonicate (2xl02 cells/well) in a total volume of 200pl.
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Control wells were also included containing lymphocytes and RPMI-FCS only.
Cultures were incubated for 4 days at 37°C before being pulsed with 0.7|iCi [3H]-
methyl thymidine (Amersham Life Sciences, Little Chalfont, UK) per well over the
final 24 hour culture. The cells were then harvested onto glass fibre filters using an
Automash 2000 cell harvester (Dynatech, UK). One ml of hydro-lumo scintillant
(Luman, Belgium) was added to each vial before counting and the [3H]-methyl
thymidine incorporation measured in counts per minute (cpm) using a liquid
scintillation counter (Canberra Packard, Zurich, Switzerland). The results are
expressed as cpm ± SEM.
2.4 Cytokine profiles following HSV infection of
keratinoctyes in vitro and in vivo
2.4.1 In vitro infection of PAM-212 cells
The spontaneously transformed mouse keratinocyte cell line PAM-212 was used and
cells were plated out at cell density of approximately lxlO5 cells per well in 6 well
culture plates (Nunc, Gibco, Paisley, UK) or in 25cm2 cell culture flasks (Falcon,
Oxnard, USA). Once 80% confluent the cells were infected with HSV at moi of 0.5.
For RNA extraction, cells were washed in PBS and then lysed at various time-points
after infection in ice-cold reagent D (4M guanidinium isothiocyanate, 25mM sodium
citrate pH7, 0.5% sodium lauryl sarkosinate, 0.1M 2-mercaptoethanol) and stored at
-70°C. Time-courses were also carried out in which PAM-212 cells were either UVB-
irradiated alone (10mJ/cm2), as described in section 2.1.5.2, or UVB treated
immediately prior to identical HSV infection. Within each experiment three wells per
time-point for each treatment were used. Identical experiments were set up for
determination of cytokine protein production. Culture supernatants were collected and
centrifuged at lOOOg for 5 mins before use. Cells were lysed in a triple detergent lysis
buffer (50mM Tris-HCl (pH 8.0), 150mM NaCl, 0.02% sodium azide, 0.1% sodium
dodecyl sulphate (SDS), 1% NP-40, lOOpg/ml phenylmethanesulphonyl fluoride
(PMSF), lpg/ml aprotinin, 0.5% sodium deoxycholate) at 0, 12 and 24 hours after
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infection/UVB treatment. These supernatants and lysates were used in an IL-10
ELISA (section 2.4.8).
2.4.2 In vivo infection
C3H/HeN mice were shaved dorsally and then anaesthetised with halothane before
their dorsal skin was lightly tape-stripped approximately 6-8 times, and infected
epicutaneously with HSV (approximately lxlO5 pfu per mouse in a 20|il volume) by
rubbing the virus into this site with a plastic pippetie tip. Mice were killed at 0, 3, 6,
12, 24, 48, 72, 96 and 120 hours after treatment and 1-1.5 cm2 pieces of back skin
were removed. Any sub-cutaneous fat was carefully removed and the skin was cut
into pieces using a sterile scalpel blade, before being immediately homogenised on ice
in 4M guanidinium isothiocyanate using an Ultra-Turrex T8 hand-held electric
homogeniser (IKA Laboratories, Stafen, Germany). The homogeniser was
decontaminated between samples by soaking in a 1% Virkon solution. A time-course
following tape-stripping alone, without infection, was also carried out to control for
this procedure. Three mice were used per time-point for each treatment where
possible. Samples of skin were also collected and frozen at -70°C for cryostat
sectioning. All mice developed lesions between days 3-8 following infection. In a
few instances mice developed zosteriform lesions which resulted in hind-leg paralysis
and these mice were killed immediately.
2.4.3 Immunohistochemistry
PAM-212 cells were cultured in eight-chamber slides for immunocytochemical staining
(Life Technologies, Glasgow, UK). Cryostat sections (5pm) were cut from the mouse
back skin samples and these were air-dried overnight before being fixed in acetone for
20 mins at room temperature. Slides were air-dried and stored at -20°C until required.
Indirect immunoperoxidase staining was then performed on the PAM-212 cells and
frozen tissue sections using an anti-HSV type-1 purified immunoglobulin fraction of
rabbit antiserum (DAKO, Glostrup, Denmark), known to react with all the major HSV
glycoproteins and at least one core protein. Staining was carried out in a Sequenza
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(Shandon Life Science International, Basingstoke. UK), a semi-automated
histochemical staining unit. Slides were placed in plastic disposable cassettes which
allow a controlled flow of solution over the sample. Briefly, monolayers or sections
were washed in Tris-buffered saline (TBS) and endogenous peroxidase activity was
blocked by incubation in 1% hydrogen peroxide in methanol for 10 mins. Sections
were incubated for 20 mins in normal rabbit serum (1:5 dilution in TBS) to block non¬
specific background staining. They were then incubated for 30 mins with the rabbit
anti-HSV type 1 antibody diluted optimally to 1:100 in TBS. Sections were then
exposed to the secondary antibody, biotinylated goat anti-rabbit immunoglobulins
(DAKO, High Wycombe, UK) at a 1:400 dilution in TBS. After a 20-30 min
incubation with avidin/horseradish peroxidase (HRP; Vector Laboratories,
Peterborough, UK), sections were incubated for 3-5 mins with the peroxidase
substrate, 3,3'-diaminobenzidine terahydrachloride (DAB; Sigma), made up by
dissolving a lOmg DAB tablet in 10ml of distilled water with the addition of 14pl
hydrogen peroxide. Sections were counter-stained with haematoxylin and Scott's tap
water substitute, dehydrated by passing through increasing concentrations of solvent
and then mounted in DPX (BDH, Poole, UK). Using this technique, positive
staining appeared as a brown colour. Control sections were stained using an anti-
cytomegalovirus (CMV) isotype control antibody (DAKO).
2.4.4 RNA extraction
Total RNA was extracted from cell and tissue lysates using a phenol-chloroform
procedure (Chomczynski and Sacchi, 1987). Briefly, the samples were extracted
twice with phenol / chloroform / isoamylalcohol (25:24:1 v/v) and precipitated
overnight at -70°C in 0.6 volume of ethanol to selectively precipitate RNA (Jackson et
al., 1996). The RNA was then washed in 70% ethanol, dried and dissolved in 20-40jil
distilled water. Samples were then quantitated spectrophotometrically (Philips
spectrophotometer model PU8625) and stored at -70°C.
82
2.4.5 Reverse transcription
2pg total RNA was used as a template to generate complementary DNA (cDNA). The
volume was made up to 9|ll and the RNA denatured at 65°C for 2 mins, and then
immediately quenched on ice. A reverse transcription (RT) cocktail was then added to
each sample which consisted of : 1 x RT buffer (50mM Tris-HCL 75mM KC1. 3mM
MgCl2); 1.25mM each dinucleoside triphosphate (dNTP); 30 units human placental
RNase inhibitor; 200 units Moloney murine leukemia virus reverse transcriptase (M-
MLV RT); 2)ig oligo dT(is); 0.01M dithiothreitol (DTT) to give a total volume of 20 (il
per reaction. After incubation for 1 hour at 37°C, the reaction was terminated by
heating to 95°C for 5 mins. The M-MLV RT, 5x RT buffer and DTT were obtained
from Gibco and the dNTPs, RNA guard and oligo dT were obtained from Pharmacia
Biotech (St. Albans, Herts, UK).
2.4.6 Semi-quantitative PCR
2.4.6.1 Primer labelling
Each primer was y{32P]-dATP -end labelled in a 30pl reaction mix consisting of 5p.M
primer, 5mM DTT, 30 units T4 polynucleotide kinase (PNK) (New England Biolabs,
Beverly, MA, USA,) lx PNK buffer (70mM Tris-HCl, lOmM MgCb) and 5pl
0.08mCi/ml y{32P]-dATP (ICN Biochemicals, Thame, Oxfordshire, UK) at 37°C for
1 hour before denaturing at 95°C for 5 mins.
2.4.6.2 PCR amplifications
PCR was performed using 2|il RT-reaction in a PCR cocktail containing 0.08mM
dNTP mix (Pharmacia Biotech); 0.5units thermally stable "Red-hot" DNA polymerase
(Advanced Biotechnologies Ltd, Leatherhead, Surrey, UK); 1 x PCR buffer (20mM
(NH4)2S04, 75mM tris-HCl, 0.01% Tween) and lpM tetramethylammonium
chloride (TMAC; ICN Biochemicals). For each primer set the optimum Mg2+
concentration of the PCR mix was determined to eliminate non-specific signals and is
shown in Table 2.1. Reactions were overlayed with 20(ll of mineral oil to prevent
evaporation. All PCR reactions were 'hot-started' (D'Aquila et al., 1991) by addition
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of 0.375pM of each primer in a 1.5|il mix at 85°C and amplified on a Techne PHC-3
or Gene-E dri-block cycler (Techne, Cambridge, UK) at 94°C for 1 min
(denaturation), 65°C for 1 min (annealing) and 72°C for 1 min (polymerisation). [3-
actin, IL-la and IL-10 primer sets were purchased from Pharmacia Biotech and TNF-
a primers were obtained from Clontech (Palo Alto, CA, USA). Primer sequences and
the size of predicted cDNA amplification product are listed in Table 2.1. The optimum
number of cycles was determined for each set of primers by plotting product
accumulation against cycle number, following autoradiography (section 2.4.6.3). The
cycle number for further amplifications was chosen from a point within the linear
exponential portion of the plot to ensure that the PCR reaction for each cytokine was
not saturated.
2.4.6.3 SDS-PAGE and autoradiography
Radioactive y{-^Pj-dATP-labelled PCR products were resolved on 12% SDS-
polyacrylamide electrophoresis (SDS-PAGE) at 150 volts for 1.5 hrs. PCR products
were identified on the basis of their predicted size. The gels were exposed to Kodak X
Omat AR autoradiography film (Sigma). Autoradiographs were developed using
AGFA developer and fixative (HA West Ltd, Edinburgh, UK) and were visualised on
the Seescan system image analyser (Seescan, Cambridge, UK) and integrated optical
density (OD) units were obtained using gel analysis software vl .0 ID (Seescan). The
house-keeping gene (3-actin was used to control for differences in abundance of cDNA
resulting from variation in the efficiancy of each RT reaction. This was done by
normalising the densitometry values for each sample to that of the [3-actin gene signal
for that sample. The ratio of integrated OD units for each cytokine : (3-actin, was used
to compare relative cytokine mRNA expression at time-points after treatment. All
samples and controls in a particular experiment were amplified within the same run,
subjected to SDS-PAGE and autoradiographed at the same time. All PCR reactions
for each cell / tissue sample used cDNA from identical RT reactions. All PCR
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2.4.7 Controls
RNA from phorbol-12-myristate-13-acetate (PMA)-stimulated EL-4 cells (mouse T
cell line) was used as a positive control for (3-actin and IL-10 mRNA expression. For
TNF-a mRNA expression, RNA from mouse spleen cells stimulated with 5 pg/ml con
A for 24 hours was used as a positive control RNA source and for IL-la, RNA
extracted from tape-stripped mouse ear homogenate was used. Negative controls
consisted of cDNA synthesis reactions of RNA from positive controls without the
reverse transcriptase enzyme, in order to rule out the possibility of amplifying genomic
DNA. PCR reactions with distilled water instead of cDNA were also used to check for
contamination of PCR reagents.
2.4.8 IL-10 specific ELISA
A mouse IL-10 ultrasensitive Immunoassay kit was purchased (Biosource
International, Camarillo, CA, USA) and used according to the manufacturer's
instructions to detect IL-10 protein in the range of 0.62-80 pg/ml.
2.5 Mixed skin lymphocyte reaction (MSLR)
2.5.1 Preparation of epidermal cell suspensions
The method used was as that of Vestey et al (1990). Briefly, suction blisters were
raised under negative pressure from UV-unexposed areas of either the lower forearm
or upper, inner arm. A set of raised suction blisters are shown in Figure 2.3. The
roofs were cut off and placed in 0.5% trypsin (Sigma). They were incubated at 37°C
for one hour with regular agitation and then gently pipetted to disaggregate the cells
and give a single cell suspension. 15% heat-inactivated pooled human serum was then
added before the cells were washed twice in PBS and then resuspended in RPMI
supplemented with 10% human serum at concentrations of 6xl04, lxlO5 and 3xl05
live cells/ml.
86
Figure 2.3 Skin blister roofs
Suction blister cups were held in place using an elasticised bandaged. An negative
pressure of -300mmHg was applied using a hand-operated pump. Suction blisters were
raised in 45-60 minutes and the blister roofs were removed using sterile scissors.
Epidermal cell suspensions were prepared as outlined in section 2.5.1.
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2.5.2 Cis- and trans-UCA treatment of epidermal cells
Epidermal cells were resuspended in lOOpl of either cis- or trans-UCA at a
concentration of 100 |lg/ml, or PBS for 1 hour at 37°C. The cells were then washed
and resuspended at the appropriate concentration. Trans-UCA was purchased from
Sigma and cis-UCA was obtained by preparative thin layer chromatography of UVB-
irradiated trans-UCA as previously described [Norval, 1989 #930]
2.5.3 UVB treatment of epidermal cells
For in vitro exposure suction blisters were raised from an unirradiated site,
disaggregated as described and then the cell suspension irradiated with 5-60 mJ/cm2
UVB, as described in section 2.1.5.2.
For in vivo exposure of epidermal cells, the MED of each donor was determined using
a Philips 20W T12 bulb housed in a plastic tube with 10 apertures, the light from
which was attenuated to varying degrees by metal foil, to give a range of known UV
irradiances (Dept. of Medical Physics and Medical Engineering, University of
Edinburgh). The tube was held against (unexposed) back skin for 1 minute and the
lowest amount of UVB which produced a visible erythema 24 hours after exposure
was recorded as the MED for that individual. A previously UV-unexposed area of the
upper fore-arm, sufficiently large to cover the area of the suction blister cup, was
exposed each day for 7 days with 0.5 MED UVB. On day 8, suction blisters were
taken from the irradiated and also an unirradiated control site.
2.5.4 Preparation of peripheral blood mononuclear cells (PBMC)
Venous blood from an individual, assumed to be allogeneic, was collected into
preservative-free heparin (10 U/ml final concentration) and PBMC were isolated by
centrifugation (1500g for 20 min) on Lymphopaque (Nyegaard Ltd. Birmingham,
UK). Cells were washed three times before the viable cell number was determined by
trypan blue exclusion. Cells were resuspended in RPMI containing 15% heat-
inactivated pooled human serum, at a concentration of lxlO6 cells/ml. In some
experiments Mini-MACS separation of PBMC was carried out to obtain a CD3-
purified cell population which was used as responder cells.
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2.5.5 MSLR
lxlO5 PBMC were incubated in 96 well round-bottomed plates (Nunc) with epidermal
cells, at various responder to target cell ratios, at 37°C for 4 days. Control wells were
set up containing PBMC or epidermal cells alone. All tests were done in triplicate.
Cells were pulsed with 0.7p.Ci [3H]-methyl thymidine (Amersham Life Sciences,
Little Chalfont, UK) added to each well over the final 18 hour culture. The cells were
then harvested and the [3H]-methyl thymidine incorporation measured as described in
section 2.3.4. The data are represented as the mean cpm ± SEM from triplicate
cultures. Some results are expressed as the mean stimulation index ± SEM.
Stimulation indices were calculated as:
stimulation index = mean cpm test
mean cpm control
The percentage suppression of the MSLR for the experiments in which EC were
treated with cis- and trans-UCA, were determined using the equation in section
2.2.3.2.
2.6 Effect of phototherapy on systemic immune function
2.6.1 Broadband UVB phototherapy
Subjects known to be seropositive for HSV were exposed to whole-body broad-band
UVB in a Waldmann 1000 cabinet containing 26 Sylvania UV6 fluorescent tubes
(approximate spectral output 280-400 nm, peak output 323 nm; 0.3% UVC, 58%
UVB and 42% UVA) at the Department of Dermatology, Royal Infirmary of
Edinburgh. Subjects were treated three times a week for four weeks, with incremental
doses of UVB, depending on skin type, as previously described (Gilmour et al.,
1993). The study protocol was approved by local ethics committees. Blood samples
were taken from subjects before treatment started and at 10, 20 and 30 days after the
start of treatment.
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2.6.2 Human HSV-specific T cell cytotoxicity assay
2.6.2.1 Generation of cytotoxic T lymphocytes
In order to generate cytotoxic T lymphocytes (CTL) in vitro, a method described by
Tarpey et al. (1994), based on the protocol outlined by Macatonia et al (1991) was
employed and is summarised in Figure 2.4. Venous blood was collected from an
HSV-seropositive subject and PBMC were separated from whole blood by
centrifugation on Lymphopaque as described in section 2.5.4. Adherent and non¬
adherent cells were separated by incubation of PBMC in a T75 culture flask for 1 hour
at 37°C. Non-adherent cells (population A) were removed from the flask in the
supernatant, collected as a pellet by centrifugation at 600g and resuspended in fresh
RPMI containing 10% autologous plasma. Dendritic cell (DC)-enriched cell
populations were then prepared by density gradient centrifugation on metrizamide
Nygaard, Oslo. Norway) as described by Macatonia (1986). Briefly, 5mls of non¬
adherent cell suspension was carefully layered onto 5 mis of 14.5% metrizamide,
made up just prior to use, in RPMI containing autologous serum (RPMI-serum). This
gradient was then centrifuged for 20 mins at 600g at room temperature. The low
buoyant density population (DC+) that accumulated at the interface was collected and
washed twice in medium. DC were resuspended in 2mls RPMI-serum and were
incubated with lOOpl UV-inactivated HSV (equivalent to lxlO6 pfu) at 37°C for 2
hours. They were than washed and recombined with washed population A cells at a
ratio of between 40:1 and 10:1, depending on DC yield. Cells were cultured in 24
well plates (Nunclon) in RPMI-serum at approximately 2xl06 cells per well for 6 days
prior to the cytotoxicity assay.
2.6.2.2 MiniMACS cell separation
The in vitro stimulated cells were harvested and used as the CTLs in the cytotoxicity
assay. Purified populations of CD4 and CD8 expressing cells were prepared from
these CTLs using a MiniMACS cell separation column (Miltenyi Biotec Inc, Bisley,
Surrey, UK) according to the manufacturer's protocol. Briefly, enrichment for CD4+
cells was carried out directly using MACS microbeads coated with CD4 antibody and
90
Figure 2.4 Schematic of the protocol for the generation of CTL and
HSV-specific cytotoxicity assay
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enrichment for CD8+ cells was carried out indirectly using a mouse anti-CD8
monoclonal antibody, followed by goat anti-mouse IgG microbeads.
2.6.2.3 Preparation of target cells
The target cells for the cytotoxicity assay were autologous B cell lines (BCL) prepared
for each subject by transformation with Epstein-Barr virus. The transformation was
carried out by Sarah Lockett, Centre for HIV Research, ICAPB. University of
Edinburgh. One million BCLs were resuspended in lOOpl of UV-inactivated HSV
(lxlO6 pfu equivalent) and incubated for 2 hours at 37°C. Control cells were
incubated for 2 hours in RPMI only. BCLs were then washed and labelled by
incubation with lOOqCi of Na2[5'CrJOq ([51Cr], Amersham Life Sciences) for 2
hours at 37°C. The cells were again washed twice in RPMI-FCS and resuspended in
medium at 5xl04 cells/ml. Two round-bottomed 96 well plates (Nunc) were prepared
with wells containing lOOpl of either HSV-target cells or control target cells.
2.6.2.4 Cytotoxicity assay
CTLs and the CD4+ and CD8+ enriched cell populations were washed twice and
resuspended at 2xl06 cells/ml. A doubling dilution of each cell type was then carried
out and lOOpl of each cell suspension was added to wells, in triplicate, in order to give
final effector to target cell ratios of between 40:1 and 1.25:1. Identical plates were set
up using the control and HSV-target cells. Spontaneous [51Cr] release was
determined by addition of lOOpl of RPMI-FCS to triplicate wells of each set of target
cells. Maximum release was determined by addition of lOOjil of 2% acetic acid to
triplicate wells of the target cells. The assays were incubated at 37°C for
approximately 18 hours. To harvest the assay, the plates were centrifuged at 500g for
10 minutes before lOOql of the supernatant from each well was removed for
determination of radioactivity (mean cpm) using a Packard liquid scintillation counter.
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Mean percentage release values were calculated according to the formula
% specific [51Cr] release = [test release - spontaneous release ] x 100
[maximum release - spontaneous release ]
These assays were carried out with the assistance of Bill Neil.
2.6.3 Determination of Natural Killer Cell Activity
K562 erythroleukaemic cells, which are sensitive to lysis by NK cells were used as
target cells in this assay (Lozzio and Lozzio, 1975). One million cells were labelled by
incubation with lOOpCi of sodium chromate (Amersham Life Sciences) for 2 hours at
37°C. The cells were washed twice in RPMI-FCS and resuspended in RPMI-FCS at
5xl04 cells/ml. lOOjil of these [51Cr]-labelled cells (5xl03 cells) were placed in each
well of a round-bottomed 96 well plate (Falcon).
PBMC prepared from venous blood of human subjects (see section 2.5.4) were
resuspended at 2xl06 cells/ml and doubling dilutions were carried out in RPMI-FCS.
lOOjj.1 of each dilution was added to triplicate wells of the labelled target cells, to give
effector to target cell ratios of 40:1 to 2.5:1. Spontaneous [51Cr] release was
determined by adding lOOlil of RPMI-FCS to triplicate wells of target cells.
Maximum release was determined by addition of lOOpl of 2% acetic acid to triplicate
wells. The cells were incubated for 18 hours at 37°C, 5%CC>2. The plates were then
centrifuged at 500g for 10 minutes before removing lOOjil of the supernatant for
determination of radioactivity using a Packard liquid scintillation counter. The
percentage specific [51Cr] release was determined using the equation shown in section
2.6.2.4.
2.6.4 Phenotypic analyses
Cell populations (5xl05 cells) were incubated on ice for 30 minutes with lOpl of either
neat primary monoclonal antibody (see table 2.2) or the appropriate isotype control.
Monoclonal antibodies recognising CD3, CD4, CD8, HLA-DR and CD 14 were
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obtained from the Scottish Antibody Production Unit (SAPU, Carluke, Scotland,
UK). Monoclonal antibodies recognising CD56, as well as a triple colour reagent
containing monoclonal antibodies against CD3, CD4 and CD8 were obtained from
DAKO. Cells were washed once with 2mls of PBS and then incubated with a sheep
anti-mouse IgG FITC conjugate (Serotec, Oxford, UK) for 30 minutes on ice.
Negative control cells were incubated with this secondary antibody only. Finally the
cells were washed once more in PBS, fixed in 1% formal saline and analysed using a
Coulter XL flow cytometer.
Cells were identified first using their forward scatter (FS) and single angle light scatter
(SS) characteristics to quantify their size and granularity. Regions were placed around
the cell population of interest and around the total cell population. Ten thousand
events were accumulated and the events within each region were then displayed on
histograms of log fluorescence intensity (x-axis) against cell count (y-axis). Negative
controls were routinely set at 1 %. The percentage of cells expressing each marker and
the density of expression (mean fluorescent intensity) of the marker were recorded.
Table 2.2: Antibodies used in flow cytometric analysis
Specificity Target cell Isotype Clone Supplier
CD3 T cells IgGl UCHT1 SAPU
CD4 CD4+ T cells IgG 1 LT4 SAPU
CDS CD8+ T cells IgGl LT8 SAPU








CD14 Monocytes IgGl BA8 SAPU
CD56 NK cells IgGl kappa MOC-1 DAKO
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Chapter 3
The Effect of UVB on the Contact Hypersensitivity
Response to Oxazolone in C3H/HeN mice
3.1 Introduction
Allergic contact dermatitis is characterised clinically by an eczematous reaction at the site
of contact with an allergen, for example nickel found in some jewellery. This CH
response only occurs in individuals whose skin has previously been sensitised by contact
with the allergen. The CH response to a chemical allergen is commonly used as a model
of cutaneous immunity and in particular to explore the integrity of cutaneous immune
responses following UV exposure.
As described in section 1.2.1, the CH response can be divided into two distinct phases
(reviewed inBour et al., 1997). The sensitisation, induction or afferent phase occurs at the
initial contact of the skin with a specific hapten and leads to the generation of hapten-
specific T cells in the lymph node. The second phase is known as the elicitation or efferent
phase and occurs upon challenge of the skin with the same hapten. A number of
chemicals have been used as experimental contact sensitisers in animal models, including
dinitrofluorobenzene (DNFB) (Elmets et al., 1983; Toews et al., 1980),
trinitrochlorobenzene (TNCB) (De Fabo and Noonan, 1983) and oxazolone (OXA)
(Moodycliffe et al., 1994).
Experiments to investigate the effects of UVB exposure on CH have, in general, targetted
the sensitisation phase of the response (Moodycliffe et al., 1994; Toews et al., 1980). The
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literature reveals that in vivo exposure prior to sensitisation results in a suppression in the
CH response upon challenge, both in mice (Moodycliffe et al., 1994; Shimizu and
Streilein, 1994; Toews et al., 1980) and humans ((see section 1.4.2) Cooper et al., 1992;
Tie et al., 1995). This suppression can be a systemic effect, where suppression occurs
even if the sensitiser is applied at a site distinct from that exposed to UVB. Following
certain UVB exposure regimens the suppressive effect is a local one, that is sensitisation
only at the site of irradiation results in hyporesponsiveness. Local and systemic
suppression are discussed more fully in section 1.4.2.2. Throughout this chapter the
classical definitions of local and systemic immunosuppression will be used. These refer
to the effect of irradiation on the sensitisation phase of CH, irrespective of the site of UVB
exposure in relation to challenge.
The initial studies of the effects of UVB exposure on the elicitation phase of CH were
carried out in guinea-pig models. A decreased intensity of the elicitation response of CH in
sites irradiated prior to challenge with UVB, compared with non-irradiated sites, was
reported (Haniszko and Suskind, 1963; Morison et al., 1981). This finding led Polla and
coworkers to study the effects of UVB exposure on the elicitation phase of the CH
response using a mouse model with TNCB and DNFB as contact sensitisers (Polla et al.,
1986). In contrast they found that local exposure of the site of elicitation of CH prior to
challenge, in sensitised mice, resulted in a significant enhancement of the CH response.
The same results were observed in two strains of mice and with both contact sensitisers.
The enhancement was demonstrated to result from a local rather than systemic effect of the
UVB radiation.
The aim of this work was to try to repeat these findings using our mouse model of CH,
with oxazolone (OXA) as the contact sensitiser. Experiments such as these, to study the
effects of UVB on the elicitation phase of CH, rather than on the initial sensitisation to a
particular allergen, would appear to better represent the natural sequence of events in
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human contact sensitisation. In other words, once an individual has been sensitised to a
particular contact allergen, such as nickel, will exposure to sunlight result in a more severe
or prolonged hypersensitivity response upon subsequent contact with the allergen? This is
of consequence to the 1-2% of the general population affected by allergic contact
dermatitis, but in particular to those individuals with a higher incidence, such as workers
exposed to common sensitisers in the building and chemical industries.
The experiments discussed in this chapter are of three types and are designed to study the
following:-
(i) The effect of UVB on the sensitisation phase of CH (section 3.2.2.1).
(ii) The effect of UVB on the elicitation phase of CH (section 3.2.2.2).
(iii) The effect of local and systemic UVB exposure on the sensitisation and elicitation
phase of CH (section 3.2.3).
The basic protocol employed throughout these experiments to measure the CH response of
C3H/HeN mice to OXA is outlined in Figure 3.1. Mice were sensitised with OXA,
applied to shaved abdominal skin on day 0 and were then challenged on day 7 by
application of OXA to the dorsum of each ear. Ear thickness was measured using a
spring-loaded micrometer before and twenty-four hours after challenge, when the CH
response is maximal. The increment in ear swelling was used as a measure of the
development of CH.
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Figure 3.1 Protocol employed to assess the contact
hypersensitivity response to oxazolone
DAYO SENSITISATION
50|il 1 % OXA
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ear thickness (24 hours after challenge)
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Mean CH response determined for each group
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3.2 Results
3.2.1 Dose response of oxazolone concentrations for sensitisation
Preliminary dose response experiments were carried out to establish a suitable OXA
concentration to use for sensitisation in this model. Figure 3.2 shows such a dose
response experiment, with OXA concentrations of between 0.06% and 4% (w/v) used for
abdominal sensitisation. These solutions were made up in a vehicle (VEH) of acetone:
olive oil (AOO; 4:1 ratio) to aid penetration of the contact sensitiser, and this vehicle was
used as a control solution with which to sensitise a group of mice in each experiment.
Mice were challenged in all experiments with 0.25% OXA, known to be a sub-
inflammatory concentration. The CH response elicited, even using the higher OXA
doses, were less than those obtained using similar OXA concentrations applied to dorsal
skin. In all future experiments the abdominal skin was shaved using electric clippers
followed by removal of any remaining fine hairs with a razor blade, as described by Polla
et al (1986). Figure 3.3 shows the effect of this shaving procedure on the CH response
elicited. Mice sensitised with both 1% and 4% OXA mounted a good CH response upon
challenge, which was found to be significantly different from that made by the negative
control (VEH-sensitised) group of mice (p<0.001). A 1% OXA solution was therefore
used to sensitise mice in all subsequent experiments, since increasing the concentration
above 1 % does not appear to result in a greater CH response, based on this experiment.
3.2.2 The effect of UVB exposure on the sensitisation and elicitation
phases of the CH response to OXA in C3H/HeN mice
To establish the effect of UVB exposure in this CH model, mice were exposed daily to 70
mJ/cm2 UVB either for four days prior to sensitisation (days -3 to 0) or for four days
prior to challenge (days 4 to 7). Figure 3.4 shows a representative experiment
demonstrating the effects of these UVB exposure regimens on the CH response. It is
important to note that the experiments discussed in this section involve a systemic model
99
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of CH, ie. a model in which the UVB exposure occurs on a distinct site from that of
sensitisation.
3.2.2.1 The effect of UVB exposure on the sensitisation phase of CH
The effects of UVB exposure prior to sensitisation are shown in Figure 3.4. The positive
control group (group B) mounted a good CH response which was significantly greater
than that of the negative control group (group A; pcO.OOl). The CH response of mice
exposed to UVB prior to sensitisation, was shown to be significantly suppressed
(p<0.001) compared to positive control group. This UV-induced suppression was
calculated to be a 71% suppression of the normal CH response.
In all subsequent experiments mice in group C were irradiated on days -4 to -1, with all
mice being sensitised on day 0 and challenged on day 7 (see explanation in section
3.2.2.2). Figure 3.5 shows a representative experiment using the amended protocol. A
suppressed CH response of approximately 19% was seen in the group of mice exposed to
UVB before sensitisation in this experiment.
3.2.2.2 The effect of UVB exposure on the elicitation phase of CH
Figure 3.4 shows a representative experiment demonstrating the effects of the UVB
exposure regimen described, on the elicitation phase of the CH response. Three identical
experiments were carried out and similar results were obtained each time. Mice were
challenged four hours after the final UVB exposure of group D on day 7 (see Figure 3.4)
and therefore an additional control group of mice was required, which received the same
UVB regimen but were challenged with OXA (group E), in order to control for UVB-
induced ear swelling.
On initial inspection, there appears to be no enhancement of the CH response as a result of
UVB exposure prior to challenge. However, since the mice were challenged just four
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hours after the final UVB exposure, it seems likely that much of the ear swelling in these
mice (group D) was due to the irradiation rather than as a direct result of the challenge
procedure. UV-induced ear swelling was compensated for using the results from control
mice (group E).These mice received an identical UVB regimen to those in group D and
were challenged with OXA, but VEH sensitised so that they did not respond to the
elicitation procedure itself. Compensating for UV-induced oedema in this way, an
enhancement of the CH response could be seen and was calculated to be a 67%
enhancement of the normal CH response in this experiment.
This experimental protocol was used in a number of experiments, and although the same
trend was seen after compensation for UVB-induced ear swelling, the enhancement of CH
elicitation by UVB in this system remained to be firmly established as a phenomenon. The
protocol was therefore altered slightly to try to clarify the situation. In all subsequent
experiments mice received the same total dose of UVB as before, but with no irradiation
being given on the same day as either sensitisation or challenge, allowing twenty-four
hours for the UV-induced oedema to reduce before challenge. Mice in groups D, E and F
were irradiated on days 3 to 6, with all mice being sensitised on day 0 and challenged on
day 7.
The experiment represented by Figure 3.5 followed this amended protocol and shows the
CH response to be significantly enhanced (p<0.01) following UVB irradiation prior to
challenge, in comparison to that of unirradiated mice. In this experiment an additional
control group was included (group F), which was sensitised with OXA, UVB exposed as
group D but challenged with VEH. This group was thought to serve as a more appropriate
control for UVB-induced ear swelling in the experimental group D. The enhancement was
calculated to be 15% using the mean increase from group E and 56% using the mean from
group F.
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3.2.3 Local / systemic effects of UVB exposure on the sensitisation and
elicitation phases of the CH response to OXA in C3H/HeN mice
In order to determine whether the effects of UVB exposure on the CH response to OXA
previously described are local or systemic, two experiments were carried out. To examine
the local effects of the UVB exposure regimen employed, mice were exposed as before,
either on days -4 to -1 (before sensitisation) or on days 3 to 6 (before challenge). The mice
were sensitised on day 0 on the dorsum of each ear rather than on abdominal skin, and
were then challenged as before on day 7 on each ear. To verify the systemic effects of the
UVB exposure regimen previously demonstrated, mice were shaved dorsally before UVB
exposure and had their ears covered during the irradiation. These mice were sensitised on
abdominal skin and challenged on the ears as in previous experiments. This experiment
was designed to ensure that the UVB regimen was not having any direct effect on the ears
of the mice. The protocols for these experiments are outlined in Figure 3.6 and Figure 3.7
respectively.
Figure 3.6 shows the results following sensitisation, UVB irradiation and challenge of
mice, all on the same site and therefore provides information about the local effects of the
UVB exposure regimen employed. Exposure of mice before sensitisation resulted in a
reduced CH response, although this was not significant (p-0.095) compared with
unirradiated mice. The percentage suppression was calculated to be 23.2%. Exposure of
mice before challenge resulted in a statistically significant increase in the CH response in
comparison with unirradiated mice (p<0.01). The percentage enhancement, allowing for
UVB-induced ear swelling (control group E), was calculated to be 23.8%.
Figure 3.7 shows the results following UVB exposure of mice through shaved dorsal
skin, with their ears covered throughout the irradiations. Mice were sensitised on the
abdomen and challenged on the dorsum of each ear and both of these sites were therefore
unirradiated.UVB exposure of mice to 70 mJ/cm2 on four consecutive days before
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sensitisation was found to cause a statistically significant suppression of the CH response
compared with unirradiated mice (p<0.05). This suppression was calculated to be 59.9%.
In contrast to the previous experiment, no enhancement of the CH response was seen
following UVB exposure of mice before challenge, at a site distant from that of challenge.
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3.3 Discussion
3.3.1 Effect of UVB on the sensitisation phase of CH
The basic protocol employed in the early experiments in this study was identical to that
of Polla and coworkers, with mice exposed on four consecutive days to 70 mJ/cm2
UVB. These sub-erythemal doses have been demonstrated to cause local suppression
of the induction phase of CH and result in the production of hapten-specific
suppressor T cells (Elmets et al., 1983). The UVB exposure regimen employed here
would not be expected to induce systemic suppression of the CH induction. As
described in section 1.4.2.2, systemic suppression is usually only induced following
an acute, low dose regimen if sensitisation is delayed until at least twenty-four hours
after the last irradiation. However, the experiment shown in Figure 3.4 demonstrates a
significant suppression (71%) of the sensitisation phase of CH using this UVB
regimen. In contrast, in the next experiment shown in Figure 3.5, a suppressed CH
response was observed (21%), but this was not significantly different from the
positive control response. It is possible that this discrepancy results from the slight
differences in the timing of the final UVB irradiation in relation to sensitisation
between these experiments. However, based on the findings of Shimizu and Streilein
(1994), a greater suppressive effect would have been anticipated to occur in the second
of these two experiments. Other workers have also reported that immunosuppression
was enhanced by increasing the interval between irradiation and sensitisation
(Miyauchi-Hashimoto and Horio, 1996). It may be that the slightly higher doses of
UVB employed in this study compared to others, can partly explain the high level of
suppression seen in the experiment represented in Figure 3.4 (Miyauchi-Hashimoto
and Horio, 1996; Shimizu and Streilein, 1994b).
However, a significant suppression of the CH response following UVB exposure of
mice prior to sensitisation is shown in Figure 3.7, supporting the fact that systemic
immunosuppression is being induced in this system. The induction of systemic
immunosuppression in this model would suggest the involvement of soluble
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mediators, rather than a mechanism in which the primary effect of irradiation is on LC
since the UVB exposure is at a distant site to that of sensitisation.
3.3.2 Effect of UVB on the elicitation phase of CH
The results shown here demonstrate that exposure of mice to 70 mJ/cm2 UVB on four
consecutive days before challenge caused an enhancement of the elicitation of the CH
response to OXA in C3H/HeN mice. This result was confirmed in later experiments in
which the UVB-induced ear swelling was greatly reduced by leaving 24 hours
between the final UVB exposure and challenge. Any increase in ear thickness in
irradiated mice was therefore due to the challenge procedure, as well as any UVB-
induced immunological effects, rather than as a direct consequence of the irradiation.
The results shown in Figures 3.5 and 3.6 are very similar. In contrast, no
enhancement of the elicitation response is seen in the experiment represented in Figure
3.7. Since UVB irradiation and challenge were both through the ears in Figure 3.6,
while UV irradiation was through shaved dorsal skin in Figure 3.7, it seems
reasonable to conclude that the enhancement of the CH response to OXA in this
system is a local effect. This finding is in agreement with Polla et al (1986) who
demonstrated that the enhancement effect seen in their system resulted from a local and
not a systemic effect of UVB radiation. They demonstrated this by covering the left
ear of one group of previously sensitised mice during each pre-challenge irradiation.
On challenge the exposed right ears of these mice had significant enhancement of the
elicitation response compared to the covered left ears.
3.3.3 Comparison with other studies
Both Haniszko et al (Haniszko and Suskind, 1963) and Morison et al (Morison et al.,
1981) used guinea-pigs in their experiments rather than mice and it may be that there
are differences in the immune responses between the two species, which explain the
differences in the results obtained. Additionally, these earlier studies used erythema as
an end point, rather than oedema, with a categorised scoring system which is open to
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more subjectivity than direct measurement of ear swelling. Finally, the dose of UVB
radiation and the exposure regimen employed varied between studies, making direct
comparisons difficult.
Polla et al (1986) demonstrated an enhanced CH response following UVB exposure
prior to challenge, in both C3H/HeJ and A/J inbred mice. It has been demonstrated
here that this enhancement of CH is also seen in C3H/HeN mice. Yoshikawa and
Streilein categorise C3H/HeJ and A/J mouse strains as UVB-resistant, and C3H/HeN
as UVB-susceptible (Yoshikawa and Streilein, 1990). In contrast, Noonan and
Hoffman categorise all three mouse strains as being of the intermediate susceptibility
phenotype (Noonan and Hoffman, 1994). These classifications are explained in detail
in section 1.4.2.3. A study by Yoshikawa and coworkers supports the fact that UVB
irradiation amplifies the expression of CH in both UVB-resistant and UVB-susceptible
mice (Yoshikawa et al., 1992). They demonstrated this phenomenon in C57BL/6
(UVB-susceptible) and BALB/c (UVB-resistant) mice, using DNFB as the contact
sensitiser.
In a human study, UVB radiation impaired CH expression among volunteers
originally sensitised through UVB-treated skin, but had the opposite effect among
individuals originally sensitised via normal, unirradiated skin (Tie et al., 1995). To
study the effect of UVB exposure on the sensitisation phase of CH, twenty-four
volunteers were subjected to an acute low dose UVB radiation protocol of 144 mJ/cm2
on four consecutive days. The UVB exposure was on two buttock sites (previously
unexposed skin) and within 30 minutes of the final irradiation, the individuals were
sensitised through one irradiated site with DNCB. Individuals were designated to be
either UVB-resistant or UVB-susceptible, depending on their ability to make a CH
response upon challenge 30 days after sensitisation. Seventeen subjects (71%)
responded to challenge (UVB-resistant), while seven were found to be UVB-
susceptible.
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In contrast it was found that when the CH response was induced through normal
human skin, its expression was enhanced, in some individuals, when they were
challenged on skin previously exposed to UVB radiation. Sixteen individuals received
a UVB exposure of 144 mJ//cm2, on four consecutive days, to a single buttock-skin
site. After the final irradiation, each subject was sensitised with DNCB, applied to an
unirradiated buttock site. Eleven days later each individual received two DNCB
challenges, one applied to the forearm (unirradiated), the other applied to the
previously irradiated buttock site. Eight of these subjects (50%) displayed more
intense CH reactions at the UVB-exposed site than at the unirradiated site. Although
the timing of UVB exposure with respect to elicitation differs from murine
experiments, this result implies that the phenomenon observed in mice also occurs in
certain humans. It would be interesting to see such a human study extended to try to
identify any correlation between those individuals in which an enhanced response is
seen and their skin type or other phenotypic characteristics.
3.3.4 Possible mechanisms to account for the enhancement of the
elicitation of CH
Several mechanisms may account for the enhancement of elicitation of CH. Firstly,
UVB is known to stimulate the production and release of a number of inflammatory
mediators, including histamine (Malaviya et al., 1996) and prostaglandins (DeLeo et
al., 1985; Pentland et al., 1990), irrespective of the timing of the exposure. It is
thought that while these mediators have been shown to cause suppression, they may
serve to amplify the elicitation response under certain conditions. It is likely that the
local micro-environment induced by UV exposure is the critical factor in determining
the response mediated by UVB-induced soluble factors. For example, the presence of
suppressor T cells may influence the local microenvironment following UVB
irradiation. Secondly, recruitment of immunological competent cells to the site of
irradiation recurs, ie an increase in the number of effector T cells or cells with antigen-
presenting ability. For example, an influx of T6(CDla)~ HFA-DR+ cells, thought to
be macrophages, into the epidermis as reported by Cooper (Cooper et al., 1985).
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Finally, an increase in the local capacity of epidermal cells (EC) to present antigen to
sensitised T cells may account for the enhanced CFI response seen. It was found that
EC obtained from human skin immediately after in vitro or in vivo exposure to UVR
had a decreased ability to present alloantigen in the allogeneic epidermal ceil
lymphocyte reaction (ELR). In contrast, EC harvested 24 hours or more after UV
exposure in vivo exhibited a marked dose-dependent enhancement of allostimulation in
the ELR. The time course of this enhancement coincided with the reported appearance
of the macrophage population in the epidermis, as well as with a decrease in the
percentage of LC. A similar response to UV exposure is believed to occur in mice,
with increased accessory cell activity of murine EC being reported for cells prepared
from sites exposed to UVB 3 days earlier (Lynch et al., 1983). It is therefore possible
that the enhancement of the elicitation phase of CH may result from increased antigen
presentation by recruited macrophages.
An important question is why the same UVB exposure protocol employed in this
study, and in that of Polla et al, resulted in a suppression of the induction phase of CH
but an enhancement of the elicitation phase. If the enhancement is a result of the
antigen presenting ability of recruited cells, then a possible explanation would be a
qualitative difference between the ability of LC and these macrophages to induce or
elicit immunity. The induction phase of CH represents a primary immune response and
so LC are likely to be the principle APC. The elicitation phase represents a secondary
immune response, in which antigen-specific primed T cells exist and non-professional
APCs, such as MHC class II+ keratinocytes, may be sufficient to stimulate a specific
immune response.
3.3.5 Role of TNF-a in the regulation of CH
Streilein's group has confirmed the findings of Polla et al and suggest that local
production of TNF-a is responsible for the increase observed in the elicitation phase
of CH (Yoshikawa et al., 1992). The dichotomy between the effect of TNF-a on
elicitation, as compared to the induction of immunity, is consistent with observations
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reported by Granstein and coworkers, examining the effect of TNF-a on LC (Grabbe
et al., 1992).
Yoshikawa et al (1992) reported that exposure of mouse ear skin to acute low dose
UVB (40 mJ/cm2 on four consecutive days), exaggerated the expression of the CH
response to DNCB. Irradiations were given on days 4, 5, 6 and 7 after sensitisation
on the abdomen, and mice were challenged one hour after the final UV exposure, by
application of DNCB to the UVB-exposed dorsal surface of the ears. Intradermal
injection of TNF-a at the site of challenge was also found to enhance the expression of
CH in sensitised mice. Whereas the suppression of the induction of CH by acute low
dose UVB exposure only occurs in UVB-suscepible strains ofmice, the enhancement
of CH expression by injection of TNF-a occurred in both UVB-susceptible and UVB-
resistant mice. Interestingly, while TNF-a amplified the expression of CH in the ears
of all mouse strains, anti-TNF-a antibodies neutralised UVB-enhanced CH only in
UVB-susceptible mice. The observation that DNFB painted on UVB-exposed or
TNF-a-treated skin was much less effective at eliminating LC from the epidermis than
epicutaneous application of DNFB on untreated skin led to the hypothesis that TNF-a
caused LC to be transiently immobilised within the epidermis. UVB exposure was
hypothesised to cause this apparent blocking of LC migration indirectly by stimulating
keratinocytes to produce TNF-a. The evidence presented by Streilein and colleagues
support the proposition that TNF-a, released from UVB-exposed EC, is a crucial
mediator of the effects of UVB radiation on both the induction and elicitation of CH.
In contrast however, Moodycliffe et al have reported that UVB enhances migration of
LC and accumulation of in LN draining the site of irradiation (Moodycliffe et al.,
1992). It has also been reported that intra-dermal injection of homologous
recombinant TNF-a resulted in a reduced frequency of LC in the epidermis at the site
of injection (Cumberbatch et al., 1994). In addition, an increase in the number of DC
within DLN was reported (Cumberbatch and Kimber, 1992). Further evidence was
provided by experiments in which mice were treated systemically with neutralising
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anti-TNF-a antibody. This treatment resulted in a marked inhibition of DC
accumulation in DLN induced by contact allergens and caused a significant inhibition
of CH when the antibody was administered two hours prior to sensitisation
(Cumberbatch and Kimber. 1995). It has also been demonstrated that treatment with
the same antibody significantly inhibited the accumulation of DC in DLN, resulting
from local UVB irradiation (Moodycliffe et ai, 1994). TNF-a is therefore believed to
provide an important signal for the migration of LC from the skin and consequently is
an important mediator for CH.
The role of TNF-a in the regulation of CH, and in particular in the elicitation phase,
therefore remains a controversial issue. However, the fact that anti-TNF-a antibodies
neutralised UVB-enhanced CH in UVB-susceptible mice, suggests that TNF-a may
play a role in the phenomenon of UVB enhancement of the elicitation phase of CH
described here in C3H/HeN mice.
Returning to the paradoxical situation of UVB causing exaggerated expression of CH,
while also being able to impair the induction of CH to epicutaneously applied hapten.
It was suggested above that enhanced expression of CH may result from an increase in
the number of effector T cells recruited to the challenge site. It has been reported that
UVB radiation as well as TNF-a and IFN-y induce the expression of ICAM-1 on
keratinocytes (Norris/f al., 1990). Such upregulation of cell adhesion molecules may
result in an increased migration of leukocytes into the epidermis. In addition, TNF-a
is known to have the capacity to alter the endothelial surfaces of vessels by
upregulating expression of cell adhesion molecules and therefore allowing increased
recruitment of effector T cells and other inflammatory cells into the dermis (Pober et
al., 1986). However, a more recent study demonstrates that although TNF-a mRNA
and protein in human skin are upregulated by in vivo UVB exposure, no significant
alteration in ICAM-1 or VCAM-1 expression was involved (Strickland et al., 1997).
In addition TNF-a did not appear to be involved in the early induction of E-selectin.
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3.3.6 Criticisms of experimental design and suggestions for
further work
The experimental protocols employed in this study were necessarily complex but made
interpretation of the results difficult at times. Although Polla et al did not make any
calculations of percentage enhancements, it was felt important to use control groups of
mice to compensate for UVB-induced ear swelling, to distinguish this from antigen-
specific effects. Since mice in the experiments of Polla and coworkers were
challenged four hours after the final UVB irradiation, and in some experiments UVB
doses of up to three times the magnitude used in our experiments were employed, it
seems unlikely that direct UVB-induced ear swelling would not need to be taken into
account. The percentage enhancement of the CH response to TNCB in C3H/HeJ mice,
using data from this paper and taking into account UVB-induced ear swelling, was
calculated to be 31%, following the same UVB exposure protocol employed in our
experiments (Polla et al., 1986).
Ideally, the antigen-specificity of suppression and enhancement of CH should have
been investigated. This could be carried out by including controls in which the
sensitiser or challenge hapten was a different chemical, such as DNCB. However, it is
important to note that the inclusion of the vehicle only at the sensitisation stage does go
some way to answer this point. In addition, the observation that OXA challenge, after
vehicle and subsequent UVB exposure, lead to an increase in CH, argues that the
UVB treatment was itself causing damage to the skin. This may have been aggravated
in a non-specific way by the addition of chemical and independently of specific
sensitisation.
In order to elucidate the mechanism involved in the UVB-mediated enhancement of
CH, it would be interesting to utilise the techniques of Yoshikawa et al (1992) to
determine whether, for example, anti-TNF-a antibodies were able to neutralise the
UVB-enhanced CH in our system. It would also be interesting to study the cytokines
produced during the different phases of CH, and following the UVB exposure
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regimen employed in this study, either at the protein level or mRNA level using RT-
PCR. Finally, a phenotypic analysis of the cell populations within the epidermis
during the elicitation phase of CH would be of interest. Such a study would identify
any particular subset of cells responsible for the enhancement observed, comparable
perhaps with the suppressor T cells thought, at least in part, to be responsible for the
hapten-specific unresponsive state induced by UV irradiation.
3,3.7 Summary
The aim of this study was to optimise a protocol for the establishment and elicitation of
CH using the contact sensitiser OXA in C3H/HeN mice. The UVB exposure regimen
used by Polla et al (1996) was then employed to try to repeat their finding of an
enhancement in the elicitation response of CH, as well as to examine the effects of
UVB on sensitisation, in this model system. Exposure of mice to 70 mJ/cm2 UVB on
four consecutive days prior to challenge was found to result in an increased CH
response in comparison to unirradiated mice. This finding supports the results of
Polla et al (1986) and Yoshikawa et al (1992) in murine models. In addition an
observation in humans made by Tie et al (1995) suggests that a similar phenomenon
occurs in certain humans. This has implications for individuals who suffer from
contact dermatitis reactions and may be exposed to UVB, either through environmental
exposure or through the use of sunbeds or a course of phototherapy treatment, before
subsequent exposure to the contact sensitiser.
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Chapter 4
The Effect of UVB on the Immune Response to
Murine Herpesvirus-68
4.1 Introduction
The ability of low doses of UVB to induce suppression of cell-mediated immunity
suggests that UVB-modulation of such immune responses to infectious agents may occur.
In fact there is now a body of evidence, obtained from rodent models, to suggest thai
UVB can indeed affect immune responses to a range of pathogenic organisms (section
1.8.2).
The delayed-type hypersensitivity (DTH) response is one of the classical immune
reponses used in experimental models as a measure of a specific inflammatory response.
UVB-induced immunosuppression of the DTH response to a range of agents have been
recorded to date. A number of groups have demonstrated the suppression of DTH
responses to sheep red blood cells, alloantigens and protein antigen with single UVB
exposures (Molendijk et al., 1987; Mottram et al., 1988; Ullrich, 1986; Ullrich et al.,
1986).
To date the DTH response to a range of pathogenic organisms, namely HSV-1 (Howie et
al., 1986a; Norval and El-Ghorr, 1996), reovirus (Letvin et al., 1981), Mycobacterium
bovis BCG (Jeevan and Kripke, 1989), Mycobacterium lepraemurium (Jeevan et al.,
1992a), Listeria monocytogenes (Goettsch et al., 1996)Borrelia burgdorferi (Brown et
al., 1995), Candida albicans (Denkins et al., 1989), Trichinella spiralis (Goettsch et al.,
1994b), and Leishmania major (Giannini, 1986) has been shown to be suppressed by
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UVB exposure in animal models. The degree of suppression as well as the
persistence of the suppressed state vary greatly in these models. These parameters
are likely to be dependent on the UVR regime used, ie the dose and numbers of
exposures, as well as the nature and route of infection.
Human HSV-1 infection has acted as a prototype for the study of the effects of UVB
on the immune response to viral agents. The virus can recrudesce from latency at
intervals and exposure to sunlight is a common stimulus for this (Norval, 1992) as
described in section 1.8.1.1. In the mouse model, a single exposure to UVB prior to
subcutaneous infection with HSV, induces suppression of the DTH response to the
virus when the mice are subsequently challenged (Howie et al., 1986a). The
knowledge that UVB exposure can cause systemic immunosuppression, for example
to contact sensitisers, presents the possibility that exposure to UVB may affect the
immune response to more systemic viral infections too.
The gene homology and in vivo observations described in section 1.7 would seem to
indicate that murine herpesvirus-68 (MHV-68) may act as a model for EBV,
providing a unique opportunity to study the pathogenesis of and immune response to
gammaherpesviruses in general. Unlike HSV, MHV-68 has no cutaneous
involvement and establishes a persistent infection in the spleen. Therefore it
provides an opportunity to examine the effects of UVB exposure on a pathogen
which is entirely systemic.
T lymphocytes are important in the immune response against MHV-68, with CD8+ T
cells playing a critical role in the control of viral clearance in the lung and the control
of latently infected B cells in the spleen (Ehtisham et al., 1993; Nash et al., 1996).
CD4+ T cells also appear to have some function since the kinetics of viral clearance
are delayed in mice deficient in these cells (Ehtisham et al., 1993). In addition, the
infiltration of mononuclear
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phagocytes, as well as T lymphocytes, into the site of infection is characteristic of the
immune response to MHV-68. The DTH response to MHV-68 was therefore used as a
measure of the cell-mediated immune response to this virus and the effects of UVB on this
immune parameter were studied.
The primary aim of this study was to establish an effective protocol for the induction and
elicitation of an MHV-68-specific DTH response in C3H/HeN mice. It was anticipated
that the effect of a single sub-erythemal dose of UVB, or a series of such exposures on
both the induction and elicitation phases of this immune response would be examined.
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4.2 Results
4.2.1 Establishment of MHV-68-specific DTH response
The first experiment was to establish that MHV-68 was able to infect C3H/HeN mice
when administered intranasally using halothane anaesthesia. Previous investigations of the
pathogenesis of MHV-68 and the immune responses to it used BALB/c mice and ether
anaesthesia for intranasal administration of the virus. The use of ether is now prohibited
in University of Edinburgh animal facilities and halothane does not cause the characteristic
inhalations thought to aid uptake of the virus. However, plaque assays carried out using
homogenates of lung tissue following intranasal infection of mice with halothane,
demonstrated that the mice had been successfully infected. Infectious virus titres were
comparable, although slightly lower than those reported following infection using ether
anaesthesia in BALB/c mice (Sunil-Chandra et al., 1992a). Representative viral titres
following intranasal infection of 4 week old mice are shown in Table 4.3.
The ability of adult mice to generate a specific DTH response to MHV-68 was established
in subsequent experiments. Previously only mice of 3-4 weeks of age were known to be
successfully infected with the virus using the intranasal route (Sunil-Chandra et al.,
1992a). However, at this age the immune response of the mice is not fully developed and
so a balance had to be reached between successful infection and the ability of the mice to
generate the necessary cell-mediated immune response. The protocol adopted is shown in
outline in Figure 4.1 (days 0-9). Briefly mice were infected by intranasal infection with
4x10^ pfu MHV-68, followed by elicitation of the DTH response 8 days later. This was
done by injection of UV-inactivated virus equivalent to 4.5xl06 pfu into the dorsum of
each ear.
It was established that mice of 5 weeks and older could generate an MHV-68-specific
DTH response, as shown in Figure 4.2, while mice of 4 weeks and younger could not.
The DTH response to the virus was directed against MHV-68 antigens rather than BHK
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Figure 4.1 Protocol employed to assess the
DTH response to MHV-68
Mice A'ere sensitised by L-.ra-nasal infection with MHV-68. Control mice were
sensitised with BHK-2 1 cell sonicate. Eight days later the ears of each mouse were
measured before challenge of each mouse by intra-dermal injection of inactivated
MHV-68 into the dorsum of each ear. Twenty-four hours later the increase in ear
thickness was assessed and used as a measure of the DTH response. To determine the
effects of UVB (96 mJ/cm2) on the induction phase of DTH, groups of mice were
exposed to UVB on shaved dorsal skin three days prior to sensitisation.
Figure4.2Thedelayed-typehypersensitivityesponsetoMHV-68 Ageofmice at infectionSensitisation /infectionChallenge PBSInactivated MHV-68 5weeksBHKceD sonicateInactivated MHV-68 MHV-68Inactivated MHV-68 PBSInactivated MHV-68 6weeksBHKceD sonicateInactivated MHV-68 MHV-68Inactivated MHV-68
H»
01020 Meanincreasenrthickn ss(mmx10-2)
Eightmicewerusedp rgroupandresensit se thiPBS,BHK-21c llsonicate(app oximatelyIxlO4c lls/mouse)r4x10-p̂fu MHV-68intra-nasally.Eightd yslatermicew rchalleng dbinjectionof4.5xl06pfuequivalentsfUV-i activatedMHV-68toach ear.Post-challengemeasurementsfethickn ssw rad24h uaft rlengendtm anin serthick ssoachroup wascalculatedandishownsmea±SEM.ignifi ntdiffere cebetweep i ivenegativegroupsred t rminedusingth student'st-test. **p<0.001comparedt5weekBHKlls nic tnegativco rolgroup;pcO.OIcomparedt6w ekBHKllsonicatecontrolgroup.
cell antigens. Since no significant difference was seen between the negative control
groups sensitised with PBS or with BHK-21 cell sonicate, only the BHK-21 cell sonicate
control was used in all subsequent experiments since it provides a more stringent control
for the specificity of the DTH assay. In addition, mice of at least six weeks of age, at the
time of sensitisation, were used in all subsequent experiments, unless otherwise stated.
4.2.2 Suppression of MHV-68-specific DTH response by UVB exposure
To examine the effect of pretreatment of mice with UVB on the generation of DTH to
MHV-68, the protocol outlined in Figure 4.1 was employed. Figure 4.3 demonstrates
that a single exposure to a suberythemal dose of UVB irradiation induced a significant
(41%) suppression of the DTH response to MHV-68 (p<0.05). A repeat experiment
showed a 40.1 % suppression of the DTH in the UVB group.
4.2.3 Induction of MHV-68-specific tolerance
To determine the duration of the suppressive effect of a single exposure to UVB. mice
previously UVB-exposed (96 mJ/cm2) and demonstrated to have a suppressed DTH
response, were re-challenged at two week intervals, without being subjected to any further
UVB exposure. The UVB-irradiated group showed a reduced DTH reponse at each
challenge and therefore the MHV-68-specific immunosuppression was found to be long-
lasting (Table 4.1), as tested (up to one month) after the initial challenge. It would
therefore appear that specific tolerance to MHV-68 has been induced in these mice. The
negative control response from challenge one was used to calculate the percentage
suppression at each challenge. These percentage suppressions are shown in Table 4.1.
4.2.4 Attempt to transfer MHV-68-specific tolerance into syngeneic mice
The suppression of delayed and contact hypersensitivity reactions by UV irradiation is
frequently associated with the appearance of antigen-specific T suppressor lymphocytes in
the spleen (Kripke, 1984), as reported, for example, for the DTH response to HSV
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(Howie et al., 1986b). To determine whether UV-induced suppression of the DTH
response to MHV-68 was also transferable with spleen cells, an identical experimental
protocol was employed to that of Howie (Howie et al., 1986b). Spleens from mice with
suppressed DTH responses were removed and single cell suspensions prepared. Normal
syngeneic mice were infected with live virus (4xl05 pfu/mouse) and then eight days later
2xl07 spleen cells from UVB-suppressed mice were transferred intra-venously by
injection into the tail vein. Twenty-four hours later the recipient mice were challenged as
usual. A control group of mice received 2xl07 control spleen cells from untreated mice
intra-venously. As shown in Table 4.2, recipients of spleen cells from mice irradiated
before sensitisation (group D), showed a reduced MHV-68-specific DTH response upon
challenge, in comparison to mice sensitised with MHV-68 but which did not receive any
spleen cells i.v (group B). Although the mean DTH response of group D was not found to
be statistically significantly different from the control group (group C; p=0.087), as
determined by the student's /-test, the suppression was calculated to be 28.8%. The
group of mice (group C) which had 2xl07 control spleen cells transferred prior to
challenge did not demonstrate a DTH response that was statistically different from the
control group (group B; p=0.47). This would seem to indicate that the transfer of spleen
cells itself had no effect on the subsequent elicitation of the DTH response.
4.2.5 Suppression of the elicitation phase of the MHV-68-specific DTH
response by UVB exposure
A more natural sequence of events, with respect to the human situation, might involve the
exposure of individuals to UV at a time point after primary infection. Experiments were
therefore carried out to identify any effects of UVB exposure, subsequent to primary
infection, on the DTH response to MHV-68 in mice. Mice infected with MHV-68 on day
0 were then exposed to one of two UVB regimens prior to challenge. The regimen
consisted of either a single 144 mJ/cm- exposure (day 8) or exposure to 96 mJ/cm2 UVB
on three consecutive days (days 6, 7 and 8). The DTH response was elicited as before, on
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day 11. Since mice in group C (see Figure 4.4) were exposed to a cumulative dose of 288
mJ/cm2 UVB, which would result in UV-induced damage and swelling of the ears,
making measurements difficult, all mice were anaesthetised with Hypnovel/Hypnorm and
their ears covered with foil during the irradiations.
Exposure of mice to one sub-erythemal dose of UVB (144 mJ/cm2), three days prior to
challenge of mice during primary infection (group D), was found to significantly suppress
the DTH response (p<0.05), as shown in Figure 4.4. Exposure of mice to three sub-
erythemal doses of UVB on consecutive days, up to three days before challenge (group C)
also resulted in a reduced, although not significantly so, DTH response. The percentage
suppression for groups C and D were calculated to be 41.4% and 43.7% respectively, in
comparison with group B.
The ability of post-sensitisation UVB exposure of mice to alter the elicitation phase of the
DTH response to MHV-68 was also studied in mice latently infected with the virus at the
time of exposure to UVB. Latency has been shown to be established in mice 2-3 weeks
after intranasal infection with MHV-68 (Nash et a!., 1996; Sunil-Chandra et al., 1992a),
provided the mice are less than three weeks of age at the time of infection. Latently
infected mice (infected 3 weeks previously) were exposed to UVB of the same doses as
previously described, either 3 days prior to challenge (144 mJ/cm2), or 3, 4 and 5 days
prior to challenge (96 mJ/cm2 per day). The results are also shown in Figure 4.4.
Latently infected mice were demonstrated to be able to mount a good DTH response to
MHV-68 and this response was shown to be significantly suppressed (p<0.05) by either
three sub-erythemal doses given on consecutive days before challenge (group F) or one
sub-erythemal dose of UVB three days before challenge (group G). The percentage
suppression of the DTH response induced by these UVB regimens was calculated to be
104.8% and 78.7% respectively, in comparison with group E.
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4.2.6 Effect of in vivo UVB exposure on viral replication
Experiments were carried out to determine whether UVB exposure of mice had any direct
effect on viral replication following infection of 4 week old mice with MHV-68. Control,
unirradiated mice and mice exposed to 96 mJ/cm2 UVB on shaved dorsal skin, were
infected intranasally with 4xl05 pfu MHV-68 per mouse 24 hours later. The lungs from
three mice from each group were collected at 1, 3, 5 and 10 days after infection. The viral
titres were determined by plaque assay of tissue homogenates and the results are
represented in Table 4.3 as iogiopfu/organ. The figures represent the mean viral titre for
the pooled homogenate from three mice per time-point. These results, although
preliminary, would seem to suggest that exposure of mice to 96 mJ/cm2 UVB, one day
before infection with MHV-68, has no effect on viral replication in the lungs during a
primary infection, since the viral titre results do not differ greatly between the two groups.
The only possible difference between the groups is that the viral replication in the UVB
irradiated group of mice appears to be slightly delayed in comparison to the unirradiated
control group, with the peak titre reached at 5 days rather than 3 days post-infection.
Table 4.3 Viral titres of lung homogenates from UVB-irradiated and
unirradiated mice, as determined by plaque assay
Time after infection Viral titre (logiopfu/organ)3





a Limit of detection of plaque assay was 10 p.f.u/organ ((logiopfu/organ= 1.00)
bMean infectious virus titre for pooled homogenate from three mice (age 4 weeks at time
of infection) per time-point following inoculation with 4xl05 p.f.u. of virus /mouse
c ND= below detectable level of this assay system
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4.2.7 Inability of in vivo UVB exposure to reactivate latent virus
MHV-68 establishes latency in the spleens of the majority of mice, several weeks after
primary infection. UVB exposure is known to trigger the reactivation of HSV.
Experiments were therefore carried out to determine whether UVB exposure had any
effect on latent MHV-68 infection. More specifically, the question was asked whether
exposure of mice to a single sub-erythemal dose of UVB could lead to the reactivation of
latent virus. Two groups of mice were infected with MHV-68 intranasally using a protocol
known to result in latent infection 2-3 weeks after primary infection. Three weeks after
primary infection, the mice were shaved on their dorsums and one group of mice was
exposed to 96 mJ/cm2 UVB. Spleens were then collected 1, 3 and 5 days after
irradiation. The spleens were homogenised and the viral titre for each pooled homogenate
(spleens from 3 mice per time-point) was determined by plaque assay. No plaques could
be seen for any of the spleen homogenates. This indicates that if there was any infectious
virus in any of the organs then it was below the limit of detection of this assay since
positive control virus stocks were used to confirm the validity of the assay. The plaque
assays were repeated using different aliquots of the homogenates but no plaques could be
seen. This experiment therefore does not provide any evidence that exposure of mice to a
single sub-erythemal dose of UVB causes reactivation of latent MHV-68.
4.2.8 Other immune responses to MHV-68
In order to investigate the effects of UVB exposure on other immune response to MHV-
68, attempts were made to set up assays for other immune parameters. These included a
lymphoproliferative assay and an enzyme-linked immunoassay (ELISA) to test for MHV-
68-specific antibody in the serum of mice.
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4.2.8.1. MHV-68-specific lymphoproliferation assay
Initial experiments involved the infection of mice intranasally with MHV-68 or control
inoculation with either BHK-21 cell sonicate or PBS. Mice were reinoculated sub-
cutaneously two weeks later and then lymph nodes were collected at time intervals and
single cell suspensions were prepared. Lymph node cells (2xl05 per well) were set up in
quintuplicate wells and were stimulated with con A. UV-inactivated MHV-68 and BHK-
21 cell sonicate, as described in section 2.3.4. Table 4.4 shows the proliferative
responses induced in such an experiment. The con A-induced proliferation of lymph node
(LN) cells from all three groups of mice peaked at 5 days after the secondary inoculation.
In this experiment the proliferation of LN cells from mice inoculated with MHV-68 in
response to con A was consistently less than that of cells from either control group.
Normal mouse serum (NMS) was used instead of FCS in the medium control wells since
this has previously been demonstrated to give lower background proliferations (Williams
et al., 1991). At both 3 and 5 days after secondary inoculation, an MHV-68-specific
proliferative response can be seen in cells from mice inoculated with MHV-68, but not in
cells from mice inoculated with either PBS or BHK-21 cell sonicate. The MHV-68-
specific response was significantly different from both the BHK-21 sonicate and PBS-
induced proliferative responses at both 3 and 5 days, as determined by a student's Mest
(pcO.OOl). This MHV-68-specific response appears to be lost by 8 days post-inoculation.
Cells from BHK-inoculated mice proliferate in response to in vitro stimulation with BHK-
21 cell sonicate by 3 days post-inoculation but were not seen to do so at 5 days. Lymph
node cells from MHV-68-inoculated mice did not respond to BHK-21 cell sonicate,
demonstrating that the proliferation induced by the MHV-68 antigen is a specific response.
Although an MHV-68-specific proliferative response was observed in this experiment,
such a response could not be consistently induced. Attempts were made to simplify the
experimental protocol by collecting LN cells for in vitro stimulation after only one
inoculation of the mice. However, no MHV-68-specific proliferative response by LN cells
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was observed at any time point tested after a single inoculation. No MHV-68-specific
lymphoproliferative response was generated by spleen cells from MHV-68-infected mice
either.
The primary productive infection of MHV-68 in mice is localised to the lung, following
intranasal administration of the virus (Sunil-Chandra et al., 1992a). Attempts were
therefore made to isolate lymphocytes from lung tissue and identify any MHV-68-specific
lymphoproliferative responses in these isolated cells. Lungs from infected mice were
homogenised and lymphocytes isolated by density gradient centrifugation on Lympholyte-
M. An additional step in which lung homogenates were exposed to collagenase-dispase
(0.1 U/ml and 0.8 U/ml respectively) was also employed to try to disaggregate the lung
tissue further before isolation of lymphocytes as described by van Ginkel (van Ginkel et
al.. 1995). This technique yielded fairly low numbers of lymphocytes (approximately
5xl04 cells per lung) and although the cells isolated were viable, as determined by trypan
blue exclusion, and were able to proliferate at low levels in response to stimulation with
conA, no MHV-68-specific proliferation could be induced by in vitro stimulation with
inactivated virus.
In summary, no consistent MHV-68-specific lymphoproliferative response was found
using LN cells, spleen cells or lymphocytes isolated from infected lungs. It was therefore
not possible to determine whether UVB exposure of mice had any effect on this cell-
mediated response.
4.2.8.2 MHV-68-specific ELISA
Attempts were also made to establish an ELISA to detect the presence of MHV-68-specific
antibodies in the serum of infected mice. As a positive control, a hyperimmune serum
was made by infecting a group of mice subcutaneously with an emulsion of MHV-68 and
Freund's complete adjuvant. These mice were subsequently boosted twice, at 4 week
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intervals, with an emulsion of virus in Freund's incomplete adjuvant. The mice were then
bled and the serum pooled. This positive immune serum and control mouse serum were
used to optimise the ELISA system. However, it proved difficult to produce hyper¬
immune serum for MHV-68 which was sufficiently different in titre from the control
serum to allow an effective test to be evaluated.
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4.3 Discussion
4.3.1 Suppression of the DTH response to microorganisms by
UVB exposure
4.3.1.1 Nature and dose of UVB exposure
Recent studies have addressed the significance of UVB-induced suppression of cell-
mediated immune responses with respect to infectious disease. UVB irradiation has
been demonstrated to cause abrogation of the DTH response to a number of
microorganisms, as previously described. However, these studies vary greatly in
terms of the nature and dose of UVB exposure employed. Systemic suppression has
been demonstrated for the DTH response to M. bovis BCG and C. albicans (Denkins
et al., 1989; Jeevan and Kripke, 1989), as well as for CH (Morison and Kripke, 1984;
Noonan et al., 1981a), by exposure to a single high dose of UV radiation of
approximately 45 kJ/m2 (4500 mJ/cm2). However, this dose greatly exceeds a typical
dose encountered in a single exposure to solar irradiation and therefore the relevance of
such experiments in relation to environmental exposure is not clear. Studies by
researchers in Kripke's group have since utilised smaller doses given over a protracted
period of time. For example, mice exposed to 2.26 kJ/m2 UVB (226 mJ/cm2;
approximately 1 MED for the BALB/c mice used) on between one and fifteen
occasions prior to sensitisation, demonstrated an impaired ability to mount a DTH
response to M.bovis BCG (Jeevan and Kripke, 1990). Later in the course of this
chronic UVB exposure regimen, mice recovered the ability to mount an effective DTH
response.
In contrast, the suppression of the DTH response to HSV was seen following a single
sub-erythemal exposure to UVB (Howie et al., 1986a). Few studies to date have
examined the potential of such sub-erythemal doses of UVB to affect the DTH
response to viral agents which do not have any cutaneous manifestations. It has been
demonstrated here that a similar sub-erythemal dose UVB exposure can suppress the
DTH response to a respiratory viral pathogen. The possible mechanisms for this
suppression are discussed below.
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4.3.1.2 Effect of UVB on induction/elicitation phases of DTH
It was found that a single dose of UVB could suppress both the induction and
elicitation phases of the DTH response to MHV-68. The UVB-induced suppression of
the DTH responses to M. bovis BCG and C. albicans also occur both at the induction
and elicitation stages (Denkins et al., 1989; Jeevan and Kripke, 1989). The results
from the C. albicans study in particular suggest that the suppression of DTH occurs by
two different mechanisms, depending on the timing of UV exposure relative to
sensitisation (Denkins et ai, 1989). Irradiation before sensitisation is known to lead to
the appearance of splenic suppressor cells (see below). However, irradiation after
sensitisation appears to interfere with the elicitation phase of the DTH response by a
mechanism not involving splenic suppressor cells.
4.3.1.3 The development of splenic suppressor cells
It has been reported that the suppression of the DTH response to HSV-1 induced by
exposure to 96 mJ/cm2 UVB three days before sensitisation (Howie et a!., 1986a) can
be transferred by injecting spleen cells from mice irradiated with UVB before
immunisation with live virus, into syngeneic animals (Howie et al., 1986b). This
suppression of DTH to HSV was shown to be due to two distinct T cell subsets,
namely Lyl+2" and Lyl"2+ (Howie et al., 1986b). Ultraviolet irradiation before
sensitisation also leads to the appearance of suppressor cells for the DTH response to
C. albicans (Denkins et al., 1989), as well as for other antigens that induce DTH
(Mottram et al., 1988; Ullrich, 1986; Ullrich et al., 1986) The suppressor cells
specific for C.albicans were identified as having the phenotype Thyl.2+, Lyt2+,
L3T4", Lytl" (Denkins et 1989). It should be noted that different protocols for the
transfer of suppression were employed in these studies. The ability to transfer UV-
induced suppression of DTH to C. albicans with spleen cells was demonstrated by
transfer of spleen cells from UV exposed mice, known to have a suppressed DTH
response, into naive mice. These recipients were immediately sensitised with C.
albicans antigen and their DTH response measured six days later. In contrast, Howie
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et al demonstrated the transfer of suppression to HSV by injecting spleen cells from
suppressed mice, into syngeneic mice that had been infected with live virus eight days
previously (Howie et al., 1986b). This latter protocol allowed the examination of the
cells responsible for the efferent suppression of DTH to HSV and was the protocol
employed to investigate the possibility of transfer of suppression in the MHV-68
system.
The transfer experiment, carried out to test whether suppressor spleen cells are induced
upon UVB-induced suppression of the DTH response to MHV-68, was inconclusive
because the group of mice which received spleen cells from mice known to be
suppressed did not demonstrate a statistically significant reduction of the DTH
response upon challenge. However, there was a 41.4% suppression in the DTH
response of this group and it would therefore be worth repeating the experiment
several times to establish whether the suppression observed following spleen cell
transfer was a genuine result, indicating the presence of MHV-68-specific suppressor
cells. It is possible that insufficient spleen cells were transferred into the recipient
mice, although suppression of the DTH response to HSV-1 was transferable with
between lxlO7 and 3xl07 spleen cells (Howie et al., 1986b).
4.3.1.4 Effect of UVB on antigen-presenting capacity of cells
UVB irradiation is known to affect the antigen-presenting capacity of the skin (Perry
and Greene, 1982; Stingl et al., 1981) which can partly explain the suppression of
immune responses to cutaneous viruses such as HSV. It has been demonstrated that
the functional ability of epidermal cells to present HSV is altered following in vivo
UVB exposure (Howie et al., 1986c). It was also shown that suppression of the DTH
response occurred if mice were inoculated at the site of HSV infection with epidermal
cells from irradiated mice (Howie et al., 1987). This suppression was shown to be
specific and to be associated with splenic T cells. It is therefore believed that
suppression of the DTH response to HSV is mediated by splenic suppressor cells and
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that the initial presentation of antigen by epidermal cells determines whether the DTH
response itself or suppressor cells are generated (Norval and El-Ghorr, 1996).
It is possible to imagine that the same mechanisms involved in the UVB-induced
suppression of DTH to HSV are also responsible for the suppression induced to other
cutaneous pathogens. It is more difficult to imagine how exposure of the the skin to
UVB can result in suppression to a pathogen administered directly into the respiratory
tract. There is some evidence that UVB irradiation can affect the antigen-presenting cell
function in the spleen and lymph node (Gurish et al., 1982; Simon et al., 1990) and it
is possible that the suppression is generated in such lymphoid tissue.
4.3.1.5 The role of cytokines in the UVB-induced suppression of DTH responses
Keratinocyte-derived IL-10 is an essential mediator for the UV-induced suppression of
DTH to alloantigen (Rivas and Ullrich, 1992; Ullrich et al., 1990). In a mouse model
of infection with B. burgdorferi, the DTH response was diminished by exposure of
mice to 10 kJ/m2 (1000 mJ/cm2) UVB 4 days before immunisation (Brown et al.,
1995). Administration of antibody to IL-10 at 4 and 24 hours after UV irradiation
abrogated this effect of UVB. Injection of rIL-10 (10 ng/mouse) into mice 4 days prior
to sensitisation was found to reduce the DTH response by approximately 50%. These
results confirm the importance of IL-10 as a mediator of UVB-induced
immunosuppression of DTH responses.
Experiments to investigate the role of keratinocyte-derived soluble mediators in the
UVB-induced suppression of DTH to M.bovis BCG have also been carried out.
Supernatants from UV-irradiated keratinocytes were injected intra-venously into mice
and were able to suppress both the induction and elicitation phases of the DTH
response (Jeevan et al., 1992b). The results suggest that soluble mediators released
from keratinocytes may act by interfering with certain macrophage functions. This
provides one explanation for the systemic impairment of the immune response caused
by exposing the dorsal skin of mice to UV radiation. To further characterise the
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cytokines involved, UV irradiated mice were injected with antibodies to various
cytokines. Injection of mice with anti-IL-10 immediately after UV exposure restored
the DTH response and reversed the observed UV-induced inhibition of bacterial
clearance (Jeevan et al., 1996). Injections of anti-TGF-(3l only partially restored the
DTH response. Cytokines and in particular IL-10, therefore appear to play a role in
the UVB-induced suppression of the DTH response to several microorganisms. It is
possible that such soluble mediators are involved in the suppression of the DTH
response to MHV-68, although this hypothesis remains untested.
4.3.2 Relationship between suppression of DTH response and
pathogenesis of the infectious disease
The demonstration of UVB-induced suppression of a relevant immune response gives
cause for concern, particularly when the suppression results from an environmentally
relevant UVB dose. However, a more important consideration is whether this
suppression can affect the pathogenesis of the infectious disease. For example,
exposure to UVB has been shown to trigger the recrudescence in mice with latent HSV
infection (Yasumoto et al., 1987).
Attempts have been made in a number of animal models of infectious disease, to
investigate any effect of UVB on pathogenesis. One such study was carried out to
determine whether UV irradiation, known to inhibit the DTH response, also affects the
pathogenesis of systemic C. albicans infection. It was found that the survival time of
mice exposed to UVB one day before challenge of immunised mice with a lethal dose
of viable yeast, was reduced by more than 50% (Denkins and Kripke, 1993).
The study in which the DTH response to M.bovis BCG was suppressed early in the
course of chronic UVB exposure, also showed an increase in the number of bacterial
colony-forming units in the spleen and LN of the irradiated animals compared with
unirradiated controls (Jeevan and Kripke, 1990). With continued exposure, the mice
regained the ability to mount a DTH response and there was no longer an increase in
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the number of viable bacteria in the lymphoid organs. In a model of L.mcijor infection,
although the DTH response was depressed in UV-irradiated mice, the appearance of
lesions was actually improved by exposure of the mice to UVB prior to infection;
however, UV irradiation did not reduce the number of parasites in the infected skin
(Giannini. 1986).
The experiments involving the effects of UVB on MHV-68 viral replication and
latency are preliminary and so it is not yet clear whether the UV regimen used to impair
the DTH response to MHV-68 is associated with an increase in susceptibility to
infection. However, the fact that exposure of mice to UV radiation alters their ability to
generate and elicit an immune response to MHV-68 raises the possibility that increased
pathogenicity, or a decrease in the ability of mice to prevent the establishment of
latency may result. This has possible implications for the human situation and EBV
infections. Further work is therefore required to determine whether there is a risk of
increased pathogenicity in the mouse model of MHV-68 and the potential therefore of
such a detrimental effect on human health.
Exposure to UVB is believed to cause reactivation of latent HSV by causing a transient
suppression of the local immune response at the site of reactivation, which allows
latent virus to replicate and a productive infection may result. It is thought that while
antibody-mediated immune responses contribute little to recovery from primary HSV
infections, they are important in terms of preventing the establishment of latency (Nash
and Cambouropoulos, 1993). For example, agammaglobulinaemic mice suffer a more
severe HSV infection of the nervous system and have a higher incidence of latent
infection (Kapoor et al., 1982). It is therefore unlikely that UVB-mediated suppression
of cell-mediated immune responses will aid the establishment of HSV latency.
However, since T cells are known to be important in the regulation of B cells latently
infected with MHV-68, it is possible that such suppression may enable latency to be
established when it otherwise wouldn't be as a result of the regulatory immune
response, or a greater degree of latency to be established. In addition, while there is
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not currently any available information as to the predominance of a Thl or Th2 type
response to MHV-68, it may be that the reported selective suppression of Thl type
responses by UVB, allows MHV-68 to establish a latent infection in the spleen more
readily.
4.3.3 Criticisms of experimental design and suggestions for
further work
Since only sub-erythemal doses of UVB were employed in the experiments to study
the effects of such exposure on the induction phase of the DTH response to MHV-68,
it was originally felt that there was no need to cover the ears of the mice as they
underwent UVB exposure, as no UV-induced ear swelling was anticipated. However,
since the virus was administered intranasally and not through a cutaneous route, the
suppression induced by UVB exposure can be said to be systemic. It would however
have been interesting to have shielded the ears during irradiation to see if this affected
the amount of suppression of the DTH response compared to that observed in
unshielded ears, in order to eliminate the possibility that local irradiation of the test site
causes the suppressive effect seen.
It would also be interesting to determine the duration of the suppressive effect of a
single exposure to UV radiation. To do this mice should be UV irradiated, and
sensitised at several timepoints thereafter, ie do mice exposed to UVB earlier than 3
days prior to sensitisation all exhibit a markedly depressed DTH response. Studies
with C. albicans show that exposure to 46.8 kJ/m2 between 3 and 14 days prior to
sensitisation resulted in a 64-100% suppression of the DTH response (Denkins et al.,
1989). Exposure to the same UVB dose 21 days before sensitisation did not result in
an impaired DTH response. Similar studies were carried out using HSV and it was
found that if irradiation took place 7 days before inoculation with virus, suppression of
the DTH response occured. However, if irradiation took place 14 days before, no
suppression was found (Howie et al., 1986a).
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The preliminary experiments to identify any possible effects of low dose UVB on viral
latency should have included the co-cultivation techniques employed by Sunil-Chandra
(Sunil-Chandra et al., 1992a). This involves the co-cultivation of tissue with
permissive cells for 5 days prior to the plaque assay and allows the isolation of
latent/persistent virus. This technique would have allowed absolute verification that
the mice were latently infected. It would also have shown any effects of UVB
irradiation of mice, prior to sensitisation, on the establishment of latency.
The inability to generate hyper-immune serum to MHV-68 may reflect the technique
used as others have produced such serum by intramuscular inoculation of live virus in
Freund's complete adjuvant, followed by booster injections in incomplete adjuvant
(Sunil-Chandra et al., 1992a). The poor hyper-immune serum generation may also be
an indication of the non-immunogenic nature of this virus. Since a strong virus-
specific immunoproliferative response could not be consistently induced either, it
seems probable that the virus is relatively non-immunogenic, being a poor inducer of
both cell-mediated and antibody responses. It is possible that this is a contributory
factor in the ability ofMHV-68 to establish latency.
A protocol for an ELJSA for MHV-68-specific antibody has recently been published
(Usherwood et al., 1996b). It may therefore be interesting in the future to use this
protocol to identify any effects of UVB irradiation on the generation of a humoral
immune response to MHV-68. However, anti-viral antibody is of relatively little
importance in the resolution of the primary lung infection (Usherwood et al., 1996b).
Although the mice used throughout these studies were successfully infected with
MHV-68, by determination of infectious viral titre in the lungs, the titres obtained were
lower than the mean titres reported following intranasal infection of BALB/c mice
using ether anaesthesia (Sunil-Chandra et al., 1992a). Approximately 50% of the
BALB/c mice developed clinical signs and symptoms 7 to 9 days post-infection. In
severe cases, these consisted of ruffled fur, hunched stance, severe weakness and
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emaciation. Some severely sick mice died 10 to 12 days post-infection, whereas those
with mild clinical symptoms recovered during this period. Comparable symptoms
were not seen in the C3H/HeN mice used in this study, although a few mice appeared
to have some of the signs described. This could be an indication that either the
infection procedure using halothane anaesthesia or the different mouse strain, or a
combination of both factors, result in a less severe infection.
4.4 Summary
The primary aim of this study was to establish a protocol for the induction, elicitation
and measurement of the DTH response to the systemic gammaherpesvirus MHV-68 in
C3H/HeN mice. The effect of a single sub-erythemal dose of UVB on the induction
phase of DTH was investigated. Mice irradiated with 96 mJ/cm2 on shaved dorsal
skin, three days before intranasal injection of MHV-68, showed suppressed DTH
responses (by approximately 40%) to challenge with inactivated virus, compared with
non-irradiated control animals. This suppression was specific for MHV-68. Further
studies found the suppression to be long-lasting, as tested up to one month after the
first challenge, which would suggest that tolerance to MHV-68 antigen was induced.
UVB exposure was also shown to suppress the elicitation phase of DTH in both
productively and latently infected mice. Preliminary data suggest that exposure of
mice to sub-erythemal doses of UVB has no effect on the replication of MHV-68 in the
lungs following primary infection or on latent virus.
146
Chapter 5
Expression of Cytokine mRNA in
Herpes Simplex Virus Type 1-Infected
Keratinocytes in vivo and in vitro
5.1 Introduction
Herpes simplex virus (HSV) infects its host at a mucosal or epithelial surface. It
replicates in the epidermis, inducing a vesicular lesion, and may then establish latency
in the cell bodies of peripheral nerves innervating this site. Reactivation of the virus
can occur following certain triggering factors which stimulate new viral synthesis in
the sensory ganglion followed by travel of the virus down the sensory axons and
infection of epidermal cells at the site of first exposure. During primary infection the
immune response serves to control the production of infectious virus and to localise
the lesion. However, while a great deal is known about the immune responses
generated systemically to HSV, relatively few investigations have been carried out to
identify the local immune responses initiated by infection with HSV. These may be
critical in determining the outcome of the infection and the subsequent interaction of
the virus with the host during latency and recrudescence.
A range of cellular immune components have been implicated in local anti-HSV
immunity (see section 1 ^ 2.1). A study in which sections of skin biopsies from
patients with recurrent peripheral HSV lesions were immunoperoxidase stained with a
variety of antibodies has been carried out (Cunningham et al., 1985). It revealed a
great deal about the types of cells recruited into HSV lesions and hence the relative
importance of these cells in the local immune response against HSV. Helper T
lymphocytes were the predominant cell type in subepidermal and perivascular regions
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of early lesions (12-24 hrs), but this Leu3 (CD4)+ Th cell predominance over Leu2
(CD8)+ cells was reduced in later lesions. From two days onwards, as seen in these
later lesions, monocytes/macrophages became more prominent in the inflammatory
infiltrate, particularly adjacent to vesicles. Since no B cells and very low numbers of
NK cells were detected in the subepidermal infiltrate, it was suggested that T cells and
monocytes migrated selectively into the lesions. A more recent report of the immune
cell infiltration into corneal tissue following UV-induced reactivation of HSV-1 in the
trigeminal ganglion, also reported the predominant early infiltrating cells to be T cells,
although these were both CD4+ and CD8+ cells (Shimeld et al., 1996). In addition
large numbers of B cells subsequently appeared, suggesting a role for local antibody
production in the control of reactivated infection in this model.
An important consideration is the antigen-presentation of viral antigen necessary for
the initiation of effective primary and secondary anti-HSV immune responses.
Studies have revealed that while spleen cells are capable of presenting FISV to non¬
immune virus-specific T cells in vitro, epidermal cells do not share this ability
(Williams et al., 1991). Epidermal cells were however capable of restimulating the
HSV-specific response of in vivo primed mouse T cells. Cell depletion studies
revealed the HSV-specific responder cells to be mainly Thy-1+, Lyt-1 (CD5)+, L3T4
(CD4)+, Lyt-2 (CD8)~ and I-A", which agrees with the predominant T cell type
observed in the immunohistological study. The activation of HSV-specific T cells does
not therefore appear to take place locally in the epidermis during the initial encounter
with the virus. However, during secondary challenge, for example upon reactivation
of latent virus, LC are able to present antigen efficiently to primed T cells.
In addition to the infiltrating inflammatory cells, keratinocytes are likely to play an
important role in the establishment of the local immune environment. Throughout its
natural infection, HSV interacts with epithelial cells, known to be predominantly
keratinocytes, at the entrance of the infectious agent through the skin and during
recurrent infections. Based on the fact that keratinocytes can present HSV-1 antigen to
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T cells (Cunningham and Noble, 1989) and that keratinocytes are capable of both
transcribing and producing a range of cytokines (see table 1.1), a crucial role has been
suggested for keratinocytes in the immune response to HSV. It is thought that
infiltrating macrophage and T cell-derived IFN-y induces MHC class II expression on
epidermal keratinocyes, allowing these cells to present antigen directly to T
lymphocytes in recurrent HSV infections (Cunningham etal., 1985). It is believed that
the enhancement of keratinocyte-derived cytokines in vivo may also have effects both
locally and systemically, allowing the epidermis to have a considerable regulatory role
during immune responses.
Exposure to sunlight is one of the precipitating factors involved in the recurrence of
HSV infections (see section 1.8.1.1). A number of studies have been carried out to
investigate the effects of UVB irradiation on immunity to HSV infection in mice.
UVB irradiation of mice prior to infection with HSV either sub-cutaneously (Howie et
al., 1986a) or intradermally (Yasumoto et al., 1987), resulted in a suppressed DTH
response when mice were subsequently challenged. Antigen-specific T lymphocytes
were found to have been generated in the spleens of UVB-irradiated mice, which were
capable of mediating suppression upon transfer into mice already infected with HSV
(Howie et al., 1986b; Yasumoto et al., 1987). This T cell-dependent phenomenon was
demonstrated to be due to two phenotypically distinct subsets; one Lyl~2+ (CD4+)
and the other Ly l+2" (CD8+) (Howie et al., 1986b). The suppression of DTH could
also be induced by the transfer of epidermal cells from UV-irradiated mice, as long as
these cells were injected into the recipients at the same time and into the same site as
the virus (Howie et al., 1987). Additionally, antigen-presentation by epidermal cells
was shown to be impaired by UVB (Howie et al., 1986c). Irradiation of mice prior to
a secondary HSV infection resulted in an increased severity of infection which may be
due to modulation of local antigen presentation (El-Ghorr and Norval, 1996). Further
studies have tried to elucidate the possible mechanisms which might lead to
recrudescence (Aurelian et al., 1988; Yasumoto et al., 1987). UVB exposure of the
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site of viral infection has been shown to result in a higher incidence of zosteriform
lesions in mice.
Araneo and co-workers (Araneo et al., 1989) reported that UV exposure depresses IL-
2 and enhances IL-4 production by activated T lymphocytes in mice. They suggested
that UV irradiation may induce promotion of cytokines of a Th2 type with concomitant
down-regulation of Thl cells. This concept of preferential activation of Th2 cells after
irradiation may be important in the context of cutaneous HSV infection, because
clearance of HSV is known to primarily depend on DTH responses, mediated by Thl
cells. A delay in the clearance of HSV from the infected cutaneous site could
potentially lead to the development of more severe skin lesions. Similarly, altered
local cytokine profiles could lead to a higher frequency of recrudescence.
The aim of this study was to develop and characterise in vitro and in vivo models of
HSV infection. The in vitro model consisted of infection of a murine keratinocyte cell
line, PAM-212, with HSV-1. In the in vivo model C3H/HeN mice were infected
epidermally with HSV-1. Using these models, cytokine profiles, at the mRNA level,
were examined at time intervals following HSV infection. The cytokines examined
were IL-la, TNF-a and IL-10.
IL-1 is a pro-inflammatory cytokine secreted by many cell types. The major cell source
of IL-1 in the epidermis is keratinocytes which produce active IL-la and the inactive
IL-1 (3 precursor. The production and regulation of IL-la are described in section
1.5.2.3. IL-la has a pivotal role in epidermal inflammation. It induces adhesion
molecules on endothelial cells and stimulates the secretion of secondary cytokines such
as IL-6 (Partridge et al., 1991), IL-8 (Larsen et al., 1989) and GM-CSF (Kupper et
al., 1988) from many cells including fibroblasts and keratinocytes.
The pro-inflammatory cytokine TNF-a induces the secretion of IL-1 (Kutsch et al.,
1993), IL-6, IL-8 and GM-CSF by KC. TNF-a also stimulates the expression of
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MHC class II, IL-2 receptor and the adhesion molecules ICAM-1 and E-selectin on
endothelial cells. TNF-a is expressed at low levels in normal skin (Oxholm et al.,
1991). TNF-a is implicated in the migration of FC from the epidermis (Cumberbatch
and Kimber, 1992) and is thought to be one of the key soluble mediators of UVB-
induced immunosuppression (see section 1.5.3.1).
The sources of IF-10 and its function as an inhibitory regulator of the immune system
have previously been described in section 1.5.3.2(i). IF-10 regulates the
inflammatory immune response by inhibiting the synthesis of IL-la, TNF-a, GM-
CSF and CSF (de Waal Malefyt et al., 1991) and IFN-y production by T cells (Enk,
1994; Fiorentino et al., 1991) . The latter may be partially mediated by the down-
regulation of IL-12 p40 by IL-10 (D'Andrea et al., 1993). IF-10 directs the immune
response towards a Th2 type response by inhbiting Thl cell function and augmenting
Th2 cell growth (Gajewski and Fitch, 1988).
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5.2 Results
5.2.1 Infection of PAM-212 cells with HSV-1
PAM-212 cells were infected with HSV-1 at a m.o.i. of 0.5 and, by 12 hours post¬
infection, a characteristic cytopathic effect (c.p.e) was visible microscopically,
presenting as rounded, ballooned cells in foci. Figure 5.1 shows uninfected PAM-212
cells and cells at 12 and 24 hours post-infection.
5.2.2 Infection of mouse skin with HSV-1
Preliminary studies were carried out to establish a suitable site for HSV infection of
C3H/HeN mouse skin. Initially the ears were lightly tape-stripped and infected with
the virus, since they provide a localised site for cutaneous infection. However, no
lesions developed on any ears infected in this way. In addition, when cryostat sections
were made of the ears, and these sections were examined following
immunoperoxidase staining with anti-HSV antiserum as described in section 2.4.3, no
positive staining could be identified. This suggested that mouse ears were not a
suitable site for the study of localised HSV infection. It is possible that the tape-
stripping procedure necessary to allow penetration of the virus, does not leave
sufficient epidermal cells for establishment of a cutaneous infection at this site.
Subsequent infections of mice with HSV were made on dorsal skin. The dorsum was
shaved and tape-stripped, as described in section 2.4.2. All mice developed lesions
between 3 and 5 days post-infection and mice with typical lesions are shown in Figure
5.2. Cryostat sections of skin samples taken at intervals after infection, were made
and stained using an immunoperoxidase method with anti-HSV antiserum. Examples
of such immunohistochemical staining of mouse back skin sections are shown in
Figure 5.3. Viral antigen could be detected in these sections from 3 days after
infection. Positive staining was largely localised to the epidermis. The lesions were
self-healing and had generally resolved by 10-12 days post-infection.
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Figure 5.1 HSV-infected PAM-212 cells
A ilif0




Uninfected PAM-212 cells (A) and at 12 hours (B) and 24 hours (C) after infection with
HSV-1 at moi of 0.5, demonstrating viral-induced cytopathic effect. Magnification xlOO.
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Figure 5.2 Mice with dorsal HSV-1 lesions
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Figure 5.3 Sections of HSV-l-infected mouse back skin
*
i * I
Immunoperoxidase staining of mouse back skin sections at (A) 0 hours (B) 48 hours and
(C) 96 hours post-infection with HSV-1 using an anti-HSV polyclonal antibody, and a
control section stained using an anti-cytomegalovirus primary antibody (D) 96 hours
post-infection. (All at xl 10 magnification).
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5.2.3 Semi-quantitative PGR
5.2.3.1 Optimum cycle number determination
In order to analyse cytokine mRNA expression semi-quantitatively. the optimum cycle
number for each PCR product was determined. A pool of cDNA taken from PAM-212
cell and one from mouse skin RT reactions, from all stages of a HSV timecourse of
infection experiment were used as target sequences. Figure 5.4 shows the
autoradiographs for these cycle experiments. Forty cycles was the maximum cycle
number used in this study since above this number the reaction is likely to plateau due
to exhaustion of DNA polymerase and other PCR reagents. Integrated OD units of
PCR products from the cycle experiments were derived and the linearity of PCR
product accumulation versus cycle number was determined (Figures 5.5 and 5.6).
Optimum cycle numbers for detection of each cytokine mRNA determined from Figure
5.5 for PAM-212 cell cDNA were 28 cycles for p-actin, 32 cycles for IL-la and 36
cycles for IL-10 and TNF-a. Optimum cycle numbers for mouse skin cDNA samples
determined from Figure 5.6 were 28 cycles for P-actin. 32 cycles for IL-la and IL-
10, and 34 cycles for TNF-a.
5.2.3.2 Semi-quantitative expression of cytokines following HSV infection
5.2.3.2 (i) In vitro model of HSV infection
The expression of IL-la and IL-10 mRNA was analysed in PAM-212 cells at intervals
after infection with HSV-1. Representative autoradiographs of PCR products for these
cytokines at the optimum cycle number are shown in Figure 5.7(a). Comparable
observations to those described here were seen upon repeat PCR of the same samples
and also following RT-PCR of a second set of samples.
Figure 5.8(a) represents the expression of IL-la mRNA after HSV infection in PAM-
212 cells. HSV infection induced a decrease in the level of mRNA expression of this
cytokine between 0 and 6 hours post-infection. After this time, the level of IL-la gene
expression gradually increased towards the initial level by 24 hours post-infection.
156
Figure 5.4 Determination of optimum cycle numbers
Cycle number
PAM-212 cells Mouse skin
22 24 26 28 30 32 34 — + 22 24 26 28 30 32 34 - +
p-actin ***** » 540 bp
IL-la
26 28 30 32 34 36 38 - + 26 28 30 32 34 36 38 - +
— —. 4* 6:25 bp
IL-10
26 28 30 32 34 36 38 - + 2 4 26 28 30 32 34 36 - +
237 bp
TNF-cc
28 30 32 34 36 38 40 - + 28 30 32 34 36 38 40 - +
692 bp
PCR reactions were performed using pooled RT reactions, as described in section
5.2.3.1. Reaction tubes were removed at determined cycle number. Products were
subjected to SDS-PAGE and autoradiographs of these gels are shown.
Figure 5.5 Linearity of PCR product accumulation with
increasing cycle number for PAM-212 cells
(3-actin IL-la
Cycle number
Densitometry of PCR products shown in Figure 5.4 was performed and accumulation of
PCR product versus cycle number is shown.
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Figure 5.6 Linearity of PCR product accumulation with




Densitometry of PCR products shown in Figure 5.4 was performed and accumulation of
PCR product versus cycle number is shown.
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Figure 5.7 Cytokine expression following
infection with HSV-1
(a) In PAM-212 cells
Time after treatment (hrs)
0 0.5 1 3 6 12 24 - +
p-acti"
^ m 540 bp
IL-la <m» mm «** 625 bp
IL-10 » 237 bp
Autoradiographs of representative [32P]-labelled cytokine PCR products of PAM-212
cells subjected to SDS-PAGE.
Figure 5.7 Cytokine expression following
infection with HSV-1
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Autoradiography of representative [32P]-labelled cytokine PCR products of mouse back
skin, subjects to SDS-PAGE. The mouse skin samples were either taken from tape-
stripped skin (TS only) or skin that was epicutaneously infected with HSV-1 following
tape-stripping (TS/HSV).
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Time after treatment (hrs)
(a) In PAM-212 cells following HSV-1 infection. The data represent the mean ± SEM of
triplicate samples at each time-point
(b) In mouse back skin following tape-stripping alone (TS) or with subsequent HSV
infection (TS + HSV). The data represent the mean ratio for skin samples from three mice
per time-point, where possible. Mean ± SEM shown from 72 hours after treatment.
Integrated optical density units were obtained by image analysis of autoradiographs.
Relative expression of IL-la is shown as a ratio of the cytokine : p-actin.
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As shown in Figure 5.9(a), HSV infection induced an upregulation in the production
of IL-10 mRNA in the keratinocyte cell line PAM-212, with a peak at 12 hours post¬
infection. At this time in the course of infection, signs of viral cytopathic effect were
visible microscopically. Between 12 and 24 hours post-infection, the level of mRNA
expression for IL-10 began to decrease.
5.2.3.2 (ii) In vivo model of HSV infection
Cytokine profiles induced in vivo were studied following epicutaneous infection of
shaved, lightly tape-stripped dorsal skin with the same strain of HSV-1. Back skin
was removed at intervals after infection, immediately homogenised and RNA extracted
as described in section 2.4.4. A time-course following tape-stripping of skin alone
without infection was also carried out to control for this procedure.
Figure 5.8(b) shows the data for IL-la mRNA expression, in the in vivo model of
HSV infection, represented graphically. Both the control mice which had been tape-
stripped only (TS) and the experimental mice which had been tape-stripped and then
subsequently infected with HSV (TS + HSV), showed an initial trend of increasing
IL-la mRNA expression up to 24 hours post-infection. After this time, the HSV-
infected mice displayed a gradual increase in mRNA expression for this cytokine, with
peak expression at 72 hours (3 days) post-infection. However, this increase was not
found to be significantly different from the control group between 72 and 120 hours
post-treatment, as determined by the student's /-test. In contrast the uninfected mice
did not show this late peak in IL-la gene expression.
As in the in vitro model, IL-10 mRNA production was up-regulated in the in vivo
model of HSV infection, as shown in Figure 5.9(b). Autoradiographs of
representative PCR products for IL-10 at the optimum cycle number are shown in
Figure 5.7(b). The tape-stripping procedure itself caused an early increase in IL-10
mRNA up to 12 hours post-infection but, from approximately 4 days post-infection,
163
Figure 5.9 Expression of IL-10 mRNA
(a) In PAM-212 cells following HSV-1 infection. The data represent the mean ± SEM of
triplicate samples at each time-point
(b) In mouse back skin following tape-stripping alone (TS) or with subsequent HSV
infection (TS + HSV). The data represent the mean ratio for skin samples from three mice
per time-point, where possible. Mean ± SEM shown from 72 hours after treatment.
Integrated optical density units were obtained by image analysis of autoradiographs.
Relative expression of IL-10 is shown as a ratio of the cytokine : (3-actin.
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there was also an HSV-induced increase in 1L-10 mRNA. This increase seen in the
HSV-infected mice, was found to be statistically different from the control mice at 120
hours post-treatment (p<0.05), but not at 72 or 96 hours (p=0.3 and 0.2 respectively),
as determined by the student's t-test. In this model, visible lesions appeared at
approximately 4 days post-infection and viral antigen could be detected by
immunoperoxidase staining of skin sections from 3 days after infection.
5.2.3.3 Semi-quantitative expression of cytokines following UVB irradiation
The effect of UVB exposure of keratinocytes in vitro was examined. Time-course
experiments were carried out using PAM-212 cells to identify the effects of UVB
exposure and HSV infection, both independently and together on this keratinocyte cell
line. Problems with sample degradation prevented a parallel study from being carried
out using the in vivo model and this is discussed further in section 5.3.4.1.
Figure 5.10(a) represents the data obtained from such an in vitro experiment with
respect to IL-la mRNA expression. The mock-infected PAM-212 cells exhibited a
stable level of expression. The HSV-infected cells showed a viral-induced decrease in
expression of IL-la mRNA at 6 hours post-infection. This agrees with the previously
reported data shown in Figure 5.8(a). UVB treatment of the PAM-212 cells (10
mJ/cm-) also resulted in a decline in IL-la mRNA levels, in comparison with the
initial level, at 6, 12 and 24 hours post-treatment. The lowest expression level for IL-
la mRNA was seen at 24 hours post-UV exposure. This may reflect the slight
decrease in viable cell numbers at this time-point, as determined by trypan blue
exclusion (shown in Figure 5.12). The PAM-212 cells which were exposed to UVB
and infected with HSV showed a decreasing level of IL-la mRNA expression
between 0 and 12 hours after treatment. The level of expression then increased
substantially at 24 hours. Statistically significant differences between the mock-
infected group and the other treatment groups at each timepoint were determined using
the student's t-test and are shown in Figure 5.10.
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Figure 5.10 Cytokine mRNA expression in PAM-212 cells,
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Three wells of a 6-well cell culture dish containing 5xl05 PAM-212 cells were used per treatment per time-
point. HSV-infected cells (HSV) were infected with virus at moi=0.5. Mock-infected cells (mock) were
incubated with a volume of PBS equivalent to the viral inoculum used. UVB-treated cells (UVB) were
exposed to 10 mJ/cm' UVB and the final group (UVB/HSV) were exposed to 10 mJ/cm2 UVB immediately
prior to infection with HSV. Following RNA extraction, semi-quantitative RT-PCR was carried out using
primers for IL-la, TNF-a and IL-10. Integrated optical density units were obtained by image analysis of
autoradiographs. Relative expression of each cytokine is shown as a ratio of cytokine : P-actin. The data
represent the mean ratio + SEM of the triplicate samples. Significant differences between the mock-infected
group and other treatment groups at each timepoint were determined using the student's t-test. *p<0.01;
**p<0.05
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The results of TNF-a mRNA expression in this experiment are shown in Figure
5.10(b). Expression of the gene for this cytokine appeared to be upregulated, with
time, in mock-infected cells, HSV-infected cells and UVB-exposed, HSV-infected
cells. The greatest expression was seen at 24 hours after treatment in the UVB-
exposed group, which did not demonstrate an enhancement of expression until this
time.
Figure 5.10(c) shows the expression of IL-10 mRNA in PAM-212 cells treated as
previously described. Representative autoradiographs of PCR products from 0, 12 and
24 hour post-treatment samples are shown in Figure 5.11. Very low levels of cytokine
message were observed in mock-infected cells and in the 0 and 6 hour time-points for
all treatments. HSV-infection of PAM-212 cells induced a time-dependent increase in
mRNA expression for this cytokine. UVB exposure also induced such an increase,
with maximal expression at 24 hours post-treatment. The combination of HSV
infection and UVB exposure in fact resulted in a decrease in the cytokine expression in
this experimental group at 24 hours post-treatment.
5.2.4 Detection of IL-10 protein
The presence of IL-10 protein in PAM-212 cells was investigated using an ultra¬
sensitive ELISA kit (see section 2.4.8). No IL-10 protein could be identified in
supernatants of untreated PAM-212 cells, or of UVB-exposed or HSV-infected cells.
However, PAM-212 cell lysates were demonstrated to contain significant amounts of
IL-10 protein (results not shown).
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Figure 5.11 Expression of IL-10 mRNA in PAM-212 cells
following HSV infection and/or UVB exposure
Treatment
p-actin 0 4§ 540 bp
24 mmm• 41 540 bp
IL-10 0 • 237 bp
12 ** - m 237 bp
ii rn 237 bp
Autoradiography of representative [32P]-labelled IL-10 PCR products from PAM-212
cells, subjected to SDS-PAGE. The PAM-212 cells were either mock infected, HSV-
infected (moi=0.5), UVB-exposed (10 mJ/cm2) or HSV-infected and UVB-exposed.
Figure 5.12 Viability of PAM-212 cells following HSV
infection and/or UVB exposure
Time after treatment (hrs)
Three wells of a 6-well culture dish containing 5xl05 PAM-212 cells were used per
treatment for each time-point. Cells were treated as in Figure 5.9. At each time-point
cells were trypsinised and the total number of viable cells per well determined using
trypan blue exclusion. The data are represented as the mean cell number ± SEM.
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5.3 Discussion
5.3.1 Models of HSV infection
Since HSV recurrence in humans is often unpredictable, there is a high dependency on
animal models to provide information about the immune mechanisms that act against
HSV. Indeed the majority of current knowledge has been gleaned from mouse models,
since mice are relatively inexpensive, genetically well-defined and easily manipulated.
However, in many cases, studies of HSV disease in the mouse do not serve as a true
analogue for human disease. The routes of infection used are frequently different and in
particular recrudescent infection in mice surviving primary infection cannot consistently be
induced. With respect to the model of infection used in this study however, efforts were
made to mimic the natural human infection by infecting the mice epidermally with a clinical
isolate of HSV-1. No attempt was made here to study any aspect of recrudescence,
although it is anticipated that immune mechanisms identified as being important in the
primary infection will also be relevant to recurrent infections. Although variations
between human and murine skin would be expected, it is anticipated that parallels can be
drawn between the two systems and therefore both the murine model and the in vitro
model can provide useful information, relevant to the human situation.
A characteristic of herpesvirus-infected cells is the rapid shut-off of host macromolecular
metabolism, early in infection. This includes host DNA synthesis shut-off, and a decline
in host protein synthesis. The products of the HSV gene vhs are responsible for the
destabilisation and degradation of host mRNA leading to host shut-off (Roizman and
Sears, 1996). In addition, destabilisation of viral mRNA occurs, which allows a rapid
transition from one regulatory class to the next. For the in vitro infection of keratinocytes,
a moi of 0.5 was used and no host shut-off of mRNA was seen during the time period of
24 hours examined in this study. It is possible however that infected cells are not
synthesising mRNA and the production seen is actually from neighbouring, uninfected
170
keratinocytes. It is likely that these cells will receive signals, for example through
cytokine production, from infected cells early on. It would be interesting to further dissect
the production of cytokines by infected and uninfected cells. This could be done by
comparing results from experiments in which different moi were used.
5.3.2 Expression of cytokine mRNA by keratinocytes
5.3.2.1 IL-la
Since keratinocytes release stored IL-la in response to cell damage, it could be anticipated
that infection with HSV would provide such a 'damage' signal. However, following in
vitro infection of keratinocytes with HSV, a decrease in IL-la mRNA was seen initially
(Figure 5.8(a)). This is unexpected as IL-la acts as a signal for the production of both
secondary inflammatory cytokines and adhesion molecule expression necessary for the
characteristic infiltration associated with a HSV lesion. However, this early depression in
gene expression was also seen in a subsequent experiment (Figure 5.10(a)). It is possible
that this decrease in IL-la mRNA expression is a result of viral shut-off as an immune
evasion strategy to permit easier infection. Although not known for HSV, some viruses
encode homologues of the extracellular binding domain of cellular cytokine receptors.
These proteins are secreted, bind to the cytokine and interfere with its activity by
preventing interaction with cellular receptors. Examples of such soluble receptors are the
TNFR and IL-lpR encoded by vaccinia virus (Alcami and Smith, 1992; Alcami and
Smith, 1995). Vaccinia and cowpox viruses also encode a serine protease inhibitor which
inhibits the IL-1 p-converting enzyme (ICE) which cleaves pro-IL-lp to give active IL-lp
(Ray et al., 1992).
In contrast to the in vitro situation, IL-la mRNA increased in the in vivo model of
infection from approximately 48 hours post-infection. By this time viral replication,
which is known to take between 18-20 hours in fully permissive tissue culture cells, is
well underway. While the sheer numbers of keratinocytes make them the likely source of
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the IL-la mRNA detected, it is possible that some may be being produced by activated
monocytes or macrophages, another major cellular source of this cytokine. However, this
is unlikely since the clonal expansion and activation of specific CD4+ T cells, between 4-
12 days after infection, is a necessary prerequisite for the recruitment and activation of
macrophages in any significant number. Immunohistochemical studies verify that a
significant number of macrophages are only seen in the inflammatory infiltrate of late
lesions, ie from 48 hours onwards (Cunningham et al., 1985).
5.3.2.2 TNF-a
From Figure 5.10(b) it can be seen that although HSV infection of PAM-212 seems to
induce the up-regulation of TNF-a mRNA by 24 hours post-infection, a similar increase
was also seen in mock-infected cells, suggesting that the increase in gene expression may
be a time-dependent rather than an HSV-specific phenomenon. It would be interesting to
repeat this experiment to verify any HSV-induced TNF-a production at either the RNA or
protein level. In vitro infection with other DNA and some RNA viruses have been
demonstrated to induce the production of TNF-a and TNF-(3 and these cytokines were
shown to have anti-viral activity. They were able to synergise with interferons in the
induction of resistance to both RNA and DNA virus infections, including HSV-2 (Wong
and Goeddel, 1986).
5.3.2.3. IL-10
HSV infection induced an upregulation in the production of IL-10 mRNA in the
keratinocyte cell line PAM-212, with a peak at 12 hours post-infection (Figure 5.9(a)).
Although murine keratinocytes and the PAM-212 cell line have been reported to secrete
IL-10 protein as well as synthesise IL-10 mRNA (Enk et al., 1993b; Nash and
Cambouropoulos, 1993; Rivas and Ullrich, 1992; Teunissen et al., 1997b), secretion of
IL-10 protein into the culture supernatant by this strain of PAM-212 cells could not be
detected by us or others (N.Gibbs, Photobiology Unit, University of Dundee; personal
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communication) by ELISA. Preliminary studies did however reveal these cells to be
synthesising IL-10, since cell lysates were found to be positive for IL-10 protein by
ELISA. It is possible that this phenotype is specific to the particular PAM-212 cells used
in these experiments and selective pressures over time may have resulted in a particular
non-IL-10-secreting clone predominating in the cultures.
The production of IL-10 mRNA was similarly up-regulated in the in vivo model of HSV
infection. It is likely that HSV is inducing keratinocytes in the epidermis to produce IL-
10, as supported by the in vitro cell line result. Alternatively, it is possible that the IL-10
mRNA found in this model may be being produced by other cells infiltrating the dermis
and epidermis, such as Th2 lymphocytes. However, immunohistochemical studies
suggest that while T cells are the predominant early infiltrating cell type, from two days
monocytes/macrophages are more prominant and CD4+ T cells no longer selectively
migrate into infected areas (Cunningham et al., 1985).
IL-10 has been implicated as an important suppressor factor in both T lymphocyte and
antigen presenting cell effector functions. It is known to affect the antigen presenting
ability of Langerhans cells, allowing them to stimulate Th2 cells, but induce only tolerance
or anergy in Thl cells (Moore et al., 1990). IL-10 also acts on macrophages to down-
regulate MHC class II expression which may result in the inhibition of cytokine synthesis
by activated Thl cells and NK cells. This could result in vivo in a switch in the immune
response from a delayed type hypersensitivity-type response (Thl) to an antibody-type
response (Th2). In terms of HSV infection, an antibody response is believed to contribute
minimally to recovery from a primary infection and is known to be ineffective once latency
is established. Therefore HSV-induction of IL-10 may be important in aiding the
infectivity of the virus and in evasion of the host immune response sufficiently to allow
latency to be established. Indeed a viral analogue of IL-10 is known to exist within the
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genome of some Herpesviruses, including the product of the BCRF1 gene of Epstein Barr
virus (Moore et al., 1990), although such an analogue has not been reported in HSV.
In order to persist in their host it is essential that viruses have mechanisms of evading the
host's immune response. HSV has evolved several such mechanisms and it is quite
possible that it has other as yet unknown evasion strategies. Firstly, HSV establishes
latency in neural cells and during this period only a region of the HSV genome encoding
latency-associated transcripts are transcribed and these do not encode any known protein
products. In addition, neural cells do not express either class I or class II MHC molecules
and therefore avoid cell-mediated immune recognition should any viral antigens be
produced. A second viral strategy employed by HSV involves the interaction of viral
proteins with components of the humoral immune system. Two examples of this are
known and they are virally-encoded Fc and complement receptors. Finally, it was
recently reported that the HSV immediate-early protein, ICP47, blocks the transporter
associated with antigen presentation (TAP) which translocates antigenic peptides across
the endoplasmic reticulum membrane (Hill et al., 1995). This inhibits the association of
viral peptides with MHC class I molecules, so that peptides are not presented to anti-HSV
CD8+ T cells (York et al., 1994).
5.3.3 The effects of UVB on cytokine mRNA expression
The study involving the infection and/or UVB exposure of PAM-212 cells was not carried
out in the in vivo infection model and therefore the extrapolation of results to the
cutaneous system must be limited. None the less, the study contains some interesting
findings and provides a preliminary insight into the possible interactions between HSV
infections and UVB.
An increase in TNF-a mRNA was seen following UVB exposure. A smaller but more
gradual increase was seen after HSV infection and a similar pattern of expression was
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seen in the infected and UVB exposed group. Strickland et al found that TNF-a mRNA
was increased by 8 hours in human skin following exposure to 2.5 MED, and to reach a
maximum by 24 hours post-exposure (Strickland et al., 1997). In addition, UVB
irradiation of human keratinocytes has been shown to induce production of TNF-a (Kock
et al., 1990).
The expression of IL-10 mRNA increased with time following HSV infection and to a
greater extent following UVB exposure. However, only a very small increase was seen at
12 hours post-treatment in the infected and UVB exposed cells and no increase was seen
at 24 hours. This is difficult to explain, particularly because no significant difference was
seen in the viabilities between the control, mock-infected cells and any of the experimental
groups of cells (p<0.05; student's t-test), other than the mock-infected cells which had
proliferated by 24 hours.
5.3.4 Criticisms of experimental design
5.3.4.1 Problems with sample degradation
Comparable experiments to those depicted in Figure 5.10, using mouse skin samples
rather than PAM-212 cells were not completed because of problems of sample
degradation. It is believed that the skin contains RNase enzymes which are responsible
for the degradation of samples, since RNA samples do not normally degrade if stored at
-70°C. RNA usually degrades from the ends inwards and hence it may not be possible to
carry out RT reactions with oligo dT priming if samples are slightly degraded and hence
have lost the poly-A tail. Attempts were made to carry out RT reactions using random
hexamer priming but no more samples were successfully reverse-transcribed than using
oligo dT.
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5.3.4.2 Use of (3-actin as a house-keeping gene
The house-keeping gene P-actin was chosen for this study because of its wide usage.
However, there have been some reports that in certain cell types the expression of the gene
is dependent on the differentiation state of the cell. The literature reveals that this
phenomenon has only been reported for adipocytes (Spiegelman and Farmer, 1982). It is
unlikely to pertain to keratinocytes since very little variability in the [3-actin signal was
seen throughout the samples used in these experiments. Attempts were however made to
use another set of house-keeping gene primers, namely primers for ribosomal RNA, s 18
(Hamilton et al., 1995). These proved difficult to use and the results were not consistent.
Therefore, although ideally several house-keeping genes should be used to verify the
results obtained, this was not practically possible.
5.3.4.3 Possible viral DNA contamination of samples
The possibility of viral DNA contamination of RNA preparations had to be considered,
although viral DNA is likely to move into the phenol phase of the RNA extraction mixture
with cellular DNA and hence be removed. However, the consequences of any such
contamination should be examined.
The purity of RNA samples was estimated by measuring the optical density (OD) of each
sample at 260 and 280 nm, which gives an indication of purity. Pure DNA and RNA
preparations have expected ratios of >1.8 and >2.0 respectively. Any contaminating viral
DNA could potentially be included in the OD measurements and affect the correct
estimation of the concentration of RNA in each sample. This could mean that the amounts
of RNA used for each sample for an RT reaction could vary, depending on the amount of
contaminating viral DNA. However, since the procedure of semi-quantitative RT-PCR is
dependent on generating ratios of cytokine expression to house-keeping gene expression,
variations of this type will be taken into account at this stage.
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The second possible effect would be contaminating fragments of viral template DNA
hybridising to the RNA and serving as primers during reverse transcription. However
since specific primer pairs are used for the PCR reaction, any such transcriptions made
would not be successfully primed.
Attempts were made to confirm the conclusions that viral DNA contamination would not
affect the final result. Oligoribonucleotides were removed from the cellular RNA
preparation by treatment of each sample with DNase, after initial extraction. It was
demonstrated that the protocol employed resulted in effective degradation of DNA.
However, when used on skin samples it was found that the DNase treatment rendered it
impossible to reverse transcribe the RNA samples, probably due to the presence of
endogenous RNases in the skin which cause degradation of the RNA during the
incubation period at 37°C necessary for effective DNase treatment.
5.3.5 Comparison of results with other studies
Several investigators have studied the effect of HSV infection on cytokine production by a
range of cell types. For example, the induction of cytokine mRNA in splenocytes,
following infection with HSV, has been reported (Kita et al., 1993). After HSV infection
IFN-a, IFN-p, IFN-y, IL-1(3, IL-4, IL-6 and TNF-a mRNA were significantly induced.
This study demonstrated that cytokine mRNA, other than IFNs, may play a role in the
defence mechanism against HSV infection.
A separate study investigated the effects of three herpesviruses, including HSV, on the
synthesis of cytokines by infected peripheral blood mononuclear cells (Gosselin et al.,
1992b). It was found that HSV infection caused the up-regulation of IL-6 and TNF-a
protein, which are both immunoregulatory cytokines secreted mainly by activated
monocyte/macrophages. In addition HSV-induced alterations in IL-6 and TNF-a were
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also seen at the transcriptional level in human mononuclear blood cells (Gosselin et al.,
1992a).
The effect of HSV-1 infection of keratinocytes, both in vitro and in vivo, on the gene
transcription of various cytokines has also been examined by others. A marked reduction
of IL-la gene expression was noted 6 hours after HSV-1 infection of murine primary
keratinocytes in vitro, and almost total shut-off was noted after infection for 24 hours
(Enk et al., 1991). In contrast, HSV-1 infection of mouse skin was found to induce IL-
1(3, TNF-a and IL-6 gene transcription in keratinocytes at 24 hours post-infection
(Sprecher and Becker, 1992). Induction of IL-1(3 and TNF-a but not of IL-6 gene
transcription was detected in Langerhans cells obtained from infected mice at 24 hours
post-infection.
Differences between the results shown here and those of Enk (Enk et al., 1991), with
regard to IL-la production by HSV-1-infected murine keratinocytes, may reflect a
number of differences in experimental protocol. Firstly we used a mouse keratinocyte cell
line rather than the primary cells used by Enk. Secondly, the fact that Enk et al observed
host cell shut-off of gene transcription is likely to reflect the fact that they infected cells at a
moi of 5, whereas we used a moi of 0.5.
Yasumoto and colleagues studied the production of cytokines by lymph node and spleen
cells taken from UVB irradiated, HSV-l-infected mice (Yasumoto et al., 1994). They
found that exposure of shaved abdominal skin to 120 mJ/cm2 UVB prior to HSV infection
of the same site caused a marked suppression in IFN-y production in comparison to that of
non-irradiated controls .
Finally, ocular infection of mice with HSV-1 induced IL-12 (p40) mRNA in the cornea
and DLN (Kanangat et al., 1996). Protein was also detected in the cornea and it is
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thought that infiltrating inflammatory cells are the main source of this IL-12. Since this
cytokine is known to stimulate the proliferation and differentiation of Thl cells, it may
induce a protective Thl-type response.
An interesting possibility is the direct interaction between the immune system and the
nervous system, mediated by cytokines. The role of cytokines in the latency and
reactivation of HSV is of particular interest. Following primary infection with HSV-1 of
the eye or oral mucosa, antigen expression has been shown to peak in the trigeminal
ganglion at 3 days post-infection. An inflammatory response is induced and elevated
cytokine expression in the trigeminal ganglion was seen. By 10-14 days post-infection,
HSV replication ceases as a host immune response is mounted and latency is established.
If true latency of HSV-1 is established, cytokine expression in the trigeminal ganglion
should cease in the absence of viral antigen. However, several studies have found
evidence of lingering cell-mediated immunity in the trigeminal ganglion of latently infected
mice (Shimeld et al., 1995). Recently it was reported that TNF-a and T cell-associated
transcripts (eg IL-10 and IFN-y) were consistently present in latently-infected trigeminal
ganglia at 1-2 months after infection, suggesting T cell cytokine expression to persist well
into latency (Halford et al., 1996). Low level expression of HSV proteins during latency
could account for lymphocyte infiltration and cytokine expression in the latently infected
trigeminal ganglion. However, neurons do not express class I MHC molecules and are
therefore incapable of presenting endogenous antigens to CD8+ T cells. This data
suggests that viral antigens are present in sufficient quantities during latency to stimulate
an ongoing immune response, although the mechanism of antigen presentation remains
unknown.
5.3.6 Suggestions for further work
The first and simplest way to continue this work would be to extend the range of
cytokines investigated and to carry out in vitro studies using a wider range of cells,
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including other keratinocyte cell lines, as well as primary keratinocyte cultures. Human
keratinocytes could therefore be included in the study to establish similarities in the
cytokine profiles obtained after HSV infection.
It would be interesting to investigate further which cytokines are expressed locally by
keratinocytes following HSV infections and in skin lesions. In addition, it would be
extremely useful to identify the cytokines expressed in the lymph nodes draining an HSV-
infected site. Such studies would ideally include the identification of cytokine protein as
well as mRNA. Studies in which phenotypic changes in both epidermal cells and DLN
cells were monitored would also be of great interest . This could identify whether the
down-regulation of IL-2 and upregulation of IL-4, described by Araneo et al (1989), is
directly relevant in situ to HSV infection. These studies could be extended to look at
secondary and possibly recrudescent HSV infections.
Further work would be necessary to ascertain whether UV-induced alterations in the
cytokine profiles leads to more severe symptoms or to recrudescences in the case of
latency. Also studies to compare cytokine expression during HSV infections in normal
and single cytokine knock-out mice would help to further a knowledge of local immune
responses to HSV. These experiments will clarify the sequence of local events which is
required to control HSV infections of the epidermis and will help to resolve the
mechanism of action of UV in altering the balance between the virus and the host in such
cutaneous sites. The results will be of relevance in understanding the pathogenesis of
HSV infections of human subjects and in the development of possible treatment strategies
such as the local administration of IFN-y.
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5.4 Summary
In this study in vitro and in vivo HSV infections have been established and characterised,
and the mRNA expression of several cytokines in these systems have been studied. In the
case of in vitro infection of keratinocytes, HSV infection was confirmed microscopically
by the appearance of the characteristic HSV c.p.e. In the in vivo model, in which mice
were infected epidermally with HSV-1, vesicular lesions usually developed by 3 days
post-infection. Immunohistochemistry of sections of infected skin revealed HSV antigen
to be detectable from 3 days post-infection. The HSV-positive staining was localised
within the epidermis. Semi-quantitative RT-PCR using primers for IL-la, TNF-a and IL-
10 revealed several HSV-induced effects. Most importantly, an increase in IL-10 mRNA
expression was observed both in vitro and in vivo. This suggests that epidermal
keratinocytes are induced by the virus to produce IL-10, a strategy which may serve to
minimise host immune recognition of HSV.
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Chapter 6
The Effect of UVB Exposure and UCA Treatment
on the Functional Activity of Epidermal Cells in
the Mixed Skin Lymphocyte Reaction
6.1 Introduction
Langerhans cells are vital for the initiation of skin-associated immune responses and
are known to play a key role in UVB-induced immunosuppression. It has been
suggested that the decrease in epidermal LC number (Morison et al., 1984; Noonan et
al., 1984; Toews et al., 1980), the alteration in LC morphology (Noonan et al.. 1992)
or changes in the antigen-presenting function of LC (Simon et al., 1990; Simon et al.,
1991), seen following UVB irradiation, may be responsible for UVB-induced
immunosuppression.
Since LC are vital for the initiation of CH responses, it has been hypothesised that
there is a correlation between UVB-induced depletion of epidermal LC and local
immunosuppression (Toews et al., 1980). However, as described in section 1.4.2.3,
local suppression only occurs in certain mouse strains, whereas UVB-induced
depletion of LC occurs in all strains (Yoshikawa and Streilein, 1990). It therefore
seems unlikely that UVB-induced depletion of epidermal LC is causally related to local
immunosuppression.
The currently favoured hypothesis is that UVB-induced alterations in the antigen-
presenting function of LC are responsible for immunosuppression. It is thought that
UVB converts the antigen-presenting function of LC forThl cells from immunogenic
to tolerogenic (Simon et al., 1991). In essence, Thl cells become specifically tolerant
to the antigen presented by the affected LC. The most recent hypothesis is that non-
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MHC-associated receptors are responsible for the UVB-induced effects on the antigen-
presenting capacity of LC. for example adhesion molecules such as ICAM-1 and
B7/BB1 may be involved (Tang and Udey, 1992; Young et al., 1993). Alternatively,
or perhaps additionally, soluble keratinocyte mediators such as IL-10 and TNF-a may
be responsible for this effect of UVB exposure (Streilein. 1993).
One way to study the antigen-presenting abilities of epidermal LC is by a mixed skin
lymphocyte reaction (MSLR). This is an adaptation of the mixed leucocyte reaction, an
in vitro model of T cell recognition of foreign MHC gene products which is induced
by culturing mononuclear leucocytes from one individual or strain with mononuclear
leukocytes from another individual or strain. Recognition of allelic differences, both
MHC class I and II. between the two cell populations will result in proliferation,
measured by incorporation of [3H]-thymidine into DNA during cell replication. In the
MSLR the stimulator cells are epidermal cells (EC) which proliferate very little in
comparison to the mononuclear cells and therefore do not need to be y-irradiated. It has
been shown, in murine skin, that between 2 and 5% of an EC suspension consists of
LC and a similar figure is likely for human skin (Stingl et al., 1981). Suspensions of
EC were therefore used in this study, but the principal cell required for alloantigen-
presentation and hence for the proliferation of responder cells is the LC.
The aim of this study was to carry out a preliminary investigation into the effects of
UVB exposure on the functional activity of human EC. Epidermal cells from skin
blister roofs were used to investigate the effect of in vitro and in vivo UVB exposure
on the alioantigen presentation by LC, as measured in a MSLR. In addition, the
effects of pre-treating EC with cis- and trans-UCA on their antigen-presenting capacity
was examined to identify any role for UCA as a mediator of the observed UVB
effects. The evidence for c/.v-UCA as a possible photoreceptor for the effects of UVB
on the immune system is discussed in section 1.5.1.2.
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6.2 Results
6.2.1 The effect of in vitro UVB exposure on the functional activity of
human epidermal cells
Epidermal cells were obtained by raising suction blisters from the forearm of normal
individuals and then disaggregating the cells with trypsin. These cells were exposed in
suspension to broadband UVB, prior to being used in a MSLR as stimulator cells.
Allogeneic PBMC were used as responder cells (see section 2.5.1).
The effect of in vitro irradiation of EC on their functional activity in a MSLR was
examined in five responder/stimulator pairs. In each case UVB exposure of EC
suppressed the MSLR to near background levels and these results are shown in Table
6.1. An initial experiment (Table 6.1, experiment 1) showed responder and stimulator
cells, when incubated separately for 5 days, to give low counts for [2H]-thvmidine
incorporation. This confirmed that irradiation of stimulatory cells was not necessary
and that non-specific proliferation of responder cells was acceptably low.
In experiments one and two (Table 6.1). EC were exposed to 20, 40 and 60 mJ/cm2
UVB. The results of experiment one are shown in Figure 6.1. These irradiated EC
showed reduced counts compared with the appropriate non-irradiated cells in the
MSLR. This suppression was found to be significant using EC exposed to 40 mJ/cm2
in experiment one, and 20 and 60 mJ/cm2 in experiment two, as determined using a
student's r-test. (p<0.05). Since all three in vitro UVB doses used in these initial
experiments reduced the [2H]-thymidine incorporation to near the responder
background level, it was decided to use lower doses of UVB, namely 5, 10 and 20
mJ/cm2, in subsequent experiments (experiments 3-5, Table 6.1). It was anticipated
that this would allow a range of suppression to be observed, dependent on UVB dose.
In fact these reduced UVB doses also reduced the alloresponse to background
responder levels.
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Figure 6.1 Effect of in vitro UVB exposure on the functional
activity of human epidermal cells in the MSLR
(Experiment 1 in Table 6.1)
Responder : stimulator ratio
Epidermal cells were prepared from suction blister roofs and single cell suspensions were
exposed to 20, 40 or 60 mJ/cm- UVB in vitro. Irradiated and unirradiated, control EC
were used as stimulator cells. Allogeneic PBMC were used as responder cells and
responder to stimulator ratios of 33:1, 10:1 and 3:1 were used for the MSLR. The assays
were incubated at 37°C for 5 days, with 0.7gCi [3H]-thymidine added to each well for
the final 24 hours of culture. The mean c.p.m. was determined for each treatment and the
results are expressed as the mean c.p.m. ± SEM. Responder cells alone were used to
determine the background proliferation level, which is indicated by a dashed line on the
graph.
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Therefore exposure of EC to as little as 5 mJ/cm2 UVB in vitro can reduce the
functional activity of these cells.
In some of the experiments in this study, the allogeneic proliferative responses were
fairly low and so pokeweed mitogen (PWM) was added to some control responder cell
cultures. This acted as a control to demonstrate that these cells were capable of
proliferating effectively. The mean cpm for lxl05 PBMC ranged from 2.1-3.7xl04.
6.2.2 The effect of in vivo UVB exposure ori the functional activity of
human epidermal cells
For the in vivo UVB exposure experiments, the MED of each subject was determined
(see section 2.5.3) and then an area of the forearm was irradiated each day for 7 days
with 0.5 MED. On day 8, suction blisters were taken from both the irradiated site and
a non-irradiated, control site. The EC were disaggregated and used in a MSLR. The
total L?VB dose received by an individual of skin type II was typically 105 mJ/cm2.
The effect of in vivo irradiation on EC has to date only been studied using the EC of
four individuals. These four experiments are shown in Table 6.2 and the results of one
representative experiment (experiment 1, Table 6.2) are depicted in Figure 6.2.
Although the statistical differences between the assays using irradiated EC and control
unirradiated EC were only significant in experiment one (p<0.05), a consistent
decrease in the response was seen in all assays. The data therefore suggests that a
course of sub-erythemal UVB exposure can cause suppression of the MSLR, by
affecting the functional activity of EC.
6.2.3 The effect of cis- and trans-urocanic acid on the functional
activity of human epidermal cells
In order to try to identify the mediator responsible for the functional suppression
induced in UVB-irradiated EC. further MSLR assays were carried out using EC which
had been treated with either cis- or trans-UCA. In these five experiments, CD3-
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Figure 6.2 Effect of in vivo UVB exposure on the functional





















Responder : stimulator cell ratio
An area on the forearm of a subject (KH) was irradiated each day for 7 days with 0.5
MED. The total dose of UVB was 105 mJ/cm2. On day 8 suction blister were taken from
both the irradiated and a non-irradiated, control site. Epidermal cells were prepared from
these blister roofs and were used in a MSLR. Allogeneic PBMC were used as responder
cells to give responder to stimulator cell ratios of 10:1 and 3:1. The assays were incubated
at 37°C for 5 days, with 0.7gCi [3H]-thymidine added per well for the final 24 hours of
this incubation period. The mean c.p.m. was determined for each treatment and the
results are expressed as the mean c.p.m. ± SEM. Responder cells alone were used to
determine the background proliferation level, which is indicated by a dashed line on the
graph.
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separation procedure to remove any potential APC. These populations were used as
responder cells. EC were obtained from suction blister roofs as before and were
suspended in 100 pg/ml cis- or trans-UCA or PBS for one hour at 37°C. Following
this treatment. MSLR responses were carried out using these EC and allogeneic CD3-
enriched cell populations at a responder to effector cell ratio of 10:1. As a positive
control unseparated PBMC were incubated for 5 days with inactivated HSV (all the
subjects were seropositive for HSV). A population of PBMC enriched for CD3-
expressing cells was incubated with inactivated HSV, but with no EC, as a negative
control. Stimulation indices were calculated as a ratio of mean experimental c.p.m. to
the positive control value for each experiment. The mean stimulatory index for the five
experiments were calculated and are shown in Figure 6.3. These experiments were
identical apart from the EC and PBMC donors used. The results show that pre-
treatment of EC with cA-UCA suppresses the ability of these cells to induce a
proliferative response in a MSLR assay. Although this suppression was not found to
be statistically significant as determined by the student's /-test, the percentage
suppression induced by cA-UCA treatment of EC was calculated to be 71%, using the
equation shown in section 2.2.3.2. Trans-UCA treatment also reduced the allo-
response by 50%.
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Figure 6.3 Effect of cis- and trans-UCA treatment on the
functional activity of human EC in the MSLR
20
§
Positive Negative EC/PBS EC/cis EC/trans
control control
Epidermal cells were prepared from suction blister roofs and single cell suspensions were
treated with either cis-or trans-UCA (lOOgg/ml) or PBS for one hour. These treated EC
were used as stimulator cells in a MSLR assay. Allogeneic PBMC were used as
responder cells in the positive control and were incubated for 5 days at 37°C. A
MiniMACS separation procedure was carried out to give an enriched CD3+ population
which was used as responder cells in all other wells. Negative control wells contained
CD3+ responder cells and inactivated HSV only. Experimental assay wells contained
CD3+ responder cells and treated EC (EC/PBS; EC/cis; EC/trans), at a responder to
stimulator cell ratio of 10:1. All assays were carried out in triplicate and were incubated
at 37°C for 5 days. For the final 24 hours of culture 0.7pCi [3H]-thymidine was added to
each well. The cells were then harvested and the [3H]-thymidine incorporation measured
in c.p.m. using a liquid scinilation counter. The results are expressed here as the mean
stimulation index for five identical experiments ± SEM.
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6.3 Discussion
6.3.1 Effects of in vitro and in vivo UVB exposure on the functional
activity of human epidermal cells
Exposure of EC to UVB both in vitro and in vivo, caused suppression of the
alloreactive capacity of these cells in the MSLR. to some extent. Under in vitro
conditions, doses as low as 5 mJ/cm2 UVB were able to suppress the stimulatory
activity of EC. This is in agreement with the results obtained by Goettsch et al who
also found 5 mJ/cm2 UVB in vitro to be suppressive (Goettsch, 1995). In this study
they also found that twenty-fold higher doses were needed for significant suppression
of the MSLR after in situ exposure to UVB. The in situ exposure involved irradiation
of intact skin sheets, prior to the disaggregation of EC. It may therefore be that the
doses employed in our study were on the border-line for suppressive activity and this
is one reason why the MSLR was not consistently suppressed in all experiments.
However, it is important to remember that the subjects in the in vivo studies described
here had 7 days of irradiation, rather than the single irradiation of the EC in vitro. In
the in vivo experiments, the migration of cells, both into and out of the irradiated
epidermis, must be considered.
A study which examined the effect of UVB exposure on LC in mice, also found in
vitro UVB exposure of EC to have a marked and dose-dependent effect on the MSLR
response (El-Ghorr et al., 1994). The ability of EC to stimulate a MSLR response
was reduced immediately following in vivo broadband UVB irradiation, with a dose of
96 mJ/cm2 (0.6 MED for C3H/HeN mice). This is similar to the doses employed in
the in vivo UVB exposure study reported here and since Goettsch et al found human
EC to be less susceptible to UVB than rodent EC (see below), this data also suggests
that the doses we employed were border-line suppressive (Goettsch, 1995).
The doses of UVB for the in vitro exposures of EC were selected as doses higher than
20 mJ/cm2 are likely to kill the cells. The in vivo doses were chosen to be sub-
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erythemal and the subjects's MED was used to take skin type into consideration. In
one subject undergoing the localised UVB treatment (Experiment 4, Table 6.2), the
exposed area was observed to be more highly pigmented than the surrounding skin by
the end of the seven day treatment. In fact the response of EC from this individual in a
MSLR was not significantly suppressed and it is possible that the response of tanning
is protective against the functional suppression seen in this study. This observation is
interesting and deserves further investigation as it suggests that higher doses of UVB
which induce a tanning response may not, as a result, be able to cause suppression,
while lower doses could be harmful.
One of the problems encountered in this study was the low [3H]-thymidine
incorporation counts and hence the low proliferative responses obtained in some
experiments. Since the PBMC responder cells proliferated greatly in response to
PWM, the low counts obtained were not due to a functional problem with these cells.
The proliferative response induced in the responder cells is likely to be related to the
difference in MHC antigens between the EC and PBMC donors and therefore cannot
be improved upon. Attempts were however made to achieve higher counts by
incubating the assays for an additional twenty-four hour period but this did not greatly
affect the final results obtained.
It was initially anticipated that this study would form part of a larger collaboration
aimed at assessing differences in UV-susceptibility in various species. Statistical
regression models have been used to compare data from different species (human, rat
and mouse) and these studies may be useful in the long-term to gain a greater
understanding of the risk assessment cn the UVB-induced suppression of the
immunological resistance to infections in humans (Goettsch, 1995). In this study it
was found that mouse EC were the most susceptible to both in situ and in vitro UVB
exposure and that human cells were least susceptible. It was also found that the UVB
doses needed to impair the alloreactivity, were lower than the doses necessary to alter
the morphology of the LC in situ. This would suggest that the UVB-induced
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suppression in EC function is not a result of morphological changes. In contrast, it has
been shown by others that ICAM-1 expression on LC, which is important for
(allo)antigen-presentation, is very sensitive to UVB radiation (Austad and Braathen.
1985; Streilein, 1993). Such evidence suggests that low UVB doses are able to alter
the membranes of LC and through doing this, alter the (allo)antigen presenting
function.
A study of the effects of in vitro UVB irradiation using the MSLR, has been carried
out using both enriched LC suspensions (8-20% LC) and purified LC suspensions
(70-90% LC) (Rattis et al., 1995). UVB doses of between 2.5 and 20 mJ/cm- were
employed and suppressed the proliferative response of allogeneic T cells in a dose-
dependent manner. These experiments suggest that keratinocytes do not play a major
role in the UVB-induced inhibition of the MSLR. This finding would indicate that the
functional suppression induced by UVB is not mediated by soluble factors released by
keratinocytes, although the 10-30% possible contamination by other cells may be
sufficient for the production of inhibitory factors.
6.3.2 Effect of urocanic acid isomers on the functional activity of
human epidermal cells
The data presented presented here indicate that civ-UCA treatment of EC, prior to use
as stimulator cells in a MSLR. causes a functional suppression in the alloantigen-
presenting capacity of these cells. This would suggest that UCA acts as a mediator in
the UVB-induced suppression of LC function, through its isomerisation from trans- to
cis- UCA. However, this result in in contrast to that obtained by Rattis et al (1995)
who showed that the addu.on of cis-UCA, at a concentration of 2.5 mg/ml, had no
effect on the allostimulatory function of human LC in a MSLR. This difference may
result from the protocols employed in these studies, since EC were pre-incubated with
UCA in the study described here.
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A murine study showed that broadband UVB exposure caused a dose-dependent
conversion of trans- to cA-UCA in mouse ear skin (El-Ghorr et al., 1994). A
maximum of 45% cis-UCA was recorded which was thought to represent the
photostationary state (Gibbs et al.. 1993). However, no correlation was detected
between the reduction in the MSLR response seen and the formation of cA-UCA
following UVB irradiation (El-Ghorr et al.. 1994). This implies that, at least in the
murine system, cA-UCA is not acting as the main mediator in the UVB-induced
suppression of the alloantigen-presenting function of epidermal LC.
It is anticipated that the number of epidermal LC will decrease during the 7 days of in
vivo irradiation of human subjects. It is known that a sub-erythemal dose of UVB can
cause at least a 20% decrease in the number of LC in human skin (Cooper et al.,
1992). The antigen-presenting function of EC collected at the end of the irradiation
period will therefore be poor since the LC population will have been greastly reduced.
A study by Hurks et al (1997) demonstrated that following exposure of human skin to
erythemal UVB doses of 160 mJ/cm2 for four consecutive days, there was an influx of
CD36+DR+ macrophages into the epidermis (Hurks, 1997). An enhancement of the
MSLR was observed when EC from irradiated skin were used and this was associated
with the influx of the macrophage population. However, no CD36+ cells appeared in
the epidermis in a separate study, following four weeks (thrice weekly) of sub-
erythemal UVB treatment (Hurks, 1997). Since the in vivo exposures used in the
study described here were sub-erythemal and irradiation was over a period of just one
week, it is likely that no influx of macophages occurs. The lack of replacement of
APC in the epidermis following LC migration is therefore likely to explain the
suppression in allo-presenting capacity of EC in the MSLR following in vivo
irradiation.
6.3.3 Criticisms of experimental design
The process of taking suction blisters is a mild procedure, in comparison for example
to taking biopsies. Although it involves pressure being applied to the skin and hence to
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the epidermal layer, no damage to the cells is believed to be caused by this, other than
vacuolation. In fact the proliferation seen by the responder cells in the MSLR shown
here demonstrate that the functional capacity of the EC must remain intact following
suction blister treatment.
The use of localised UVB was to see any effects of in vivo UVB exposure in a
preliminary study, without the need for individuals to undergo a course of whole-body
irradiation. The use of the MED as a method of determining the relative doses of UVB
that individuals receive is a fairly effective one as it takes into consideration certain
characteristics of the individual's skin. This is better than simply exposing individuals
to a particular UVB dose which may be sub-erythemal in individuals of certain skin
types while erythemal in others.
It is possible that unirradiated control skin sites, if near to the UVB-exposed site, may
be affected by any soluble mediators released by UVB irradiated EC. Additionally, the
level of previous UVB exposure by the EC donors may affect the results obtained.
6.3.4 Suggestions for further work
This study is only a preliminary one and therefore expanding the number of subjects
providing EC would be a priority. This is particularly important with respect to
examining the effect of in vivo UVB exposure. The use of slightly higher in vivo
doses of UVB would also be informative, in the light of the findings of Goettsch et al
(1995). An interesting expansion of the study might be to include in situ irradiation of
EC, ie irradiating blister roofs before the disaggregation of EC. By comparison with
the other protocols, this may reveal details of the interactions of EC following
irradiation, perhaps through the release of soluble mediators. In addition, the use of
skin blisters taken from individuals undergoing UVB phototherapy, would further add




Alterations in the function of EC, especially LC, were studied using the MSLR. In
vitro UVB exposure of EC, derived from human skin blisters, revealed that low doses
of UVB radiation impaired the alloreactive capacity of these cells. For suppression of
the alloreactive capacity of EC after in vivo UVB exposure of skin, higher doses of
UVB radiation were required. Pre-treatment of EC with cA-UCA, and to a lesser
extent trans-UCA, caused a suppression of the functional capacity of EC in the MSLR.




The Effect of UVB Phototherapy on
HSV-Specific T Cell Cytotoxicity
and NK Cell Activity
7.1 Introduction
Exposure to UVB has been demonstrated to result in the suppression of selected
immune responses to a range of antigens. In general, evidence for this has come from
animal models, as discussed in section 1.4.2. The immunological consequences of
UV irradiation of humans are much less well characterised and studies have mainly
been confined to suppression of CH responses (Baadsgaard, 1991: Cooper et al.,
1992; Morison, 1989; Tie et al., 1995). The effect of UVB on human LC, such as the
transient alterations in the numbers, ultrastructure and morphology, is also well-
documented (Reviewed in Lappin et al., 1996). These changes are associated with
suppressed alloactivation by epidermal cells in vitro (Cooper et al., 1985) and reduced
antigen presentation (Austad and Braathen, 1985). However, relatively few studies
have examined the effects of UVB exposure on other immune parameters in humans.
7.1.1 Cytotoxic T lymphocytes
Cytotoxic T lymphocytes (CTL) kill target cells expressing specific antigen. They are
important effector cells in terms of viral infection, acute allograft rejection and rejection
of tumours. The phenotype and functions of CTLs have been reviewed elsewhere
(Berke, 1991; Kupfer and Singer, 1989; Nabholz and MacDonald, 1983). The
majority of CTLs express the CD8 molecule, use an a(3 TCR and recognise peptide
associated with class I MHC molecules. MHC class Il-restricted, CD4+ CTLS are less
prevalent but may come to dominate the cytotoxic response against some viral
infections (Schmid, 1988). T cells using the y5 TCR may also be cytotoxic but they
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are not restricted by conventional polymorphic MHC molecules. The appearance of
functional CTLs depends upon the process of differentiation from pre-CTLs. These
precursor cells have already undergone thymic maturation and are specific for a
particular foreign antigen, but lack cytolytic function. Two separate signals are
required for the differentiation of pre-CTLs to functional CTLs. The first is specific
recognition of antigen on a target cell. The second is provided by CD4+ T cell-derived
cytokines, such as IL-2, IFN-y and IL-6. The involvement of CD4+ T cells indicates
that maximal CTL responses depend upon antigen presentation, utilising both class I
and class II MHC molecules.
Differentiation of pre-CTLs involves the acquisition of the machinery necessary to
perform cell lysis. CTL killing is antigen-specific and requires cell contact. The CTL
binds to the target cell through the specific antigen receptor and through other
accessory cell molecules, such as CD8, CD2 and LFA-1. The CTL is activated by
cross-linking of its antigen receptor and then delivers a lethal hit by several
mechanisms, the relative importance of each mechanism being dependent on the
cytotoxic cell and the target. The granules of cytotoxic lymphoid cells contain perforin
and granule enzymes (granzymes). Upon activation, the cytoskeleton of the CTL
rearranges and the granules are reorientated towards the target before exocytosis.
Perforin polymerises on the target cell membrane to create holes, which act as ion-
permeable channels in the target cell plasma membrane (Krahenbuhl and Tschopp,
1991). In sufficient numbers, such channels lead to osmotic swelling of the target cell
and lysis. The function of the granzymes is less clear, although they are thought to
enter the target cell via perforin pores to activate endogenous killing mechanisms, such
as apoptosis. The second mechanism of target cell lysis involves the secretion of a cell
toxin which activates target cell enzymes that cleave DNA in the target cell nucleus.
Once the target cell DNA is fragmented, apoptosis of the target cell results (Cohen,
1991). The cytotoxic cell is protected from its own killing mechanisms and can
subsequently kill further targets.
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Classical CTL are CD8+ in humans, Lyt2+ in mice and MHC class I-restricted.
However, in humans, CD4+, MHC class II-restricted rather than CD8+T cells are
responsible for the main CTL activity of HSV antigen-expanded clones obtained from
seropositive donors (Schmid, 1988; Yasukawa and Zarling, 1984). Known targets
for anti-HSV CTL include glycoproteins gB, gC, gD and the immediate-early protein
ICP27 (Banks et al., 1991; Zarling et al., 1986). It is conceivable that these CD4+
CTLs function in the skin to destroy infected keratinocytes, induced to express MHC
class II molecules by IFN-y (Cunningham and Noble, 1989). Immunocytochemical
studies indicate that MHC class II expression on keratinocytes from HSV-1 cutaneous
lesions begins within 24 hours of infection and by 48 hours the expression is uniform
on all keratinocytes within and adjacent to the lesion (Cunningham et al., 1985). This
study also demonstrated that during the first 48 hours, only CD4+ CTLS infiltrate into
the lesion site, together with macrophages and then CD8+ T cells infiltrate, until
eventually they are present in similar proportions. Since typical HSV lesions begin to
resolve by 48 hours (Cunningham et al., 1985), a central role for CD4+ T cells in the
control of recurrent lesions would appear likely, with CD8+ late infiltrating cells
probably helping in the final stages of resolution.
7.1.2 Natural killer cells
Natural killer (NK) cells represent an extremely heterogeneous population of
predominantly large granular lymphocytes. NK cells can spontaneously kill certain
susceptible target cells in a manner which, unlike CTLs, is not MHC-restricted. They
have a relatively limited specificity repertoire and therefore the frequency of any given
specificity is high. NK cells are able to kill target cells at first contact and these
characteristics enable them to act as a first line of defence, while specific CTLs are
developing from precursors. They are therefore particularly important in natural
resistance against neoplasia and infectious agents, particularly in limiting viral infection
during the first few days of infection (Biron, 1997). The function and mechanism of
action ofNK cells are reviewed in Trinchieri (1989).
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NK cells express both T cell markers, eg CD2, and myeloid markers such as CD1 lb
and CD 16. The latter is the low affinity Fey receptor (FcRIII) which allows NK cells
to mediate ADCC directed to antibody-coated target cells. NK cells also express
CD56, a member of the neural adhesion molecule (NCAM) family of adhesion
molecules. The majority ofNK cells in peripheral blood in humans are CD56+ CD16+
CD2+ CD1 lb+ CD3" (Trinchieri, 1989). NK cells are directed by both positive and
negative interactions with their targets. They express receptors for MHC class I
molecules and activation of these receptors results in inhibition of their effector cell
function (Lanier and Phillips, 1996; Raulet, 1996). In the mouse these receptors
belong to the Ly49 protein family. Similar, although structurally distinct, receptors
have been identified on human NK cells (Moretta et al., 1996). These receptors are
believed to be critical for the mechanism that explains why for example, NK cells kill
virally infected cells, but not normal self-cells . The lack of expression of one or more
class I alleles on a target cell is thought to lead to NK-mediated target cell lysis.
Unlike CTLs, NK cells do not appear to require prior contact with target antigens to
develop cytolytic capacities. A protein, NK-TR, has been postulated to be part of the
NK target-recognition/triggering complex (Chambers et al., 1994). NK cells can be
activated to increase their ability to lyse target cells by treatment with type IIFN, IFN-
y, TNF-a or IL-2. IL-12, produced mainly by phagocytic cells, induces IFN-y
production by T cells and NK cells and is known to enhance NK cell activity
(Trinchieri, 1995). Killing of targets by NK cells involves similar mechanisms as
killing by CTLs, namely granule exocytosis and secretion of a cell toxin.
A variety of target cell types, with varying degrees of susceptibility have been
employed to measure NK cell cytotoxicity. The K562 cell line employed in this study
was derived from a patient with chronic myeloid leukemia and is highly sensitive to
NK cell lysis. This cell line lacks both MHC class I and II antigens.
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7.1.3 UVB Phototherapy
A wide variety of skin diseases are currently being treated with UVB phototherapy,
including psoriasis and atopic dermatitis. Importantly, an increasing number of AIDS
patients are having their AIDS-associated dermatoses treated with phototherapy. The
use of UVB phototherapy is largely empirical and the complete mechanism of action
remains unknown, although it is thought to act, at least in part, by modulation of
immune responses. There is growing concern about the side effects of UVB
phototherapy in terms of the potential risk of developing skin cancer, as well as the
implications of immune modulation. The majority of studies of the effects of UVB
exposure in humans have employed UV regimens which bear little resemblance to
those used therapeutically. In addition, previous studies of the effects of broadband
UVB phototherapy on human immunological parameters have mainly involved
psoriatic individuals. These studies have demonstrated that while phototherapy was
therapeutically successful, no measurable changes were observed in the phenotypes of
PBMC subsets or in the lymphoproliferative responses to HSV antigen and con A
(Gilmour et al., 1993b; Guckian et al., 1995). However, psoriatic individuals may
have a number of underlying abnormalities in their immune function, making it
difficult to extrapolate from them to normal individuals. The NK cell activity of
subjects, both psoriatic and normal individuals, during and after PUVA and UVB
phototherapy have been reported to be suppressed (Gilmour et al., 1993a).
The aim of this study was therefore to examine the effects of a standard course of
UVB phototherapy on two parameters of systemic immunity, namely HSV-specific T
cell cytotoxicity and NK cell activity, in normal individuals. To date no studies have
identified effects of broadband UVB phototherapy on CTL activity directed at viral
antigens. In addition, the phenotypes of PBMC were monitored by flow cytometry to
identify any UVB-induced alterations.
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7.2 Results
7.2.1 HSV-specific cytotoxicity assay
Normal individuals, known to be seropositive for HSV, underwent a standard course
of broadband UVB phototherapy, as used in the treatment of psoriasis. They received
whole body irradiation three times a week, for four weeks, with incremental doses
dependent on skin type. Blood samples were taken before the start of treatment and at
10, 20 and 30 days from the start of phototherapy. Samples were also taken from two
subjects (WN and MB) at 37 days after the start of treatment.
Table 7.1 Details of the subjects and UVB doses employed






WN 57 M II 2100 3
MB 40 M II 3200 4
MN 52 F I 1300 1
GK 34 F II 2100 2
As shown in Figure 7.1, two of the four individuals examined to date, showed no real
change in the cytotoxicity response elicited throughout the experimental period, using
unseparated CTL. However, the cytotoxicity response of one subject (GK) declined
from the start of phototherapy to 20 days, before returning to near basal level by the
end of treatment. The fourth individual (MN) showed a peak in cytotoxic response
after 10 days of UVB phototherapy. However, this response was found to have
decreased towards pre-UV levels in the two subsequent time-points. It is therefore
possible that the early-UV time-point for this individual (day 10) is an anomaly as it
does not reflect the general trend seen throughout the other time-points and
individuals. The data represented in Figure 7.1 is for an effector to target cell ratio of
40:1. However, similar results were observed at lower ratios. Table 7.2 shows the
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Figure 7.1 HSV-specific cytotoxicity assay using unseparated
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Time after start of phototherapy (days)
Four individuals known to be seropositive for HSV underwent a standard course of
broadband UVB phototherapy. They received whole body irradiation three times a week
for four weeks, with incremental doses depending on skin type.
The ability of these individuals to mount an HSV-specific cytotoxic T cell response was
examined. Cytotoxic T lymphocytes (CTLs) were generated by in vitro incubation of
non-adherent cells from PBMC with HSV primed dendritic cells for 6 days at 37°C.
Target cells were autologous B cell lines (BCLs) prepared for each subject by
transformation with Epstein-Barr virus. BCLs were incubated with inactivated HSV for
two hours prior to being used as target cells in the cytotoxicity assay.
The results shown here are for cytotoxic cell assays set up for the four subjects, with a
final effector to target cell ratio of 40:1. Spontaneous [51Cr] release was determined by
incubation of target cells with RPMI-FCS and maximum release by incubation with 2%
acetic acid. The SEM for each assay was always within 10% of the mean value. The
percentage specific release was determined according to the formula shown in section
Blood samples from each individual were taken prior to UVB exposure (pre-UV), and
after 10 (early-UV), 20 (mid-UV) and 30 (end-UV) days after the start of phototherapy.
2.5.2.1.
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Table 7.2 Titration of effector cells for HSV-specific
cytotoxicity assay





CTL Control BCL 40 : 1 3449.0 ± 143.4 17.39
20 :1 3214.0 ± 95.8 13.44
10:1 2971.7 ± 42.1 9.36
CTL HSV BCL 40 : 1 5161.3 ± 265.0 37.12
20 : 1 4678.3 ± 435.2 30.56
10 : 1 3793.7 ± 179.6 18.54
CD4+ CTL Control BCL 40 : 1 4094.7 ± 56.2 28.23
20 : 1 3651.3 ± 1 12.1 20.78
10 : 1 3218.7 ± 281.8 13.51
CD4+ CTL HSV BCL 40 : 1 4998.3 ± 585.7 34.90
20 : 1 451 1.0 ± 253.1 28.29
10 : 1 3589.0 ± 176.8 15.77
CD8+ CTL Control BCL 40 : 1 3159.0 ± 118.6 12.51
20 : 1 3545.3 ± 1 15.7 18.67
10 : 1 2678.0 ± 250.8 4.43
CD8+ CTL HSV BCL 40 : 1 4432.3 ±41.0 27.22
20 : 1 4246.7 ± 101.6 24.69
10 : 1 4079.7 ± 46.8 22.42
The results of HSV-specific cytotoxicity assays for one subject (GK) are shown. The assays were set up
using CTLs generated from a blood sample taken after completion of the course of phototherapy (end-UV;
day 30).
a Cytotoxic T lymphocytes (CTL) were generated by in vitro incubation of non-adherent cells from
PBMC with HSV-primed dendritic cells for 6 days at 37°C. Populations of these CTLs enriched for CD4
and CD8 expressing cells were prepared using a separation column and used as effector cells in separate
assays.
^ Autologous B cell lines (BCL) were prepared for each subject by transformation with EBV and used as
target cells. BCLs were incubated with inactivated HSV for two hours prior to being used as target cells.
BCLs incubated with RPM1 only were used as control target cells.
c The percentage specific [5lCr] release was determined according to the formula shown in section
2.5.2.1. Spontaneous [ Cr] release was determined by incubation of target cells with RPMI-FCS and
maximum release by incubation with 2% acetic acid.
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percentage cytotoxicity for one individual (GK; end-UV) for three effector to target cell
ratios. It can be seen that as the number of effector cells are reduced, so the percentage
cytotoxicity reduces. This titratable response was demonstrated for all four individuals
studied.
The HSV-specific CTL activity was further studied by the purification of the CTL
population for CD4+ and CD8+ cells (see section 2.5.2.1). These purified cell
populations were used as effector cells in the cytotoxicity assay, in the same way as
the whole CTL population. Figure 7.2 shows the results of the cytotoxicity assay
using CD4+ cells as effector cells and Figure 7.3 shows the results obtained using
CD8+ cells as the effector population. No consistent trend as to the effect of
phototherapy on these cytotoxicity assays was seen between the four individuals.
These results do not conclusively indicate a unique role for either CD4+ or CD8+
lymphocytes in the CTL response to HSV, as neither MiniMACS-purified cell
population is solely responsible for the cytotoxic response. It also appears that UVB
exposure does not preferentially affect the activity of either one of these T cell
populations. The SEM at each effector to target cell ratio and within each experiment
were always less than 10% of the mean value.
7.2.2 NK cell assay
As shown in Figure 7.4, all four individuals subjected to a standard regimen of UVB
phototherapy demonstrated suppressed NK cell activities. The SEM within each
experiment were less than 10% of the mean value. The initial percentage cytotoxicities
demonstrated by the subjects ranged from 44.9% to 70.2%. This NK cell activity was
significantly reduced in all four individuals at the first time-point after the initiation of
phototherapy (day 10). The NK cell activity continued to decline in all four subjects
until the end of phototherapy, when the percentage cytotoxicity values ranged from 12
to 25%. However, the NK response rapidly returned after the cessation of
phototherapy, in the two individuals (WN and MB) examined at this time (day 7 after
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Figure 7.2 HSV-specific cytotoxic assay, using CD4-purified
CTLs, during broadband UVB phototherapy
Time after start of phototherapy (days)
Four individuals known to be seropositive for HSV underwent a standard course of
broadband UVB phototherapy. They received whole body irradiation three times a week
for four weeks, with incremental doses depending on skin type.
The ability of these individuals to mount an HSV-specific cytotoxic T cell response was
examined. Cytotoxic T lymphocytes (CTLs) were generated by in vitro incubation of
non-adherent cells from PBMC with HSV primed dendritic cells for 6 days at 37°C. A
population of these CTLs purified for CD4 expressing cells was prepared and used as
effector cells in the cytotoxicity assay.
Target cells were autologous B cell lines (BCLs) prepared for each subject by
transformation with Epstein-Barr virus. BCLs were incubated with inactivated HSV for
two hours prior to being used as target cells in the cytotoxicity assay.
The results shown here are for cytotoxic cell assays set up for the four subjects, with a
final effector to target cell ratio of 40:1. Spontaneous [51Cr] release was determined by
incubation of target cells with RPMI-FCS and maximum release by incubation with 2%
acetic acid. The SEM for each assay was always within 10% of the mean value. The
percentage specific release was determined according to the formula shown in section
2.5.2.1.
Blood samples from each individual were taken prior to UVB exposure (pre-UV), and
after 10 (early-UV), 20 (mid-UV) and 30 (end-UV) days after the start of phototherapy.
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Figure 7.3 HSV-specific cytotoxicity assay, using CD8-purified
CTLs, during broadband UVB phototherapy
Time after start of phototherapy (days)
Four individuals known to be seropositive for HSV underwent a standard course of
broadband UVB phototherapy. They received whole body irradiation three times a week
for four weeks, with incremental doses depending on skin type.
The ability of these individuals to mount an HSV-specific cytotoxic T cell response was
examined. Cytotoxic T lymphocytes (CTLs) were generated by in vitro incubation of
non-adherent cells from PBMC with HSV primed dendritic cells for 6 days at 37°C. A
population of these CTLs purified for CD8 expressing cells was prepared and used as
effector cells in the cytotoxicity assay.
Target cells were autologous B cell lines (BCLs) prepared for each subject by
transformation with Epstein-Barr virus. BCLs were incubated with inactivated HSV for
two hours prior to being used as target cells in the cytotoxicity assay.
The results shown here are for cytotoxic cell assays set up for the four subjects, with a
final effector to target cell ratio of 40:1. Spontaneous [51Cr] release was determined by
incubation of target cells with RPM1-FCS and maximum release by incubation with 2%
acetic acid. The SEM for each assay was always within 10% of the mean value. The
percentaae specific release was determined according to the formula shown in section
2.5.2.1.
Blood samples from each individual were taken prior to UVB exposure (pre-UV), and
after 10 (early-UV), 20 (mid-UV) and 30 (end-UV) days after the start of phototherapy.
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Four individuals underwent a standard course of broadband UVB phototherapy. They
received whole body irradiation three times a week for four weeks, with incremental
doses depending on skin type. The NK cell activity of these individuals was before the
start of treatment (pre-UV) and after 10 (early UV), 20 (mid UV), 30 (end UV) and 37
(post-UV) days after treatment began. K562 cells were used as targets and assays were
carried out at various effector (PBMC) to target cell ratios. The assays represented here
are for ratios of 20:1. Spontaneous [5!Cr] release was determined by incubation of target
cells with RPMI-FCS and maximum release by incubation with 2% acetic acid. The SEM
for each assay was always within 10% of the mean value. The percentage specific release
was determined according to the formula shown in section 2.5.2.1.
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the end of phototherapy). The NK cell response in these subjects returned almost to
the respective pre-UVB treatment levels.
The results shown in Figure 7.4 represent NK cell assays in which an effector to target
cell ratio of 20 to 1 was employed. Table 7.3 shows the results of NK assays for two
individuals prior to phototherapy, using a range of effector to target cell ratios.
Although the maximum cytotoxic response obtained, ie at a 20:1 ratio, differs between
the two subjects, the percentage cytotoxicity is titratable in both individuals, as the
number of effector cells used is reduced. The NK cell response seen for all four
individuals at all time-points was titratable in this way.
7.2.3 Phenotypic analysis of PBMC
Flow cytometry was used to monitor any phenotypic changes in the subjects' PBMC,
following staining of the cells with monoclonal antibodies to various cell-surface
markers, as described in section 2.5.4. Phenotypic analysis was carried out at 0, 10,
20 and 30 days after the initiation of treatment, as for the functional assays. No
variation in the percentage of positive CD3, CD4 or CDS PBMC was seen in any of
the subjects throughout phototherapy (results not shown). Figure 7.5 shows a typical
forward-angle versus side-angle light scatter plot of unseparated PBMC and
metrizamide-separated PBMC. Approximately 90% of the unseparated PBMC were in
the region with size and granularity that is characteristic of lymphocytes. The
metrizamide-enrichment gave two populations, with approximately 50% of cells being
lymphocytes and 50% DC, as determined by their size and granularity. The DC
population were demonstrated to be 100% HLA-DR+, and the lymphocyte population
was HLA-DR". Figure 7.5 also shows representative graphs of CD8 expression on
unseparated PBMC and on a typical MiniMACS-purified CD8+ population. All
MiniMACS purified populations used were greater than 97% pure, as determined by
flow cytometry.
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Table 7.3 Titration of effector cells in NK cell assay
Effector: target
WN (pre-UV) MB (pre-UV)
cell ratio2
Mean ± SEM % cytotoxicity13 Mean ± SEM % cytotoxicityb
20 : 1 4777.3 ± 187.8 70.2 3371.7 ± 103.5 44.9
10 : 1 4184.7 ± 16.3 59.5 1950.7 ± 129.2 19.4
5 : 1 2993.0 ± 228.5 38.1 1665.7 ± 27.1 14.3
2.5 : 1 2253 ± 110.9 24.8 1301.3 ± 25.5 7.7
1.25 : 1 1719.7 ± 61.6 15.2 1094.3 ± 27.2
i
4.0
Results are shown for the NK cell assays of two subjects (WN and MB) using blood
samples taken prior to commencement of phototherapy (day 0).
a K562 cells were used as targets and assays were carried out at the various effector
(PBMC) to target cell ratios indicated.
b The percentage specific release was determined according to the formula shown in
section 2.5.2.1. Spontaneous [51Cr] release was determined by incubation of target cells
with RPMI-FCS and maximum release by incubation with 2% acetic acid.
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The size and granularity of PBMC and (B) a metrizamide-enriched DC population.
Representative CD8 expression on (D) unseparated human PBMC and (E) a
MiniMACS-purified CD8 population. The isotype control staining is shown in (C).
Representative CD56 expression on unseparated human PBMC (F). The line on each
of graphs C-F represents the region within which fluorescence is considered positive.
These regions were set using the appropriate isotype controls. The percentage of
positive cells in this region is stated on each histogram.
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7.2.3.1 Expression of CD 14
In contrast the percentage of cells expressing the monocyte marker CD 14 varied during
photherapy in all the subjects, as shown in Figure 7.6. The general trend appears to
be an initial increase in the percentage of CD14-positive cells at 10 days after the start
of treatment. This increase was seen prominantly in two of the four subjects. Between
10 and 20 days a decrease in the percentage of CD14-positive cells was observed, with
the 20 day (mid-UV) expression below the initial levels in three of the subjects. From
day 20 to day 30 three of the subjects showed an increased percentage of positive
cells, towards the basal level.
7.2.3.2 Expression of CD56
The percentage of CD56-positive cells (an NK cell marker), also varied throughout
phototherapy, as shown in Figure 7.7. From 10 days after the start of phototherapy,
the percentage of CD56 expressing cells decreased in all four subjects, to below the
initial level. Between 20 days and the end of treatment, the CD56-positive cells
increased slightly in three of the individuals. Figure 7.5 includes a representative graph
showing CD56 expression on unseparated PBMC.
213







0 10 20 30
Time after start of phototherapy (days)
Four individuals underwent a standard four week course of broadband UVB
phototherapy. Phenotypic analysis of PBMC from each subject was carried out using
flow cytometry, following staining of cells with monoclonal antibodies against cell
surface markers. Samples were collected before the start of treatment (day 0), and at 10,
20 and 30 days after the start of phototherapy. The percentage of CD14-positive PBMC is
shown for each individual at the four time-points.
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Figure 7.7 Percentage of CD56+ cells during broadband
UVB phototherapy
Four individuals underwent a standard four week course of broadband UVB
phototherapy. Phenotypic analysis of PBMC from each subject was carried out using
flow cytometry, following staining of cells with monoclonal antibodies against cell
surface markers. Samples were collected before the start of treatment (day 0), and at 10,
20 and 30 days after the start of phototherapy. The percentage expression of CD56 on
PBMC is shown for reach individual at the four time-points.
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7.3 Discussion
7.3.1 Effects of UVB on CTL activity
The currently available data regarding the effect of UVB exposure on CTL generation
and activity are very limited and on the whole restricted to studies of cytotoxicity
against syngeneic tumours and alloantigens. In studies in which mice were irradiated
in vivo, no effect of the UV exposure was reported on either the primary in vitro or in
vivo induction of T cell cytotoxicity against UV-induced syngeneic tumour cells or
alloantigens (Spellman et al., 1977; Thorn, 1978). Since these initial studies,
exposure of mice to 4.5xl03 mJ/cm2 UVB, before sensitisation with a contact
sensitiser, was demonstrated to cause depressed levels of priming for a secondary in
vitro cytotoxic response against haptenated cells (Jensen, 1983). A defect in antigen-
presenting cells was found to be largely responsible for the reduced priming response.
Additionally the irradiated, immunised mice possessed suppressor cells, capable of
blocking priming for cytotoxic responses against haptenated cells in normal mice.
Thorn showed that chronically exposed mice had depressed secondary cytotoxic
responses, generated in vitro or in vivo, against UV radiation-induced syngeneic
tumour lines (Thorn, 1978). Suppressor cells from these chronically irradiated mice
were able to block the cytolytic memory response against UV radiation-induced
tumours (Thorn et al., 1981). It remains unknown whether the UV-induced alteration
in APC function is the primary defect leading to the production of suppressor cells
specific for UV radiation-induced tumour antigens, as well as for haptens.
UVB-induced cytotoxic unresponsiveness is not observed with all antigens. Evidence
for this comes from the findings that chronically irradiated mice, as well as mice
exposed on only one occasion, make normal cytotoxic responses against allogeneic
cells (Jensen, 1983; Thorn, 1978). Such findings imply that differences exist in the
way different antigens are processed and presented to the precursor cells involved in
CTL function.
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The evidence currently available from mice suggests that UV irradiation exerts its
effects on at least two components of the immune system, namely induction of a defect
in APC function and generation of suppressor cells. Since there appears to be some
specificity in the CTL function defect, there may be antigen selectivity in the antigen-
presenting cell defect induced by UV radiation. Finally, because primary in vitro
responses in spleen cultures from UV-irradiated mice are normal, cells from UV-
irradiated mice must be able to present hapten in a recognisable manner to precursor
CTLs.
In addition there is some evidence that in vitro exposure of human target cells (Sa; an
EBV-transformed B cell line) to 10 kJ/m- UVB induces resistance of these target cells
to alloreactive CTL (Kobata et al., 1993a). This UVB-induced resistance was
correlated with a deficient conjugate formation between target cells and CTL.
Decreased surface expression of CD54 (ICAM-1), CD58 (LFA-3) and HLA were
reported following UVB exposure, although these changes were not demonstrated to
be critical for increased resistance. The same UVB-exposed target cells were shown to
induce in vitro clonal anergy in alloreactive CTLs (Kobata et al., 1993b). It is thought
that while the target cells can be recognised by CTL and can induce high affinity IL-2
receptor expression on them, they do not provide sufficient signals to induce CTL
proliferation. This may in part be due to the down-regulation of the TCR on the
anergic CTL.
7.3.2 Effects of UVB on NK cell activity
UV irradiation results in a transient suppression of immune responses to a number of
agents against which NK cell activity may play a role. These include animal models of
HSV (Howie et al., 1986a), MAIDS (Brozek et al., 1992), reovirus (Letvin et al.,
1981) and CMV (Goettsch et al., 1994a), as well as tumour antigens and allografts. In
vitro irradiation of human PBMC results in a dose-dependent suppression of NK cell
activity (Elmets et al., 1987; Schacter et al., 1983; Weitzen and Bonavida, 1984;
Yaron et al., 1995). In addition there is an indication that exposure to UV in vivo may
217
also result in a suppression in NK cell activity (Gilmour et al., 1993a; Hersey et al.,
1987). In fact, the NK cell activity of subjects, both psoriatic and normal individuals
during PUVA and narrow band UVB phototherapy, and after broadband UVB
phototherapy, have been reported to be suppressed (Gilmour et al., 1993a). The
timing of this suppression appears to be critically dependent on the lamps used, the
dose employed and the timing of the study (Gilmour et al., 1993a; Jones et al., 1996).
It was also found that in vitro treatment of PBMC with cA-UCA induced a dose-
dependent suppression of NK cell activity (Gilmour et al., 1993a). In contrast trans-
UCA had almost no effect. These results suggest that there may be a correlation
between the formation of cA-UCA in the epidermis and the modulation of NK cell
activity following UVB phototherapy. However, more recent evidence is in direct
contradiction to this. It was found that trans-UCA was a strong inhibitor of the NK
cell activity of human PBMC against K562 targets in vitro, whereas cA-UCA had no
effect on this response (Uksila et al., 1994). In addition, while the percentage of cis-
UCA in the epidermis of patients receiving narrow-band UVB phototherapy increased,
no correlation was found between this and the observed decrease in NK cell activity
(Guckian et al., 1995).
7.3.3 Effect of broadband UVB phototherapy on cellular
immune function
The course of broadband UVB phototherapy did not have any measurable effect on
HSV-specific T cell-mediated cytotoxicity. In addition, the results shown here did not
conclusively indicate a unique role for either CD4+ or CD8+ lymphocytes in the CTL
response to HSV, as neither enriched cell population was solely responsible for the
cytotoxic response. This may reflect contamination of the separated populations,
although phenotypic analysis using a flow cytometer, revealed the MiniMACS-purified
populations to be greater than 97% pure (see Figure 7.5 for representative CD8-
purified population).
218
However, broadband UVB phototherapy did cause a suppression of the NK cell
activity. This finding is in agreement with those of others, who also demonstrated that
in vivo exposure of individuals to UVB resulted in a suppression of NK cell activity
(Gilmour et al., 1993a; Hersey et al., 1987). The suppression in this study was
evident within the first week of treatment, when very small, sub-erythemal doses of
UVB were employed. In terms of environmental exposure, a standard course of UVB
phototherapy, as used in the study in chapter 7, has been calculated to be equivalent to
approximately two weeks of solar exposure in the summer in Spain (40°N). The
implications of such suppression must therefore be considered with respect to normal
individuals exposed to environmental UVB, as well as patients undergoing
phototherapy and individuals increasing their exposure through the use of sunbeds.
Since NK cells are known to provide a first line of immunological defence against a
range of infectious agents, any suppression of this function could render individuals
more susceptible to infection, particularly from viral agents. Such suppression may
also increase the possibility of developing malignancies, since NK cells are important
in natural resistance against neoplasia.
7.3.4 Relationship between phenotype and function
The main cellular expression of CD 14 is on monocytes. The slight decrease in
expression of CD 14 seen in all four subjects between 10 and 20 days from the start of
phototherapy is likely to represent a UVB-induced decrease in the total number of
CD14-positive monocytes, rather than a decrease in the cell surface expression of this
molecule. Since UVB can only penetrate the epidermis and the upper layers of the
dermis, it seems likely that any direct effect of UVB will be on circulating cells as they
migrate through the dermal vasculature. A second possibility is that UVB-induced
soluble factors, such as cytokines, are mediating the effects of UVB. Since
monocytes mediate NK cell activation through the production of IL-12, a relationship
may exist between the decrease in the number of CD 14+ cells and the suppression of
NK cell activity. However, no direct evidence exists to this effect. It is interesting to
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note such a potential UVB-induced effect on the numbers of certain cell types, as this
will affect the relative proportions of cell types in peripheral blood.
In contrast, the percentage of CD56+ PBMC appears to directly relate to the NK cell
activity during phototherapy. The CD56 expression data implies that the decrease in
NK cell activity is not a result of a loss of function but of decreased NK cell numbers.
This is particularly evident between 10 and 20 days after the start of treatment, when
the percentage of CD56+ cells in all four subjects and the NK cell activity in three of
the subjects decreased. The situation in the initial 10 day period, when the NK cell
activity decreased, but the percentage of CD56+ cells increased in two individuals,
may be explained if the increase in CD56+ cells is due to repopulation of the CD56+
population by precursor cells, unaffected by the UVB. During the next 10 days of
treatment, there will be no such unaffected precursor cells available to repopulate the
CD56+ compartment and hence the decrease in the number of circulating CD56+ cells
seen at this time. Between 20 and 30 days there appears to be a recovery of CD56-
expressing cells, although to pre-UVB levels in only two of the subjects. This increase
in the CD56+ population would suggest a recovery of precursor cells, allowing
repopulation. This may be due to adaptation of such cells to the UVB exposure,
although no mechanism is proposed at this time. It is more likely that adaptation of the
epidermis occurs by tanning and epidermal thickening, thereby protecting the CD56
population.
7.3.5 Limitations of the study
The main limitation of a study such as this one, is the relatively small number of
subjects which can realistically be recruited and undergo the treatment at any one time.
In particular, the subjects must be known to be seropositive for HSV and must live
within reach of the phototherapy facilities to be able to attend on a regular basis. The
assays used in this study are fairly time-consuming, especially the cell-separation
procedures, making it difficult to process samples from several individuals at once.
This problem is accentuated with the cytotoxicity assay since the target cells used are
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unique to each individual. The generation of B cell lines for use as targets is itself a
lengthy process which is not always successful and is therefore another factor in the
recruitment of subjects.
7.3.6 Suggestions for further work
Obviously the first priority in developing this study would be to increase the size of the
sample group by recruiting more individuals, in order to clarify some of the trends
seen during phototherapy. Since the suppression of NK cell cytotoxicity was a
consistent finding, it would be interesting to test whether particular sunscreens could
protect individuals against such immunosuppression and hence prevent any potential
increase in susceptibilty to infection. With respect to immunity to HSV, it would be
interesting to determine the Th cell subset which predominates in HSV seropositive
individuals before and during phototherapy. A preliminary study, using cell depletion
of responder cells, suggests that EC present HSV almost exclusively to CD4+ cells
(W.Neil, Dept. of Medical Microbiology, University of Edinburgh; personal
communication). To date no studies have been undertaken to ascertain whether a
systemic Thl to Th2 switch, reported to occur following UVB exposure, may occur in
HSV-infected subjects as a result of such exposure. It would be very interesting to
find out whether individuals who suffer from frequent recrudescences are induced to
have a more prominant Th2 response to HSV than those subjects who are seropositive
for HSV but who never, or rarely develop recrudescences.
To complement the human HSV cytotoxicity assay, attempts were made to establish a
suitable protocol for assaying HSV-specific T cell cytotoxicity in mice. Mice were
infected intra-peritoneally and at subsequent time-points lymph node and spleen cells
were removed and cultured in vitro with inactivated HSV for 5 days to generate CTLs.
A chromium release assay was then carried out as described in section 2.6.2. using
HSV-infected L929 cells as targets. However, HSV-specific cytotoxicity could not be
detected using either lymph node or spleen cells. The protocol was altered by giving
mice booster injections of HSV, increasing the amount of HSV used for both the
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infection of mice and for the in vitro incubation and attempting to increase the
effectiveness of the in vitro culture stage. Although such cytotoxicity assays are
characteristically difficult to establish, it would prove to be a very valuable tool in
further characterising the specific effect of UVB on anti-viral immune mechanisms.
To date the effect of UVB exposure on virus-specific cytotoxicity has not been studied
in a murine model which has obvious potential advantages in terms of manipulation.
The recent introduction of a MiniMACS system for the purification of murine dendritic
cells may make it possible to isolate these cells for use as antigen presenting cells in the
in vitro CTL-generating culture stage.
7.4 Summary
In this study four normal subjects, known to be seropositive for HSV, underwent a
standard course of broadband UVB phototherapy, as used in the treatment of
psoriasis. Before the start of phototherapy and at 10, 20 and 30 days, blood samples
were taken and phenotypic analysis, as well as functional assays were carried out. It
was found that the course of phototherapy had no measurable effect on HSV-specific
T cell-mediated cytotoxicity, using autologous B cell lines, infected with HSV as
targets. In contrast, the NK cell activity of all four subjects was suppressed within
the first week of phototherapy and further suppressed by 30 days. The percentage of
PBMC expressing CD56 decreased between 10 and 20 days of treatment in all four
individuals and this would suggest that the decline in NK cell activity results from a
reduction in the number of NK cells rather than a functional defect. The NK cell
activity of two of the subjects was studied a week after the end of phototherapy, by
which time the activity had returned towards the pre-irradiation values. The UVB-
mediated suppression of NK cell activity, although transient, has implications with
respect to infectious agents, as reducing an individual's innate immunity may result in
an increased susceptibility to infectious disease.
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Chapter 8
Final Discussion and Summary
There are mounting environmental concerns about the global depletion in stratospheric
ozone which will lead to a corresponding increase in the quantity of UVR reaching the
surface of the earth. In addition, individuals are becoming exposed to increased
natural sunlight through foreign travel and to artificial UVR through the use of
sunbeds and phototherapy. It is therefore imperative to understand the biological
effects of such increased exposure.
Since the field of photoimmunology was created twenty years ago, a growing body of
evidence indicates that exposure of human subjects and experimental animals to UVB
irradiation can modify some immune responses. However, to date, investigations into
the impact of UVR on the susceptibility to infection are relatively few.
A series of events occurs when the skin is UV-irradiated. The first is absorption of the
radiation by a cutaneous chromophore, the most likely candidates being DNA and
trans-UCA. Various mediators are then implicated, including TNF-a, IL-10 and PGs.
The outcome is complex, with multiple cellular changes, both phenotypic and
functional.
Interest has centered on the role of keratinocytes in cutaneous immune responses. The
production of cytokines by keratinocytes is believed to be critical in determining the
local microenvironment, which in turn determines the type of immune response
elicited. The importance of the cutaneous microenvironment in terms of the immune
response elicited, has been highlighted in a recent paper (Kitagaki et al., 1997). It was
found that the local cytokines present at the time of antigen presentation to T cells in
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the elicitation phase of a CH response, altered the time-course of antigen-specific
hypersensitivity from a typical delayed-type to an immediate-early type response.
Chronic exposure to an antigen (ie. repeated elicitation), was found to alter the balance
of locally released cytokines, with a shift toward a predominant Th2 response, rather
than the characteristic Thl-type response associated with a classic CH response. It is
believed that this shift in response represents an evolutionary adaptation to reduce the
deleterious Thl response elicited in response to chronic antigenic challenge.
A single exposure, or several sub-erythemal exposures, prior to sensitisation results in
suppressed CH on subsequent challenge. However, exposure of sensitised mice to
sub-erythemal doses of UVB on four consecutive days prior to challenge was found to
result in an enhanced CH response in comparison to unirradiated mice (chapter 3).
With respect to alterations of CH responses, it is quite possible that the cutaneous
cytokine milieu induced by UVB exposure plays a key role in the magnitude of the
subsequent immune response induced. It may be that the type of APC involved will
affect the local cytokines produced by keratinocytes, infiltrating inflammatory cells and
T cells, and hence a particular microenvironment will be generated, be that suppressive
or enhancing. Another possibility is that the keratinocytes themselves act as APC
during the elicitation phase of the CH response, or that other novel APC, such as
dermal dendrocytes, are involved.
The effect of UVB exposure of mice prior to infection with MHV-68, a
gammaherpesvirus with no cutaneous involvement and which establishes a persistent
infection in the spleen, was examined (chapter 4). It was found that a sub-erythemal
dose of UVB caused suppression of the DTH response. This finding adds to the
accumulating evidence demonstrating the suppressive effects of UVB exposure on the
immune responses to infectious agents, which include not only epidermal pathogens
but also ones which cause systemic infections.
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A preliminary characterisation was carried out of the changes in cytokine expression
associated with HSV infection, both in vitro and in vivo (chapter 5). It was found that
HSV infection induced an upregulation of IL-10 mRNA expression both in a
keratinocyte cell line and in mouse skin. Since IL-10 is produced by Th2 cells and by
murine keratinocytes following appropriate stimulation and blocks activation of
cytokine synthesis by Thl cells, its production could result in a switch in the local
immune response from a protective Thl-type to a Th2 response. It is believed that
such viral-induced changes in the local immune microenvironment may be important in
aiding the infectivity of the virus and in evasion of the host immune response
sufficiently to allow latency to be established. The expression of IL-10 mRNA was
also enhanced following UVB exposure of keratinocytes, although no increase in
expression was seen following irradiation and HSV infection together, in the
preliminary in vitro study. Evidence obtained from murine studies in vitro and in vivo
shows that UVR may lead to the promotion of Th2 responses with anergy of Thl
responses (Araneo et al., 1989; Simon et al., 1991). It remains to be seen whether the
combination of these UVB and HSV-induced effects on local cytokine production can
explain the occurrence of HSV recrudescent lesions following exposure to sunlight.
Such a link between the UV-induced alteration in cytokine profile and clinical
symptoms is substantiated by experiments in which the cytokine production by LN
and spleen cells of mice were examined following intradermal infection with HSV-1
(Yasumoto et al., 1994). In mice exposed to UVB prior to infection, a marked
suppression of IFN-y synthesis was found, and an enhancement of IL-4 synthesis. An
associated increase in the severity of lesions compared with unirradiated control
animals was observed.
Animal models are essential in order to assess the effects of UVB exposure during
infections in vivo, since it would be unethical to carry out such experiments on
humans. However, some experiments, such as those described in chapters 6 and 7 of
this study, provide valuable evidence that similar UVB-induced immunosuppressive
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effects occur in humans as have been reported in mice. It was found that while a
standard course of broadband UVB phototherapy had no measurable effect on HSV-
specific T cell-mediated cytotoxicity, the NK cell activity was suppressed within the
first week of irradiation. In addition, both in vitro and in vivo irradiation of human EC
suppressed the alloreactive capacity of epidermal LC. Suppression of the APC
function of EC in the MSLR by UVB exposure has also been demonstrated in mice
and rats. These rodent models along with data obtained from human experiments have
been used to try to develop a quantitative risk assessment of lowered resistance to
infections in humans due to solar UVB exposure (Garssen et al., 1996). It has been
calculated that exposure to about 100 minutes of sunlight at noon in Italy or Spain
would suppress the human lymphoproliferative response to Listeria by 50%. The
same degree of suppression is predicted as a result of 88 minutes of exposure in
Queensland, Australia in the summer, (or 55 hours in Shetland in January!).
A recent publication revealed that the antarctic ozone hole covers a larger area and
begins to form much earlier in the year than was previously thought (Roscoe et al.,
1997). Such findings are important because they are thought to reflect the world-wide
situation and because ozone-poor air from the edge of the ozone hole regularly passes
over S.America, exposing populations to larger than normal doses of damaging UVR.
The questions which remain to be answered are whether UVB-inuuced reductions in
protective immune responses are likely to exacerbate disease processes, resulting in
more prolonged or more severe infections. The accumulating data from animal
models, such as those shown in Table 1.2, suggest that they will. However, there is
considerable redundancy in the immune system so, even if one particular parameter of
immunity is down-regulated by UV exposure, another may compensate without an
exacerbation of disease symptoms. Whether an individual's resistance to reinfection
will decrease or whether an increased frequency of reactivation will occur in the case
of persistent organisms, remain to be seen. Although preliminary data from the study
of the effects of UVB exposure on MHV-68 infection did not demonstrate any effect
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of irradiation on reactivation of latent virus, the knowledge that UVB can cause
recrudescence of HSV in human subjects suggests that further investigation of this
phenomenon should be carried out.
UVB-induced immunosuppression may prove to be particularly important with respect
to diseases such as tuberculosis, once considered to be under control in industrialised
countries. These diseases are rising in incidence and are becoming a major public
health problem, not only in developing nations, but also in industrialised countries
because of an increased prevelance of mycobacterial infections in AIDS patients,
immigration and the emergence of drug-resistant strains. Since DTH responses are
important in controlling such diseases, an increase in solar UVR could exacerbate this
problem. Historical treatment of tuberculosis patients using sun exposure often took
place in cold climates, with the patient covered, except for their face.
Immunosuppressive doses of UVB were not therefore thought to have been
encountered and the occasional successful treatment is thought to be due to the fresh
air and increased standard of patient care.
The implications of UVB-induced immunosuppression must also be considered with
respect to vaccination. If a particular immunisation strategy depends upon the
induction of a cell-mediated response, there is a risk that immunosuppression might
make the vaccine less effective. Current research on this subject is limited, but a
scenario where UV-induced suppression allows the immune response to develop a
specific unresponsiveness or tolerance to a particular pathogen rather than defend
against it, has potentially disastrous consequences. Ethical permission has recently
been obtained by a group in Utrecht, to carry out a study of the effects of sub-
erythemal doses of UVB on the subsequent administration of a sub-unit hepatitis B
vaccine to human subjects. The results of this study will provide valuable information
with which to begin to assess potential risks.
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The experiments described in this study, although fairly diverse in nature, all share the
common aim of elucidating the modulatory effects of UVR on immune responses, in
particular to viral infections. The animal models and human studies described have all
been carried out using sub-erythemal doses of UVB, indicating that the sunburn
response, usually thought of as a warning sign for the effects of sun exposure, comes
too late for the effects of UVB on the immune system. In addition, the potential for
protection from a tan seems to be minimal, with immunosuppression having been
reported in both dark-skinned Australian aborigines and in fair-skinned people of
Celtic descent. This may be because the photoreceptors for UVB, such as UCA are
found nearer to the surface of the skin than the melanin-producing cells. It is likely
that adaptation will take place in response to UVB exposure in the short-term, with
tanning and epidermal thickening responses, but also possibly at the evolutionary
level, if increased environmental UVR becomes a selection pressure. The ability of
sunscreens to protect against immunosuppression remains controversial. In addition
sunscreen use can result in changes in sun-exposure behaviour, as well as altering the
spectral distribution of UVR to which the skin is exposed, the consequences of which
remain unknown. Finally, it has been shown that human subjects and certain mouse
strains fall into the categories of UV-susceptible and UV-resistant as defined by
contact hypersensitivity following irradiation. Individuals with skin cancer are almost
always of the susceptible type. However, it is not known at the present time whether
the susceptibility/resistance division is applicable to the infectious diseases situation, as
well as to cutaneous oncogenesis.
The down-regulation of the immune system by UVB is likely to have an evolutionary
origin, in order to prevent a continuous immune response against UV-induced damage
to skin cells occurring. However, an evolutionary balancing act must exist so that the
down-regulation of the cutaneous immune system does not allow neoplasia or
infections to develop and progress undetected. It is of course important to appreciate
that UVR has many beneficial effects and that the effects of UV irradiation on the
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pathogenesis of disease can differ dramatically, depending on the infectious agent, its
route of entry into the host and the immune mechanisms involved in resistance to
infection. It is therefore difficult to generalise about the effects of UVB on infectious
disease and in particular, to extrapolate from animal models to disease processes in
humans. More information is therefore required to be able to assess the full impact of
increased solar UVB radiation on human health.
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EXPRESSION OF CYTOKINE mRNA IN HERPES
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While the sytemic immune responses generated in herpes simplex virus
(HSV) infections have been well documented, little is known about the cytokines
induced locally in the epidermis in response to the virus. These may be critical in
determining the outcome of the infection and the subsequent interaction of the virus
with the host during latency and recrudescence. A mouse keratinocyte cell line
(PAM-212) was infected with HSV type 1, and ears of C3H mice were intected
epidermallv after tape-stripping the dorsal surface. RNA was extracted at various
times thereafter from lysed cells or whole ear homogenates, and the mRNA of
various cytokines assayed by semi-quantitative reverse transcriptase-polymerase
chain reaction, with normalisation relative to (3-actin mRNA signals. In the cell line,
no change in the expression of IL-1 a mRNA was apparent up to 24 hours post¬
infection, by which time viral antigens could be detected by immunoperoxidase
staining. In contrast, an up-regulation in IL-10 mRNA expression was seen, starting
at 3 hours post-infection.
